Optimized data processing algorithms for biomarker discovery by LC-MS by Christin,
  
 University of Groningen
Optimized data processing algorithms for biomarker discovery by LC-MS
Christin
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2011
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Christin (2011). Optimized data processing algorithms for biomarker discovery by LC-MS. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Optimized Data Processing 
Algorithms for Biomarker 












Paranymphs:  Tejas P. Gandhi 





























The work described in this thesis was performed in the research group 
Analytical Biochemistry, Faculty of Mathematics and Natural Science, 
University of Groningen and within the graduate school GUIDE. The project 
was funded by the Netherlands Bioinformatics Center (BioRange 2.2.3).  
 
 
Cover art created using www.juliasets.dk/Julia.htm 
Printed by: Ridderprint Offsetdrukkerij B.V. 
RIJKSUNIVERSITEIT GRONINGEN 	  	  	  
Optimized Data Processing 
Algorithms for Biomarker 




ter verkrijging van het doctoraat in de 
Medische Wetenschappen 
aan de Rijksuniversiteit Groningen 
op gezag van de 
Rector Magnificus, dr. E. Sterken, 
in het openbaar te verdedigen op 
woensdag 11 mei 2011 










geboren op 15 augustus 1981 
te Tangerang, Indonesië 
Promotores:    Prof.dr. R.P.H. Bischoff 
     Prof.dr. A.G.J. van der Zee 
Prof.dr. A.K. Smilde 
 
Copromotores:    Dr. P.L. Horvatovich 
     Dr. H.C.J. Hoefsloot 
 
Beoordelingscommissie:   Prof.dr. E. T. Hankemeier 
     Prof.dr. O. Kohlbacher 
     Prof.dr. E.R. van den Heuvel 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
ISBN: 978-90-367-4914-5. 
ISBN (digital version): 978-90-367-4915-2 
v 
 
Table of Contents 
 
CHAPTER 1 GENERAL INTRODUCTION _____________________________ 1	  
1	   Data Processing Pipelines in LC-MS ....................................................... 3	  
1.1	   Data reduction ........................................................................................ 7	  
1.2	   Noise characterization, feature detection and extraction ....................... 8	  
1.3	   LC-MS Map Alignment ....................................................................... 12	  
1.3.1	   Mass calibration .................................................................................. 13	  
1.3.2	   Intensity normalization ...................................................................... 13	  
1.3.3	   Time alignment ................................................................................... 14	  
1.4	   Peak Matching ...................................................................................... 16	  
1.5	   Peptide and protein identification ........................................................ 16	  
2	   Statistical analysis and validation ......................................................... 19	  
2.1	   Coupling feature quantification with peptide and protein identity ..... 19	  
2.2	   Feature selection/transformation methods ........................................... 20	  
2.3	   Classification methods and statistical validation ................................. 21	  
3	   Conclusions ................................................................................................ 24	  
4 References ................................................................................................... 28	  
 
CHAPTER 2 AN OPTIMIZED TIME ALIGNMENT ALGORITHM FOR LC-MS 
DATA: CORRELATION OPTIMIZED WARPING USING COMPONENT 
DETECTION ALGORITHM-SELECTED MASS CHROMATOGRAMS ______ 41	  
1	   Introduction ................................................................................................ 43	  
2	   Theory .......................................................................................................... 45	  
2.1	   Conditions for proper time alignment using COW-CODA ................ 45	  
2.2	   Component Detection by CODA ......................................................... 45	  
2.3	   Combining COW and CODA (COW-CODA) .................................... 46	  
2.3.1	   Segmentation and search space ........................................................ 46	  
2.3.2	   Segment-wise mass chromatogram selection ................................. 46	  
2.3.3	   Form of the benefit function .............................................................. 48	  
2.4	   Choosing the reference chromatogram .................................................. 48	  
2.5	   Global evaluation of the time alignment quality .................................. 48	  
3	   Material and Methods .............................................................................. 49	  
3.1	   Chemicals .............................................................................................. 49	  
3.2	   Serum samples ...................................................................................... 49	  
3.2.1	   Cervical cancer patients (Dataset 1) ................................................. 49	  
Table	  of	  Contents	  
 
vi 
3.2.2	   Factorial design (Dataset 2) ............................................................... 49	  
3.3	   Urine samples (Dataset 3) .................................................................... 50	  
3.4	   Data Analysis ....................................................................................... 51	  
4	   Results and Discussion ............................................................................ 51	  
4.1	   Design of the study ............................................................................... 51	  
4.2	   Comparison between the COW-TIC and the COW-CODA  
 algorithm ............................................................................................... 52	  
4.2.1	   Evaluation based on added, known compounds ........................... 52	  
4.2.2	   Global evaluation of alignment quality ........................................... 55	  
4.3	   Effect of reference chromatograms ........................................................ 55	  
4.4	   Assessing the inherent variability of the datasets and the  
 required processing time ....................................................................... 57	  
5	   Conclusions ................................................................................................ 57	  
6	   References ................................................................................................... 60	  
 
CHAPTER 3 TIME ALIGNMENT ALGORITHMS BASED ON SELECTED MASS 
TRACES FOR COMPLEX LC-MS DATA .......................................................... 63	  
1	   Introduction ................................................................................................ 65	  
2	   Material and Methods .............................................................................. 66	  
2.1	   Computational Methods ....................................................................... 66	  
2.1.1	   Measuring the average quality of LC-MS mass traces .................. 67	  
2.1.2	   Mass Trace Selection for Time Alignment ...................................... 68	  
2.1.3	   Dynamic Time Warping combined with LCODA-Selected  
 Mass Traces (DTW-CODA) ............................................................... 69	  
2.1.4	   Parametric Time Warping combined with LCODA Selected  
 Mass Traces (PTW-CODA) ................................................................ 70	  
2.2	   Property of the Data Sets and Data Pre-Processing ............................ 71	  
2.2.1	   Serum Samples .................................................................................... 71	  
2.2.2	   Acid-precipitated Urine Data Set ..................................................... 72	  
2.3	   Data Pre-processing ............................................................................. 73	  
3	   Results ......................................................................................................... 73	  
3.1	   Importance of data preprocessing ......................................................... 73	  
3.2	   DTW-CODA and PTW-CODA .......................................................... 74	  
3.2.1	   Performance of DTW-CODA ............................................................ 74	  
3.2.2	   Performance of PTW-CODA ............................................................. 76	  
3.3	   Comparison of DTW, PTW and COW coupled with LCODA-selected 
Mass Traces .......................................................................................... 78	  
4	   Conclusions ................................................................................................ 82	  
Table	  of	  Contents	  
vii 
 
5	   References ................................................................................................... 86 
 
CHAPTER 4 A CRITICAL ASSESSMENT OF STATISTICAL METHODS FOR 
BIOMARKER DISCOVERY IN CLINICAL PROTEOMICS ................................... 89 
1	   Introduction ................................................................................................ 91	  
2	   Experimental Procedures ......................................................................... 93	  
2.1	   Dataset Design ..................................................................................... 93	  
2.2	   Biomarker discovery methods ............................................................... 94	  
2.2.1	   Univariate Tests ................................................................................... 94	  
2.2.2	   Semi-Multivariate - Nearest Shrunken Centroid ........................... 94	  
2.2.3	   Multivariate Support Vector Machine – Reduced  
 Features Elimination (SVM-RFE) ...................................................... 97	  
2.2.4	   Multivariate PCDA and PLSDA ....................................................... 97	  
2.3	   Evaluation criteria ................................................................................ 98	  
3	   Results and Discussion .......................................................................... 100	  
3.1	   Comparison of individual methods ..................................................... 100	  
3.1.1	   t-test and mww-test ........................................................................... 100	  
3.1.2	   NSC ..................................................................................................... 102	  
3.1.3	   SVM-RFE ............................................................................................ 103	  
3.1.4	   PCDA .................................................................................................. 104	  
3.1.5	   PLSDA ................................................................................................ 104	  
3.2	   Comparison between methods ............................................................ 105	  
4	   Conclusions .............................................................................................. 106	  
5	   References ................................................................................................. 108	  	  
CHAPTER 5 SUMMARY AND FUTURE PERSPECTIVES ............................. 111 
APPENDIX A SAMENVATTING EN TOEKOMSTPERSPECTIEF ..................... 115	  
APPENDIX B SUPPORTING INFORMATION CHAPTER 2 ............................. 119 
APPENDIX C SUPPORTING INFORMATION CHAPTER 3 ............................ 137 
APPENDIX D SUPPORTING INFORMATION CHAPTER 4 ............................ 149 
LIST OF PUBLICATIONS ................................................................................. 159 
ACKNOWLEDGMENT ..................................................................................... 161 
 




















Christin C, Bischoff R, Horvatovich P. Data processing pipelines for comprehensive profiling 





The recent widespread application of mass spectrometry to quantify and 
identify large numbers of compounds in biological matrices leads to an explosion of 
acquired data. The goal of these measurements is to explore the underlying molecular 
mechanism of disease, to identify compounds (biomarkers) strongly related to the stage 
of the disease, its onset or progression for diagnostic purposes, to identify novel drug 
targets, and to follow the efficiency of treatment. The dynamic behavior of multifactorial 
diseases requires a systems biology approach to find reliable biomarkers taking 
molecular regulatory mechanisms, compound flux and concentration changes into 
account 1. To explore robust changes in molecular systems related to disease, it is 
necessary to analyse a large number of samples from different biological entities, for 
example from different, clinically well-characterised patient groups. Generally 
biomarker research is based on complex biological samples containing a large number of 
diverse compounds such as proteins, peptides and metabolites.  
Liquid chromatography coupled to mass spectrometry (LC-MS) is one of the 
most widely used comprehensive profiling techniques to measure compounds in 
biological materials. A single comprehensive LC-MS analysis cannot cover all types of 
compounds in the samples. Instead, it measures one class of compounds such as 
metabolites, lipids and proteins, leading to biomarker discovery in this class of 
molecules. Even with a technique targeting one of the afore-mentioned classes of 
compounds, not all types of molecules can be measured due to ionization limitations of 
the electrospray interface. Another challenging problem is the wide dynamic 
concentration range of the compounds, which can reach 9-11 orders of magnitude in the 
case of body fluids such as blood 2, 3. From this wide dynamic concentration range, 
modern mass spectrometers are only able to cover 2-4 orders of magnitude. The gap 
between the existing and measurable dynamic concentration range can be either reduced 
by using comprehensive fractionation (4-6 orders of magnitude), multidimensional 
chromatography (up to 8 orders of magnitude) 4 or by targeting a specific subclass of 
compounds, e.g. by using an affinity enrichment step of a certain type of glycoproteins 
on a lectin column (up to 5-7 orders of magnitude) 5. One other challenging factor is that, 
although proteins and protein complexes are directly involved in the molecular 
processes of biological phenomena, it is their peptide constituents obtained after 
enzymatic cleavage that are actually measured since they are more suitable for liquid 
chromatography analysis and they have better ionization properties than intact proteins 
or protein complexes. The most widely used endopeptidases cut proteins at well-defined 
sequence positions, resulting in non-overlapping peptides mixtures, from which only a 
fraction of theoretical possible peptides are detected. In this peptide-centric approach 
also called as “bottom-up”, or “shotgun” strategy, the quantity of initial proteins are 
therefore determined indirectly based on few or more peptides, which lead to 
misleading quantification and identification in case of the presence of multiple highly 
homologous proteins having one or few peptides in common, proteins with multiple 
splice variants, proteins presenting different degrees of post-translation modifications 
(PTM) or in case of the presence of various truncated forms of the same protein 6, 7. 
Biomarker discovery requires close collaboration between medical 
researchers, analytical chemists and bioinformaticians in order to obtain the relevant 
molecular information related to different aspects of diseases 8, 9. This includes patient 
cohort selection, sampling of biological material, sample storage, sample preparation, 
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choice and optimization of LC-MS profiling platform, data analysis providing protein 
identifications, quantification, statistical analysis and experimental validation of the 
results. Several review articles describe the various techniques and steps of protein 
profiling for biomarker discovery in detail 9, 10. 
Bioinformatics plays an important role in this process as it has the goal to 
extract quantitative and qualitative information for a large number of compounds 
(proteins and metabolites) that are present in complex biological samples and to select 
the discriminatory compounds between predefined sample sets. Recent advances in 
sample preparation methods, in liquid chromatography and in mass spectrometry 
instrumentation resulted in a large diversity of acquired data. This results in a huge 
challenge for bioinformatics to provide reliable information extraction and knowledge 
generation approaches. The computational tools must evolve continuously to keep up 
with the different types of generated data. Besides direct information extraction and 
knowledge discovery from raw data, bioinformatics plays an important role in 
experimental design, quality assessment of the profiling platform, sampling methods, 
sample handling, storage and preparation methods, or quality control of data pre-
processing, statistical analysis and statistical validation. 
This chapter focuses on fundamental data processing and current challenges 
in supporting biomarker discovery research in proteomics for diagnosis and treatment 
follow-up using LC-MS of label-free, shotgun proteomics data, highlighting significant 
innovations in the bioinformatics field such as new algorithms, data integration, high 
throughput automatic data preprocessing solutions, quality control of different data 
processing modules and complete workflows, including assessment of the quality of 
sample preparation steps and LC-MS profiling platforms 9, 11-19. We will also investigate 
how insights from analytical chemistry contribute to parameter optimization leading to 
the development of novel bioinformatics applications that provide more accurate and 
reliable information extraction from the raw data. Alternative approaches based on 
differential labeling of samples with reagents having the same chemical but different 
stable isotope constitution have been covered in other reviews 20-27 and will not be treated 
here. This chapter limits the discussion further to biomarker discovery aiming to 
determine comprehensively the identity and the quantity of sample constituting proteins 
using analytical methods with low sample throughput. Biomarker validation using 
analytical methods with high sample throughput providing quantitative information on 
preselected list of proteins by using multiple reaction monitoring, antibody arrays and 
ELISA will not be covered here. Recommendations on analytical, clinical and informatics 
aspects of biomarker discovery and validation as well as their limitations were discussed 
recently in several reviews 28-34. 
1. DATA PROCESSING PIPELINES IN LC-MS 
LC-MS has become the major platform for analyzing samples in biomarker 
discovery research due to its relatively high throughput (60-90 min for analysis of one 
sample), sensitivity, selectivity and the coverage of many peptides and proteins 9, 35, 36. In 
label-free LC-MS experiments, proteins or produced tryptic peptides are not modified 
chemically and their isotope constitution is unchanged. Large numbers of samples are 
analyzed independently by LC-MS resulting in corresponding raw data files. The 




processing pipelines. This is followed by matching compound quantity and identity 
across several chromatograms, resulting in a matrix containing quantitative information 
about a large number of compounds in the different samples. In shotgun proteomics 
approach the target compounds are proteins, therefore methods are required to 
determine the original protein composition of samples and their quantities based on 
incomplete set of measured constituting peptides. Compounds discriminating between 
predefined classes of samples are obtained from this matrix using dedicated statistical 
analysis and validation pipelines. When a system biology approach is involved in the 
biomarker discovery process, it is necessary to couple the list of discriminating proteins 
to protein interaction (e.g. STRING, BIND) or pathway (e.g. KEGG) databases 21, 37 to 
elucidate the disease mechanism. Figure 1 shows the main parts of a generic proteomics 
pipeline for biomarker discovery. 
Most of the measured signals by LC-MS are not related to real compounds but 
are part of white noise, background ions or simply chemical noise. Different mass 
analyzers generate data of different structure due to differences in scanning speed, mass 
resolution, measured dynamic concentration range, changes in peak width and 
resolution across the m/z domain and varying mass accuracy 38. The most common mass 
analyzers applied in proteomics biomarker research are quadrupole, 3-dimensional 
quadrupole ion trap, 2-dimensional linear ion trap, time of flight, and Inductively-
Coupled Resonance (ICR) trap family of mass spectrometers such as Orbitrap and 
Fourier Transform Ion Cyclotron Resonance Mass Spectrometers (FTMS) 39. Besides mass 
spectrometers may dispose different numbers of mass analysers, and could use different 
ionisation method such as electrospray, ionspray, matrix-assisted laser desorption 
ionization (MALDI) to name the most frequently used methods to analyze proteomics 
samples.  
In label-free LC-MS proteomics experiments, there are two types of widely 
used mass spectrometry data. The first data contain mass spectra obtained with one 
mass analyzer and is referred as single-stage mass spectrometry data (MS-1) in the 
literature. The second type of data is heterogeneous and contains cyclic series of MS-1 
and precursor ion fragmented spectra (MS/MS). Each cycle begin with MS-1 spectra, 
then it is followed by defined number (generally 1-10) of MS/MS spectra obtained from 
the most abundant ions of the MS-1 spectra. This acquisition mode is referred as data-
dependent acquisition (DDA) and abbreviated as DDA MS/MS data. The reader is 
referred to dedicated books 38, 40, 41 and reviews 39, 42, 43 for further reading on the main 
characteristics of different types of mass analyzers, ionization methods and acquisition 
modes. Label-free quantification is a semi-quantitative method and provides 
information on relative quantity changes of the same compounds in different samples. 
For most applications such as biomarker discovery, detection of relative protein changes 
is sufficient information, but in system biology type of studies, the use of stable isotope 
labeled standard is necessary to provide absolute quantities of proteins in samples 44. 
Quantitative information can be obtained from both MS-1 and DDA MS/MS 
data. Quantitative methods using DDA MS/MS are based on spectral counting, and use 
the number of MS/MS spectra that are acquired per peptide ion(s) for the quantification 
of a given protein. Abundant proteins generate abundant peptide fragments that have a 
higher probability to be selected as precursor ions for DDA MS/MS analysis. 
Nevertheless, despite spectral counts shows good linearity with analysed protein 
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amounts 45, 46, the number of MS/MS spectra per protein suffer from saturation effect, 
undersampling, and from the limited linear concentration range - compared to MS-1 
quantification methods 47. 
 
 
Figure 1. Main modules of a generic biomarker data processing workflow. Raw data from the mass 
spectrometer are converted to one of the standard data formats such as mzXML, mzData or mzML. 
Quantitative information and identification of proteins and peptides are performed separately from 
the same file or from a different data file. This is followed by labeling of the quantitative 
information with identifications. The statistical analysis and validation is performed on the labeled 
quantitative data and provides a list of discriminatory proteins that can be used for knowledge 
discovery with pathway analysis tools using for example KEGG (http://www.genome.jp/kegg/) 
or the Pathway Interaction Database (http://pid.nci.nih.gov/). 
 
Spectral counting methods enable both absolute and relative quantification of 
proteins. Several bioinformatics methods use the spectral counting approach 46, 48-50. 
Exponentially Modified Protein Abundance Index (emPAI) 51, 52 uses the number of 
identified peptides to calculate the relative molar or weight fraction of a given protein in 
the respective sample. Absolute Protein Expression (APEX) 53, 54 uses the measured and 
predicted peptide counts for quantification of peptides and proteins by considering the 
influence of the recovery of peptides from the cation-exchange and reversed-phase LC 
dimensions as well as the predicted ionization efficiency of the peptide in the ion source 
of a particular mass spectrometer. Recently a new method, which combines the 
quantification of MS-1 and MS/MS spectra by taking into account the ion count in MS-1 
of the three most abundant peptides provides better quantification for proteins than 
spectral counting and gives the absolute protein quantity by using a single protein 




identified peptides and proteins 56, therefore more precise quantification providing a 
larger dynamic concentration range than spectral counting can be obtained using 
peptide ion counts in MS-1 data. Recently, a modified version of the MS/MS acquisition 
strategy called directed MS was introduced with modern high resolution Q-TOF and 
Orbitrap instruments. Directed MS differ from DDA MS/MS by using a different 
strategy to select precursor ions for fragmentation. Instead of using the most abundant 
signal intensity for the precursor ion selection, it performs first an MS-1 analysis and 
obtains an inclusion list of precursor ions with retention time window after data 
processing. The second MS/MS analysis is performed on precursors, which are present 
in the inclusion list obtained previously. This method prevents multiple reanalysis of the 
same peptide, allows identification of low abundant components and peptides with 
interesting features such as distinctive isotopic pattern, mass defect or differently 
modified peptides 44, 57. 
Multiple Reaction Monitoring (MRM) is gaining popularity in targeted 
quantitative analysis for small proteomes and has the advantage to cover a large 
dynamic concentration range across 5 orders of magnitude 58-60. MRM has relatively high 
sample throughput (30-60 min for analysis for one sample), is able to measure few 
hundreds of proteins in one experiment and requires to monitor 5 peptides per protein 
selected with the help of PeptideAtlas 61 or with prediction using bioinformatics tools 
such as PeptideSieve 62. Monitoring of each proteolytic peptide requires at least 3 
optimized MRM transitions selected with use of a spectral library 63, 64. However 
experimental validation of the MRM transitions and their selectivity for a given problem 
is required to conduct reliable analysis, which can be performed by synthesis and 
analysis of synthetic peptide standards. Synthetic, stable isotope labeled peptide 
standards may be used for absolute quantification. Due to their wide dynamic 
concentration range, MRM-based methods can be successfully applied for validation of 
multiple biomarker candidates 65, 66. A recent perspective paper describes and compares 
the DDA MS/MS, directed MS and MRM based proteomics analysis strategies 
facilitating the methodological choice for experimental researcher 44. 
The large variety of raw data formats from different mass spectrometer 
vendors was recently standardized using several alternatives of Extensible Markup 
Language (XML) formats. Widely used formats are mzXML 67 (developed at the Institute 
for Systems Biology in Seattle Proteome Center) and mzData 68 (developed by the 
Human Proteome Organization Proteomics Standard Initiative or HUPO PSI). These two 
formats were lately merged by the HUPO-PSI 69, 70 into a new standard called mzML 71. 
Several standardization attempts were made recently, mainly by HUPO-PSI, to 
standardize other types of proteomics data formats such as peak list, however these 
formats are less widely used by the proteomics community 72-74. It is necessary for a data 
processing algorithm to accommodate these standardized raw data formats as the initial 
input of their pipeline. The standardization is not only necessary for raw data storage, 
but also to store intermediate results in order to enable data exchange and reusability of 
the results from each step in different data processing pipelines. 
Label-free LC-MS data pre-processing pipelines convert the raw data into a 
matrix containing quantitative information on the characterized and preferably 
identified compounds in each of the samples amenable for statistical analysis. The main 
modules of such pipelines with the data flow during this conversion is presented in 
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Figure 2. This procedure begins with raw data pre-filtering (such as noise reduction, 
data reduction etc.), and is followed by detection and quantification of peaks, and results 
in peak lists characterized among other things by quantity, retention time and m/z 
value. These peak lists can be further reduced by deisotoping and summing up the 
intensity of compound-derived ions with different charge states. However, these steps 
can be also performed after the peaks have been matched across multiple 
chromatograms. Peptide-related peaks in different chromatograms have to be aligned or 
corrected in all three dimensions of MS-1 data: time alignment in the retention time 
dimension, mass calibration in the m/z dimension and normalization in the intensity 
dimension. The final step is peak matching, which has the goal to find the same peaks in 
multiple chromatograms and to provide the quantitative peak matrix characterized by 
m/z and retention time values.  
Data processing pipeline should be flexible enough to adapt to the 
characteristics of the data sets that are dependent on pre-analytical factors, the type of 
mass spectrometer and experimental design of the sample preparation and sample-
profiling platform. Many data processing applications and workflows consisting of 
multiple modules, which are interconnected by input and output parameters and data, 
are available free of charge or commercially. Work has been dedicated to construct 
optimized data analysis pipelines for label-free LC-MS 27, 48, such as Viper 75, OpenMS 76-
79, mzMine 80, 81, XPRESS 82, SIEVE, Superhirn 83, Census 84, MapQuant 85, MaxQuant86, 
SpecArray 87, MsMetrix 88, PEPPeR 89 or XCMS 90 originally developed for metabolomics 
but also applicable to analyse proteomics data. 
 
1.1 Data reduction 
MS-1 data is three dimensional in nature with retention time, m/z and ion 
count dimensions. This information is generally stored with succeeding mass spectra 
storing information in mass – intensity pairs. This raw data is often converted into a 
two-dimensional regular matrix, with a procedure called meshing, resulting in an 
intensity matrix, where the columns and rows correspond to a given mass and retention 
time. Two types of raw mass spectrometry files are provided by the mass spectrometers. 
Profile data contains all acquired data points, and centroid data is pre-processed by the 
acquisition software generally with algorithms operating on single MS spectra. Storing 
data in centroid mode may result in loss of information for certain data processing 
algorithms, which perform peak detection in both dimensions, but reduces considerably 
the size of the acquired data. Data processing algorithms, especially those that are 
written in interpreted, complex high-level programming language such as R or Matlab, 
generally load all data into the computer memory and are thus limited by the available 
memory. These algorithms apply data reduction to fit the amount of data to the 
available memory. This is most frequently done by binning 18, 80, 90 which sums intensities 
between predefined consecutive and disjoint mass domains. This works well when most 
of the data points of the Gaussian peaks are within the mass borders of the bin, but leads 
to fluctuating “saw tooth” type splitting of the peak for centroid data when the bin 
borders fall in the fluctuation domain of the peak maxima along the consecutive m/z 




smoothens fluctuations in both retention time and mass dimensions out thus avoiding 
the “saw tooth” splitting of peaks (for details see Figure 3).  
Other approaches to reduce the intensity fluctuation of binning were reported 
recently, however each of them are computationally intensive and results in varying bin 
widths 91-93. The quality of the LC-MS data determines the accuracy of feature detection 
and quantification. Choosing between binning or 2-dimensional Gaussian smoothing of 
the data has a dramatic effect on quantification when data reduction is applied. Data 
processing pipelines using programming languages with the possibility to allow user-
defined memory management is advised as is the use of streaming to overcome memory 
limitations in the case of profile data at their original resolution. Streaming is a 
programming technique which reads and processes only part of the data in one time, 
and after processing, the results of each parts is written to a continuously growing file. 
Streaming allows to process large files independently of the available amount of RAM. 
Data reduction should be avoided if possible due to information loss. 
 
1.2 Noise characterization, feature detection and extraction 
A chemical compound with a given charge and isotope distribution is 
represented as a three-dimensional Gaussian peak in MS-1 and is often denominated as 
‘feature’ in the data processing world. Due to the natural isotope distribution and to the 
occurrence of multiple charge states, one chemical compound results in multiple 
Gaussian peaks with the same retention time. These features must, at the first level, be 
discriminated from noise to determine their main characteristics such as quantity 
represented by the peak volume, area or height, retention time and mass to charge ratio 
of the center of the peaks, as well as the extension of the Gaussian peaks in the m/z and 
retention time dimensions. The second level is the extraction of compound 
characteristics related to charge state determination and the identification of isotope 
peak clusters. First level feature characteristics are obtained by all data processing 
pipelines while extraction of second level characteristics is optional and can be 
performed at a later stage after matching the same feature of the same compounds in 
multiple chromatograms. If low resolution mass spectrometry data or considerable data 
reduction in the mass dimension are used for high-resolution mass spectrometry data, 
isotope peaks may collapse into a single Gaussian peak or into series of strongly 
overlapping Gaussian peaks. In this type of data, peak detection algorithms will detect 






Figure 2. Main modules of quantitative data processing pipelines. Raw data in standard format 
(mzXML, mzdata.xml or mzML) may be recalibrated for increased mass accuracy and converted to 
a resampled matrix, where intensity values are in the matrix, rows (or columns) correspond to m/z 
and columns (or rows) to retention time values (exact values are stored in separate vectors). This 
matrix may be optionally subjected to data reduction and noise filtering. The obtained data matrix 
is subjected to peak picking (ellipse in green) and peak quantification providing a peak list 
containing the most important characteristics of the identified peaks, usually retention time and 
m/z values of the peak centroid, peak quantity expressed in peak height, area or volume, and 
optionally peak extension in the m/z and retention time dimensions, as well as charge state and an 
index that is used to couple peaks of the same isotope cluster or different charge states of the 
isotope clusters to the same compound. Alignment in the three available dimensions (time 
alignment, mass calibration and intensity normalization) can be performed either at the peak list or 
at the raw data file level (ellipses in orange). The aligned and normalized peak lists of different 
samples are then matched (ellipse in purple), resulting in a quantitative peak matrix containing 
information about the matched peaks in different samples, where columns (or rows) correspond to 
different samples and rows (or columns) to different peaks, which are later coupled to identities at 
the peptide and protein level. This quantitative peak matrix is used for statistical analysis to 
identify discriminating peaks between predefined classes of samples. The figure indicates the two 
most common data flows with the order of modules using blue and red arrows. Dashed arrows 
indicate optional linkage of modules. Another order of the modules and data flows is possible as 






Figure 3. Raw centroided ion trap MS-1 LC-MS image of depleted, trypsin-digested human serum 
obtained after binning (summing up intensities across 1 amu intervals having borders at fractional 
decimal of 0.5 m/z for each integer m/z value), (a) and after applying a two-dimensional Gaussian 
filter using the same degree of data reduction in the m/z dimension as for binning (b). Binning 
results in noisy data, which leads to a poor feature detection and quantification efficiency, in 
contrast to the data obtained after Gaussian smoothing. Peak detection becomes extremely difficult 
in case of fluctuating peak maxima in between mass spectra in two adjacent bins, (c) as represented 
in a part of an LC-MS image highlighting a peak with extracted ion chromatograms, where the 
highest intensity of the peak in centroid data fluctuates between the border of the bins. This 
fluctuation results in a saw tooth peak shape in adjacent extracted ion chromatograms, which will 
lead to poor performance in case of use of feature detection algorithms recognizing Gaussian peak 
shapes in individual mass traces. 
 
Noise characterization is important and can be regarded as a part of the peak 
detection step, which tries to discriminate noise from compound-related features signal. 
Noise in LC-MS data originates from different sources 94-96. To discriminate noise from 
features, it is useful to take the noise model of the different mass analyzers into account 
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in the peak detection algorithm 97. Mass analysers and detectors define the background 
white noise. Another type of noise of chemical origin is called chemical noise. Chemical 
noise originates from molecule clusters formed during electrospray ionization (e.g. 
solvent clusters), from chemical contaminations inside the mass spectrometer (e.g. in the 
ion source), from the chromatographic column or from the ambient air such as 
polydimethylcyclosiloxanes, phthalate or the plasticizers di-n-butyl-phthalate and (di-(2-
ethylhexyl)-adipate) 9, 98. Ion suppression effect 99 distorts the compound-related signals 
and is dependent on sample composition and therefore on the upstream sample 
preparation steps. Formation of eluent ion clusters during electrospray ionization and 
elution of contaminants from the chromatographic columns are highly influenced by the 
water/acetonitrile ratio of the eluent, which changes gradually during reverse-phase 
LC-MS. This results in varying chemical background noise in both the retention time 
and m/z dimensions. Contaminants in the LC eluent or in the ambient air result in 
stripes of constant m/z across a large part of the retention time axis. 
Numerous denoising and baseline (average noise level) subtraction 
algorithms exist in the literature, such as moving average 18, 100, Savitzky-Golay filters 101 
or entropy-based noise reduction 102 to name a few examples. As these algorithms will 
not be covered in this review, the reader is referred to reviews and publications on this 
topic 103-108. It is important to choose baseline removal and denoising algorithms, which 
do not alter the quantitative information of the peaks. Many feature detection algorithms 
were developed to discriminate compound-related peaks from noise since the 
introduction of LC-MS. These algorithms either match the isotope pattern of compounds 
in the m/z dimension (1D peak picking) or the peak shape based on extracted ion 
chromatograms (2D peak picking) or on the full 3-dimensional LC-MS data (3D peak 
picking) to detect Gaussian-shaped peaks. Algorithms that match isotope patterns have 
the disadvantage that they do not use the full 3-dimensional structure of MS-1 data, but 
apply peak detection on individual MS spectra, which are subject to a high noise 
content. VIPER 75, SpecArray 87 and SuperHirn 83 are examples of data processing 
workflows using peak picking algorithms based on isotope pattern matching. Examples 
of 2D peak matching algorithms based on extracted ion chromatograms are the M-N rule 
18, and the Matched Filtration with Experimental Noise Determination (MEND) 
algorithms 105. M-N rules detect an LC-MS feature in extracted ion chromatograms when 
the intensity exceeds the local baseline N times for M consecutive points. MEND 
matches Gaussian peak profiles on noise defiltered extracted ion chromatograms. 
Another example for a 2D peak-shape matching algorithm is based on wavelet 
decomposition developed by Coppadona et al. 106, 107 to remove noise and define the 
baseline of extracted ion chromatograms. Finally the algorithm uses the difference of 
baseline and denoised data to detect peaks. Another group of peak detection methods 
use modified versions of the binning algorithms adapting the bin size to the peak width 
in mass dimension. These type of algorithms detect peaks in several ways. The first is by 
locating regions in centroid data with large amount of missing noise in mass dimensions 
and having high intensity signal with close mass value in consecutive retention time 
points 93. Another way of peak detection is by using Kalman filter to extract Pure Ion 
Chromatograms containing only information on peaks without noise 92. Other 
alternative is by detecting peaks containing regions based on analysis of mass variation 




continuous wavelet transformation and optionally Gauss-fitting in the chromatographic 
domain as implemented in the centWave method 91. Three-dimensional peak detection 
methods using shape matching are applied in MapQuant 85, which fits a 3-dimensional 
Gaussian curve on local maxima. The apLCMS pipeline 104 uses a two-dimensional 
density kernel function to identify groups of peaks, while MZmine 80, 81, msInspect 109 and 
LCMS-2D 108 use peak shape in the retention time dimension and the isotopic pattern in 
the m/z dimension. OpenMS 76-79 uses a three-dimensional wavelet function taking the 
average of the peptide isotope composition into account by constructing a mixture 
Gaussian model. There are many other peak detection methods and the reader is 
directed to a recent review on this topic 110.  
To compare the performance of different peak quantification algorithms, the 
peak picking methods of msInspect and mzMine was compared by analyzing a tryptic 
digest of a mixture of 48 recombinant proteins resulting in ~800 peptides by FTMS in 
MS-1 and MS/MS mode with the help of a Receiver Operating Characteristics (ROC) 
curve. The comparison showed that the isotope pattern matching algorithm of msInspect 
was superior in performance to mzMine using predefined peak shape template for peak 
detection 110. Peak tailing or fronting and saturation of the detector lead to peak splitting 
for some features. The occurrence of peak splitting depends on the peak detection 
method and should be evaluated for each algorithm using different types of data. 
Algorithm developed by Groot et al. 111 uses K-mean clustering to correct for split peaks 
and to correct peaks that were incorrectly aligned in the retention time dimension. Other 
quality control criteria applicable only to high resolution data such as Orbitrap and 
FTMS uses mass deviance to assess if a detected compound correspond to real peptides 
112. Mass deviance is the difference of the decimal fraction of the monoisotopic peak of 
the detected compound and the nearest theoretical tryptic peptide. Overlaying on a part 
of a 2 or 3 dimensional MS-1 raw or pre-processed data with the location and extent of 
detected features as it is possible in OpenMS framework enables to assess visually the 
accuracy of peak picking method 76, 78, 79. 
 
1.3 LC-MS Map Alignment 
Three-dimensional MS-1 LC-MS chromatograms are prone to nonlinear shifts 
in all of the three dimensions. In the mass dimension, alignment is based on proper 
calibration of the mass analyzer preferably with internal standards. In the intensity 
dimension, normalization may be used, and in the retention time dimension time 
alignment is necessary. Mass calibration should provide alignment to the exact mass. 
Intensity normalisation could be relative to compare relative intensity of the peptides 
and proteins, but may provide exact alignment if absolute quantification is required. 
Retention time alignment is relative, in spite of the fact that retention time indices may 
be used for identification 113. After successful alignment of all LC-MS chromatograms 
common peaks in different chromatograms are matched and their relative or absolute 
quantities are reported in form of a matrix that is amenable to statistical analysis. In this 
matrix, rows (or columns) correspond to samples and columns (or rows) to features or 
peptide peak identities. Alignment of LC-MS images can be performed with different 
goals in mind depending on the experimental design, such as to transfer peak identity 
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information from separate MS/MS data sets to MS-1, or to combine data from several 
chromatograms corresponding to the fractions of a 2D-LC-MS analysis of a single 
sample. 
 
1.3.1 Mass calibration 
The m/z dimension is the most stable dimension toward shifts. The absence 
of shifts does, however, not mean that the measured values are accurate. This requires 
calibration of the mass spectrometer, preferably with internal standards that are present 
in each spectrum. Mass analyzers are, however, measuring instruments that are prone to 
small nonlinear shifts requiring automated algorithms to compensate for inaccurate 
mass calibration or to enhance mass accuracy, especially for high resolution mass 
spectrometers. Ions of chemical background noise originating from eluents or from the 
ambient air such as polysiloxanes or continuously added calibration standards can be 
used for mass calibration and to increase mass accuracy. A polynomial mass calibration 
function was used by Scheltema et al. 114 to increase mass accuracy of metabolites 
measured with an Orbitrap mass spectrometer. The algorithm improved mass accuracy 
from 1-2 ppm to 0.21 ppm using background ions, such as polysiloxanes, as internal 
standards. Haas et al. 115 used polydimethylcyclosiloxanes to enhance mass accuracy of 
MS/MS spectra and reported a higher identification rate of peptides. Another strategy 
involves the use of already identified peptides as calibration standards, a strategy that 
was successfully applied to improve peptide identification based on MS/MS spectra 116. 
An interesting approach developed by Dijkstra et al. 117 superimposes isotope clusters of 
the same peptide at different charge states in SELDI-TOF-MS spectra to improve mass 
accuracy. This approach can be easily adapted to spectra obtained with other 
instruments and electrospray ionization, as multiple charging of peptides is a common 
phenomenon. 
 
1.3.2 Intensity normalization 
High throughput LC-MS data come with nonlinear and systematic bias in 
recorded peptide ion intensity, affected mostly by differences in injected sample amount, 
differences or drifts in ionization efficiency, differences in ion transmission efficiency or 
detector saturation, and carryover between LC runs. The resulting bias should be 
corrected in order to enhance statistical classification accuracy. Systematic bias due to a 
difference in injected sample amount should be minimized, e.g. by determining the 
injected amount with a total protein assay or by taking the area under the curve of the 
UV trace of a previous analysis into account. Sometimes normalization can be based on a 
single factor such as the average or median abundance of peptides derived from so-
called ‘housekeeping proteins’ or other compounds that are known not to be affected by 
the investigated disease or sample dilution factor, such as creatinin in urine samples 118. 
However, all intensity normalization approaches have drawbacks, e.g. normalization 
based on housekeeping proteins should not be applied for samples changing in 
constitution of these proteins considerably. Remaining nonlinear bias can be removed 
using normalization methods applied in microarray analysis, 119 e.g. by performing a 




composition. Various normalization methods were developed and assessed for label-free 
quantification using LC-MS 101, 103, 120-122. Linear regression can be applied to a bias that 
has a linear pattern across analyses such as sample carryover in the trapping column. 
Nonlinear bias caused e.g. by detector saturation can be resolved by non-linear or local 
regression techniques, and quantile normalization may be used to transform peptide 
quantity distribution of all samples to the same distribution using quantile plots. 
Callister et al. 121 compared different normalization methods using LC-FTICR-MS data 
sets and concluded that global or linear regression worked best in most cases when 
applied iteratively. A recent study by Kultima et al. 120 compared 10 different 
normalization methods using data sets from mouse, rat and quail that were analyzed by 
a nano-LC-MS system coupled either to a Q-TOF or an LTQ mass spectrometer. 
Karpievitch et al. 122 developed a normalization method based on singular value 
decomposition to remove systematic and nonlinear bias to avoid over fitting by 
dimension reduction for label-free LC-MS proteomics samples. In general, normalization 
algorithms use matched peak matrices. Therefore normalization procedures are 
implemented after peak matching and prior to the statistical analysis. 
 
1.3.3 Time alignment 
The retention time of compounds is subjected to considerable non-linear shifts 
between LC-MS experiments and requires particular attention and more sophisticated 
alignment algorithms than the two other domains. Complex proteomics samples, such 
as body fluids like serum and urine, contain several tens of thousands of peptides, so 
that even small retention time shifts may result in serious peak mismatching, if peak 
matching is only based on the retention time and m/z coordinates across multiple 
samples. Retention time shifts are due to parameters of liquid chromatography that are 
hard to control, such as small changes in eluent composition, pH, column ageing or 
temperature changes and have a highly non-linear behavior, especially when the 
combination of a trapping and separating column system is used. Accurate algorithms to 
correct retention time shifts is one of the most critical points of data processing to 
provide accurately matched peaks and quantitative data that are suitable for statistical 
analysis. 
The goal of time alignment is to find the greatest overlap between the same 
peaks in different chromatograms and to provide a retention time transformation 
function, which can be used either to change the retention times of all peaks in a peak 
list, or to change the associated retention time of mass scans in the raw data. The major 
difference between time alignments methods using MS-1 data is how many data 
dimensions they use in their benefit function to drive the time alignment procedure. 
Earlier developments considered only 1-dimensional data next to the retention time 
dimension in their benefit function (e.g. the TIC or BPC) 123-131. Recent algorithms use 
two-dimensional profiles that take the separation of compounds in the mass and the 
retention time dimension into account. The latter approaches provide more accurate 
time alignment of highly complex LC-MS ‘omics’ data. Two-dimensional alignment 
algorithms differ in terms of whether they use the raw data, pre-processed data obtained 
after noise filtering and data reduction 95, 96, 101, 127, 128, 132-134 or peak lists after the peak 
detection step 77, 97, 135. 
General	  Introduction	  
 15 
A large number of algorithms were developed to define the optimal search 
space for non-linear retention time correction, such as Correlation Optimized Warping 96, 
97, 123, 127, 129, 130, 136, Parametric Time Warping 95, 125, Dynamic Time Warping 95, 101, 126, 128, 130-134, 137, 
a geometric approach based on pose clustering 77, 138, Loess regression on matched 
compound pairs 135, the Continuous Profile Model combined with a Hidden Markov 
Model 139 to list a few. Time alignment based on DDA MS/MS data use the correlation 
between MS/MS information of the same compound 89, 140. Other types of algorithms 
create retention time and mass tags by normalization of retention time and accurate 
mass. These tags are subsequently used to align multiple LC-MS data sets in both the 
m/z and retention time dimensions or through comparison with a database 137. 
Generally time alignment is performed by selecting one chromatogram as 
reference and aligning all others to that reference pair wise. This approach requires the a 
priori selection of a reference chromatogram and must assess how selecting different 
reference chromatograms affects the quality of time alignment. Robust time alignment 
methods should not depend on the choice of the reference chromatogram 95, 96. The 
Continuous Profile Model developed by Listgarten et al. 139 does not use a reference 
chromatogram, but performs the alignment of all chromatograms in one step. The 
performance of different time alignment algorithms depends on many parameters, such 
as the number of common peaks shared between chromatograms, the complexity of the 
samples, the compound distribution in retention time – m/z space, the compound 
concentration variability and noise distribution. A comparison of different algorithms 
with different characteristics shows that time alignment methods that take the three-
dimensional nature of MS-1 data into account perform better for complex proteomics 
samples with large compound concentration variability 95-97. 
In most studies the same chromatographic columns and strict standard 
operating procedures are applied in order to lower analytical variability. It is rare that 
the elution order of compounds changes under these conditions and a monotonic time 
alignment function is appropriate 141. However the elution order may change during 
extensive studies over a long period of time or when different types of columns are used 
(e.g. when using different types of n-octadecyl bonded silica reverse phase stationary 
phases) 142. It is also known that the pH of the eluent has a dramatic influence on the 
selectivity of reverse phase (RP) columns 143, 144, and this can lead to a changing elution 
order when analysing complex proteomics samples. Inversion of the elution order of 
peptides or metabolites is not commonly reported and thus probably not recognized. It 
is important in the future to explore this phenomenon in greater detail, especially when 
different types of LC RP-C18 columns are used within one study or when large-scale 
studies are performed in different laboratories. If changes in peak elution order were 
frequently observed, this would require novel time alignment algorithms, which can 
adequately with peak elution order changes. For further reading on time alignment, the 
reader is referred to specialized reviews 141, 145 and articles presenting results from 
performance comparisons of different time alignment methods 95, 130, 138. 
The quality of time alignment is generally evaluated by visualization of the 
entire chromatogram, or by visualization of common peaks to assess the local time 
alignment accuracy. Co-injected standard peptides or peptides derived from highly 
abundant housekeeping proteins can also be used for this purpose. Comparing the 




visualization of entire chromatograms does not always allow a proper quality control of 
the time alignment results. A quality assessment method based on the sum of the 
overlapping peak area between pairs of chromatograms provides a global readout of 
alignment quality and permits comparison of the relative performance of various types 
of algorithms 95, 96. A Similarity score calculated after time alignment beside for assessing 
the quality of time alignment, may also be used to assess eventual bias in experimental 
design and to detect whether there is a systematic difference between sample replicates 
or injection order 146. 
 
1.4 Peak Matching 
The peak matching process identifies common peaks in different 
chromatograms either based on proximity of aligned retention time and mass or peptide 
identity based on MS/MS data when this information is linked to the peak list. 
Numerous clustering algorithms have been applied to match peaks such as K-mean, 
hierarchical or pose clustering 103, 145, 147. The procedure provides a list of clusters of the 
same compounds in different chromatograms, from which a quantitative feature matrix 
is constructed. The matrix contains a quantitative measure of the feature and rows (or 
columns) that correspond to the samples and columns (or rows) to the features (e.g. 
peptide ions) characterized by retention time and m/z value. Features in this matrix can 
be further processed by deisotoping and by integration of different charge states of the 
same compound resulting in a quantitative peptide matrix, which further may be 
combined with identification results. Deisotoping and decharging can also be performed 
at peak list level prior to the peak matching procedure. MS-1 data processing pipelines 
must assign a quantitative value to peaks that do not have a correspondence in all 
chromatograms. Some pipelines extract noise at the corresponding location, while others 
filter out peaks found only in a minority of samples to avoid bias for single and rare 
events in the subsequent statistical analysis. 
 
1.5 Peptide and protein identification 
Peptide and protein identifications are generally performed using information 
from MS/MS spectra. Before identification, MS/MS spectra are filtered to remove noise 
and the cleaned spectra are used for the identification process. The most widely used 
protein identification approach is database search, where lists of peaks in MS/MS 
spectra are compared with molecule fragments obtained by in-silico fragmentation of 
sequences stored in the database 148-150. This comparison may be performed by 
calculating a similarity score between the in-silico fragments and the measured 
fragments, and the peptide with the best match receives the highest score. A threshold is 
used to limit the number of false positive identifications while at the same time avoiding 
to penalize true positives. It is thus noteworthy that so-called identified peptides and 
proteins always contain a chance that they are false positives. This matching approach is 
used by the Sequest algorithm 151. Interpretative models use the assumption that MS/MS 
spectra consist of a continuous series of fragment ions that can be interpreted as a partial 
short amino acid sequence tag of the intact peptide. PeptideSearch 152, MS-Seq 153 and 
GutenTag 154 use this strategy. Stochastic model-based algorithms use probability 
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estimates for peptide fragmentation and subsequent predictions of the resulting mass 
spectra that are compared with the measured MS/MS spectra. SCOPE 155 and Olav 156 
(the basis of the Phenyx search engine) are examples of this category. Finally programs 
such as Mascot 157 and the open source OMSSA 158 apply statistical and probabilistic 
models using empirically generated ion probabilities of peptide sequences stored in the 
database. Spectral library search algorithms represent another category of peptide 
identification algorithms. These algorithms compare noise-filtered MS/MS spectra with 
databases containing high quality, experimental MS/MS spectra using similarity scores 
159, 160. Clustering MS/MS spectra of the same peptide can enhance the probability for 
successful peptide and protein identifications significantly while at the same time 
decreasing the number of spectra that are sent for database search by one order of 
magnitude 161. Database search and spectral library search algorithms have limited 
capability to identify peptides with PTMs, since the peptide with a given PTM should be 
either present in the database or must be defined by the user prior to the search. Open 
modification search programs such as Popitam 162 and Inspect 163 use MS/MS spectra of 
already identified peptides and allow unexpected mass shifts in the fragmentation 
pattern of the peptides due to PTMs. Open modification search algorithms are, however, 
computationally more intensive than database search algorithms and therefore they 
generally use a limited number of peptide sequences for identification. De novo 
sequencing algorithms such as PEAKS 164, 165, PepNovo 166, EigenMS167, Lutefisk 168, 
Sherenga 169, MSNovo 170, PILOT 171, NovoHMM 172, and AUDENS 173 use only 
information from the experimentally acquired MS/MS spectra and basic constants such 
as the mass of the amino acids to elucidate the most probable sequence of the 
fragmented peptide. 
A simple peptide identification method using label-free MS-1 data exploits so-
called accurate mass and time tag (AMT) information that is calculated from accurate 
mass and retention times with or without normalization to match pre-identified peptide 
sequences in a database to the newly acquired data 113, 174, 175. This identification strategy 
has the advantage to perform MS/MS based peptide and protein identifications on 
pooled or representative samples using time-consuming profiling techniques with a 
large peak capacity (e.g. 2D-LC-MS with DDA MS/MS data acquisition) followed by the 
quantitative analysis of a large number of samples with faster LC-MS platforms 
operating in MS-1 mode, which cover a larger measured concentration range. Basically 
this technique can be considered as a generic peptide and protein identification transfer 
system that uses mass and retention time information for the matching, and has the 
disadvantage that the identification transfer may be sensitive to the LC parameters and 
that high-resolution mass spectrometers with high mass accuracy (FTMS or Orbitrap) 
are required to reduce the chance for incorrect matching to acceptable rate 174, 175. In most 
case normalization of the retention time is performed through regression of the observed 
and predicted retention times using training data sets and a neural network for retention 
time prediction. The databases containing peptide identifications with AMT tags are 
generally obtained from different analyses by generating reference maps 113, 176. 
To decrease false positive identifications, Scaffold 177 combines identification 
results of different database search programs such as Sequest 151, Mascot 157 or X! Tandem 
178 (a version performing parallelized processing is called X!! Tandem 179) and calculates a 




the single score of one program. A protein identification score is constructed from 
identified peptide scores and relates to the probability that a given identification is a true 
positive. With its combined scores, Scaffold also provides a more reliable grouping of 
peptides for protein identification. The probability for false positives can be further 
decreased by comparing the measured and predicted retention times of the identified 
peptides. Retention time prediction algorithms use statistical methods based on 
quantitative structure–retention time relationships 180, which are in turn based on a large 
number of molecular descriptors or training data sets and regression methods taking the 
amino acid composition of the peptide into account 181, 182. 
Database search algorithms are biased to the proteins present in the database 
and are poor to detect splice variants and proteins with PTMs. In order to be able to 
identify proteins with splice variants and PTMs, the Swisspit 183, 184 workflow combines 
the results of identifications obtained with the Phenyx 156 and X! Tandem 178 database 
search type algorithms with the Popitam and Inspect open modification search type 
algorithms. This is a combination of first assigning identifications using database search 
programs and subsequently submitting unassigned MS/MS spectra to open 
modification search algorithms with restriction to use peptide sequences identified 
previously by both database search tools. The Swisspit 183, 184 workflow resulted in a 
higher identification rate of 77% for small well-annotated PTM-rich data sets compared 
to 21% obtained with the combination of the two database search programs only. 
Another ingenious approach uses spectral network analysis for peptide 
identification 185. This method finds pairs of MS/MS spectra that differ only in one 
modification or amino acid by searching for corresponding b- and y-type fragment ions. 
From multiple paired spectra, a network is constructed and is used to propagate peptide 
identification from peptide without PTM to the same peptide with different numbers of 
PTMs or amino acids changes. Spectral network analysis was further adopted to include 
data from multistage MS/MS such as MS3 or MS4 in the interpretation 186. Spectral 
dictionaries extend the sequence tag approach by generating sets of full-length peptide 
de novo reconstructions. These spectral dictionaries are then searched in a database 
equipped with hash table or suffix tree providing a fast identification algorithm, with 
high true positive identification rates 187. 
Since database search algorithms provide always a list of identified peptides 
and proteins with given scores, it is important to test the statistical significance of the 
obtained score against a decoy database containing incorrect protein sequences 
obtained, for example, by reversing or randomizing existing protein sequences 188-191. The 
presence of highly homologous proteins represents an actual challenge for the protein 
identification software, therefore in case of lists of proteins with high sequence 
homology the results should be taken with precaution specially, when only peptides 
shared with other proteins are identified. The reader is referred to dedicated books and 
reviews for further reading on the peptide and protein identification algorithms 148, 149, 192-





2 STATISTICAL ANALYSIS AND VALIDATION 
2.1 Coupling feature quantification with peptide and protein identity 
Quantitative feature matrices should be first transformed to quantitative 
compound matrices by summing up the quantity of isotope clusters and different charge 
states of the same compound (a one signal per compound matrix). Peptide quantity 
should be further matched with compound identity at the peptide and ultimately at the 
protein level. Regarding protein quantity, different methods can be used starting from 
summing up the intensity of constituting peptides to taking the sum of the three most 
abundant peptides of each protein 55. Mapping peptide identity to the quantity of 
extracted features involves several steps. Precursor ion mass of a given charge state 
should be matched to the isotope cluster of the same charge and the corresponding 
quantity (e.g. represented by the sum of all isotopomer peak heights or the peak height 
of the monoisotopic peak only) of the isotope cluster should be combined with the 
quantity of the other isotope clusters of the same peptide with different charge states. 
This step is followed by the determination of all identified peptides constituting 
individual proteins. The peptide centric nature of the shotgun proteomics approach 
makes quantification of original protein mixtures challenging in the presence of multiple 
proteins with high sequence homology, truncated protein forms, proteins having 
different PTMs or multiple splice variant 6, 7. For accurate protein quantification, either 
with MS-1 or spectral counting methods, precise peptide and protein identification 
including detection of all protein variants is necessary, because the identified peptides 
will provide the list of peptides unique for the protein and peptides that are shared 
between several proteins, which will allow accurate quantification of all protein variants. 
Recently Zhang et al. 197 evaluated different strategies for spectral counting 
quantification and found that the most accurate quantification were obtained by adding 
the corresponding molar proportion of the spectral counts of peptides shared between 
different proteins to the spectral counts of unique peptides for the protein. The 
identification of exact protein forms is also important for the development of accurate 
targeted MRM assays, while the presence of peptides shared between proteins could 
bias considerably the measured protein quantities 6, 7, 60. A recent review by Podwojski et 
al. 198 deals with this problem in detail. 
Annotated quantitative peptide matrices can be obtained through other 
methods 199 than those based on MS-1 data, such as the already mentioned MRM-based 
methods, spectral counting algorithms and by quantifying spot intensity in two-
dimensional gel electrophoresis coupled with peptide fingerprinting or LC-MS/MS 
identification 200-202. Immunochemical techniques based on antibody arrays are especially 
interesting for the targeted profiling and validation of proteins in complex biological 
samples 203-205. Quantification methods either provide absolute or relative protein 
quantities or other type of bio descriptors if the goal of the analysis is to compare 






2.2 Feature selection/transformation methods 
The main application of statistical analysis, also called post-processing 
methods, is to find peptides and proteins that discriminate between different groups of 
pre-classified samples. Discriminating peptides or proteins are selected from the 
common peaks after data processing, which means that the validity of the ultimate 
statistical result depends on the quality of data processing. Statistical analysis of 
quantitative proteomics experiments suffer from the high dimensionality given by the 
large number of identified peptides and proteins accompanied by a much lower sample 
size. Due to this characteristic, processed proteomics data are often referred as 
megavariate data 207, 208 leading to a High Dimensionality Small Sample size (HDSS) 
problem 147. HDSS is the main reason why most of the widely used classification 
methods such as linear discriminant analysis cannot be directly applied to analyze 
quantitative proteomics data sets. In data sets with HDSS properties, a large number of 
compounds may be found to differ significantly between predefined classes of samples 
using, e.g. the univariate t-test, but they may not be confirmed in other independent set 
of samples. Disease-related changes generally affect a small portion of proteins and 
peptides in living organisms, which represent the truly discriminating molecules 
between predefined groups of samples, and which stay true when measuring new 
sample sets. To find a small number of truly discriminating proteins among a very large 
number of other non disease-related proteins in data sets with HDSS, it is necessary to 
either use statistical methods that are insensitive to uninformative features (noise) or to 
reduce the number of features (dimensions) prior to the actual statistical analysis to a 
number that does not exceed the number of samples (independent observations). Only 
very few methods such as Support Vector Machines 209-211 or Learning Vector 
Quantizations 212, 213 claim to be insensitive to a large amount of noise peaks contained in 
HDSS data sets and generally do not require upfront feature selection. Other methods 
require dimension reduction, which can be performed either by removing uninformative 
peaks and selecting statistically relevant discriminative peaks (so-called feature 
selection) or to perform data transformation to accentuate class differences. Feature 
selection methods are most widely used 103, 214-217, since these methods are not only helpful 
to overcome the HDSS problem, but also to provide a list of discriminatory peaks. 
Selected features corresponding to a limited number of biomarker candidates must be 
validated by measuring a larger sample set with fast and targeted analytical methods 
such as LC-MS/MS in the MRM mode 3. The results can also be used as input for 
databases and algorithms to link them to biochemical, secretion, molecular interaction or 
signaling pathways that may be involved in disease-related biological processes. 
Feature selection can be performed in a supervised manner using univariate 
or multivariate selection algorithms. Univariate methods assume that features are 
mutually independent, so that each feature is evaluated individually based on its 
individual relevance to discriminate between predefined classes of samples. The 
simplest method for feature selection is the univariate Student’s t-test, which must be 
corrected for multiple testing. Multivariate feature selection methods take the 
interdependency between features into account, when evaluating the individual 
strength or rank of a given feature. Collective assessment and selection of variable 
subsets is another type of feature selection. This method selects a feature subset by 
evaluating all possible correlations or other forms of dependencies between features. 
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Since the number of subsets increases exponentially with the number of features, it 
becomes an exhaustive task to evaluate all possible subset combinations in the feature 
space. Therefore, most collective feature selection methods are based on heuristic search 
strategies, such as forward selection and backward elimination 218. Forward selection 
methods start with an empty feature subset and add features step-by-step to maximize a 
predefined scoring function. The procedure is stopped when newly selected features 
have a small contribution to the value of the scoring function. Backward elimination 
starts from the full feature set and eliminates features until a given scoring function 
reaches its maximum. An example of such an approach is the Reduce Feature 
Elimination method that can be combined with a classifier such as a Support Vector 
Machine 218. Feature transformation methods construct new features from the original 
features while maintaining the initial data structure as accurately as possible. Typical 
feature transformation methods create a supervised or unsupervised mapping function 
that changes the initial feature space into a transformed variable space. One of the most 
widely used methods for feature transformation are Principal Component Analysis 
(PCA), Fourier and the wavelet transformations. The most popular feature 
transformation methods coupled to statistical classification are Principal Component 
Linear Discriminant analysis and Partial Least Square Linear Discriminant Analysis. 
Many feature selection methods are available and it is difficult to predict, which of them 
perform the best with respect to the others. Since many of the features in biological 
samples are correlated, in context, collective feature selection and feature transformation 
methods taking account for this correlation are preferable. 
 
2.3 Classification methods and statistical validation 
Figure 4 shows the main modules of statistical data analysis and validation 215, 
217. Feature selection and statistical analysis form the core, which is surrounded by 
different stages of validation layers to ensure that the resulting classification models are 
robust with respect to new sample sets. From the core modules, only the classification 
module is compulsory while feature selection and ultimately biomarker selection are 
optional if the classification method is not sensitive to HDSS and if sample classification 
is the only goal without identifying the underling molecular determinants. The first 
validation layer serves to select the optimal classification model (module 4) and the 
second layer measures classifier performance (module 5) by providing an error rate 
when classifying new samples, that were not used for building and selection of the 
classification model. Finally the relevance of the discrimination of the model is 
determined by comparing its performance to models obtained by chance using e.g. 
permutation tests (module 6). Permutation tests randomly reassign sample group labels 
thus generating random models and the performance of large number of random 
models is compared to the performance of the model obtained with the correct sample 
labels 217.  
Generally validation modules 4 and 5 are based on a double cross-validation 
strategy, with model selection occurring in the inner loop and classification performance 
being determined in the outer loop. Double cross validation strategies provide an 
unbiased way of evaluating model selection criteria and classification performance. This 




model building, and a test set that is used for performance measurement in the inner 
and outer loops, respectively. Another way to assess model performance is to determine 
the sensitivity and specificity of the statistical model by calculating the so-called ROC 
curves 215, 219. Current developments in statistical analysis focus on a combination of 
several methods resulting in ensemble classifiers. The reader is referred to more 
comprehensive reviews for details about feature reduction, dimensional reduction, 
statistical analysis and validation methods 147, 217, 220.  
Most biomarker discovery studies are performed using samples from 
different groups, which are obtained from different individuals (e.g. patients or animals) 
not related to each other (cross-sectional study design). A study design where samples 
from the same individual are analyzed at different time points (longitudinal study 
design) is able to lower the biological variability. It is possible to further decrease the 
effect of biological variability by matching the different clinical parameters such as age, 
sex, smoking habits or life style. In this case statistical analysis should take the relation 
between samples into account by using adapted methods (e.g. time series analysis) to 
correlate compound concentration to time or other parameters such as drug dosage or 




Figure 4. Main steps of the statistical analysis and validation strategy for proteomics data suffering 
from the HDSS problem. Panel a) gives a schematic overview of the modules for supervised 
statistical analysis and validation. The core (modules 1-3) represents the statistical analysis modules 
for feature selection (module 1; optional), classification (module 2) and biomarker selection (module 
3; optional). The outer part represents modules for statistical validation comprised of a model 
selection module (4), a module to assess performance of the classifier (5) and a module assessing the 
relevance of the selected biomarkers by permutation tests (6). Panel b) gives an overview over the 
generic double cross validation strategy to measure the performance of the feature selection-




Quantitative peak matrices can be used for different purposes than 
identifying class specific discriminating compounds. Figure 5a shows the histogram of 
the relative standard deviation (RSD) of the quantity of all compounds in a given data 
set, where variability was only subjected to analytical variance due to the use of two 
different LC-MS analysis platforms. The histograms show that the two platforms 
perform equally well to quantify peptides in serum samples depleted of the six most 
abundant proteins 100. The aligned peak matrix contains also information about the 
global concentration variability of compounds in the different data sets. This comparison 
can be performed similarly using histograms of the RSD as presented in Figure 5b for 




Figure 5. Histograms of the relative standard deviation (RSD) of compound concentrations 
calculated based on results of the corresponding quantitative peak matrices. a) Assessment of two 
LC-MS profiling platforms used for comparative proteomics studies. The Chip-LC-MS platform 
was equipped with a reverse phase nano-LC column (75 µm internal diameter) integrated in a 
microfluidic device and coupled to the mass spectrometer via an electrospray interface, while the 
Cap-LC-MS platform used a 1 mm internal diameter reverse phase column coupled to the mass 
spectrometer via an electrospray interface using a nebulisation gas (ionspray). The histograms show 
that the Chip-LC-MS (in blue) and the Cap-LC-MS (in red) platforms result in similar compound 
concentration variability and can thus be considered as equivalent quantitative profiling platforms. 
In both cases 10 serum samples from the same patient were depleted of the 6 most abundant 
proteins and underwent individual sample preparation procedures. These data thus contains only 
the analytical variability. Five injections of the same sample in Chip-LC-MS (green) resulted in 
histograms with a lower RSD indicating that most of the analytical variability is not caused by the 
Chip-LC-MS profiling platform itself but originates from the sample preparation steps (depletion or 
trypsin digestion). b) Assessment and comparison of compound concentration variability after 
accurate data processing of different types of body fluid analyses from ongoing biomarker research 
projects. Twenty chromatograms of trypsin-digested human serum samples obtained from 10 
different patients at two time points and depleted of the 6 most abundant proteins give a narrower 
RSD histogram with respect to compound concentration (green histogram) than the same type of 
samples obtained from one patient and subjected to an experimental design study (19 
chromatograms) obtained by varying pre-analytical parameters (blue histogram). Fifty acid-
precipitated human urine samples result in the widest RSD distribution (red histogram), which may 
be explained by the fact that serum is a well-regulated body fluid while urine is excreted and thus 
devoid of homeostatic control. Figures taken with reprint permission from Horvatovich et al. 100 and 




The figure shows that there are large differences in concentration variability 
between sample sets of different origin, such as acid-precipitated urine, serum depleted 
of the 6 most abundant proteins and a serum sample from one patient that was subjected 
to varied pre-analytical factors in a factorial design study. While the compounds of the 
first two data sets were subjected to biological and analytical variability in addition to 
errors during data processing, compounds of the last data set were only subjected to 
analytical variability and data processing errors. The histograms indicate that well-
regulated body fluids, such as serum, show less concentration variability than the same 
type of sample measured with different pre-analytical factors in a factorial design study. 
An excreted, non-regulated body fluid, such as urine, shows the largest concentration 
variability. Finally, quantitative peak matrices can be used to evaluate and compare the 
quality of different data processing pipelines using data sets containing compounds that 
were added in known concentrations by spiking. Grossmann et al. 47 compared the 
quantification performance of two relative spectral count methods (emPAI and APEX), 
an absolute protein quantification method using the abundances of the three most 
abundant peptides developed by Silva et al. 55 and four different protein quantification 
methods using Superhirn (MS-1 based quantification) by assessing the robustness and 
dynamic range of the spiked-in protein as well other non altered proteins detected in the 
mixture of spiked yeast samples. The protein quantification method of Silva et al. 55 with 
own implementation or using Superhirn 83 provided the best performance compared to 
emPAI or APEX methods, however their results should be taken carefully as they have 
used one bovine protein (Fetuin-A of 38.4 kDA) for spiking, which has a very different 
composition (low homology) than the yeast proteome. One other recent paper compares 
the quantification performance of two commercial label-free LC-MS data processing 
softwares (Eluciator and Progenesis) based on spiked samples, and reported 
considerable differences in performance 225. 
 
3 CONCLUSIONS 
Improvement and development of new data processing pipelines and 
individual modules will continue into the future as mass spectrometry-based molecular 
profiling is gaining momentum in life science research and developments of new mass 
spectrometers and new sample preparation methods are on the agenda of numerous 
research groups and companies. In current bioinformatics literature, there is an 
increasing emphasis on the development of algorithms, which assess and compare the 
performance of data processing methods. These algorithms also provide substantial 
support for parameter optimization and troubleshooting of algorithms. Performance 
assessment and quality control can be only performed with high quality standard data, 
where compound composition and quantity are precisely known 226. To assess the 
performance of protein identification workflows, which report enhanced performance to 
detect known and unknown PTMs, there is a need of open access well annotated 
MS/MS data 183. Similarly, for the purpose of assessing quantitative label-free data 
processing workflows, it is necessary to provide reference data from different biological 
origins such as urine, serum treated with different depletion techniques or different cell 
lines spiked with known compounds in known concentrations. Development and access 
to standardized samples such as the recently introduced yeast standard sample help this 
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procedure 226. Well-characterized data sets are also helping to evaluate the performance 
of statistical analysis and validation strategies. Raw and processed data simulation 
softwares could, in certain circumstances, replace real data sets or create datas ets with 
particular properties, which are difficult to obtain experimentally, and which may 
reduce assessment time considerably. For this reason, well characterized and 
documented data sets stored in free access database such as Human Proteinpedia 227-229, 
and the development of accurate data simulation tools will, in the future, enhance the 
comparison and assessment of different modules and complete data processing 
workflows. An example for quality assessment and parameter optimization of time 
alignment algorithms using well-defined samples is provided by Peters et al. in a recent 
publication 230. 
Another trend is to develop data processing solutions to integrate highly 
diverse data such as data obtained with different instruments or in different laboratories. 
An example of such diverse data, which can not be processed with the actual data 
processing pipelines, is presented in Figure 6 showing a representation of two raw     
LC-MS data sets that were obtained form the same serum sample with the same ion trap 
mass spectrometer, but using two different ionization methods and two different HPLC 
techniques. While the two samples contain exactly the same compounds with same 
concentrations and measured dynamic concentration range, the differences caused by 
different chromatographic methods and ionization modes result in different peak 
distributions in the retention time and m/z space. Current LC-MS data processing 
workflows are not able to accurately combine these types of data sets, leaving this 
challenge for future developments. 
Newly developed or enhanced algorithms are emerging rapidly within 
bioinformatics research groups. However these new algorithms, with a high potential to 
ameliorate information extraction accuracy from raw data and biological knowledge 
discovery, are not used by the majority of the data producing, application-oriented 
proteomics laboratories. The main reason for the low penetration of new bioinformatics 
solutions is that mass spectrometer vendors generally provide user-friendly data 
processing and evaluation pipelines supported by training sessions favoring the 
application of their own software packages, even if the performance of these softwares is 
not assessed and compared with others. The newly developed algorithms, even if the 
open source program code is available, require on the other hand extensive 
bioinformatics expertise, which is not present in most data-producing proteomics 
laboratories. In order to allow a breakthrough for the widespread application of newly 
developed algorithms and software tools, it is necessary to develop infrastructure 
programs, which provide data processing services using integrated tools with access to 
high-capacity, parallel computing facilities, such as large local clusters or grid. Indeed 
biologists planning proteomics or in general life science experiments to answer relevant 
biological questions may work more efficiently if they have to concentrate only on the 
experimental design of the biological study, on production of high quality data and 
interpretation of the obtained data using easy to use, user friendly data processing 
services. To facilitate data interpretation, the complexity of the software and hardware 
operations should be hidden, and the end user should be only exposed to raw data 
management, parameter setting of data processing and other bioinformatics tools, to 




way. An example for such a framework software is Galaxy 231, 232 or Genepattern 233, 234, 
which is extensively used to analyse new generation DNA sequencing data. The 
framework should make the integration of new bioinformatics tool easy and allow to 
modify complex data processing workflows to adapt to the large diversity of mass 
spectrometers and sample preparation methods that generate highly diverse data. A key 
element for the efficient and easy integration of diverse bioinformatics tools in such a 
software framework is to use a standard format, which serves to interconnect the input 
and output files of the integrated tools. 
 
Figure 6. LC-MS images of trypsin-digested human serum samples depleted of the 6 most 
abundant proteins obtained with the Chip-LC-MS (electrospray) (a) or the Cap-LC-MS platform 




Attempts have been made in the field of proteomics with the framework 
program CORRA 235, which integrates the SuperHirn 83 and SpecArray 87 label-free 
quantitative  data  processing  pipelines,  and  includes  MS/MS identification  based  
onSequest 151 with a range of R-based statistical tools. CORRA uses the Annotated 
Putative Peptide Markup Language (APML) format to integrate the different modules of 
the quantitative data processing pipelines with protein identification and statistical 
analysis. CORRA provides a user-friendly web interface and executes the different 
processing tasks on a local cluster. However CORRA cannot manage large amounts of 
diverse metadata, as needed for effective project management, and the integrated tools 
are limited to bioinformatics modules developed in a closely collaborating 
bioinformatics community. Developing further CORRA and APML or other similar 
initiatives should provide a breakthrough in using newly developed bioinformatics tools 
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Correlation Optimized Warping (COW) based on the Total Ion Current (TIC) 
is a widely used time alignment algorithm (COW-TIC). This approach works 
successfully on chromatograms containing few compounds and having a well-defined 
TIC. In this paper, we have combined COW with a Component Detection Algorithm 
(CODA) to align LC-MS chromatograms containing thousands of biological compounds 
with overlapping chromatographic peaks, a situation where COW-TIC often fails. 
CODA is a variable selection procedure that selects mass chromatograms with low noise 
and low background (so-called “high-quality” mass chromatograms). High quality mass 
chromatograms selected in each COW segment ensure that the same compounds (based 
on their mass and their retention time) are used in the 2-dimensional benefit function of 
COW to obtain correct and optimal alignments (COW-CODA). The performance of the 
COW-CODA algorithm was evaluated on three types of complex datasets obtained from 
the LC-MS analysis of samples commonly used for biomarker discovery and compared 
to COW-TIC using a new global comparison method based on overlapping peak area: 
trypsin-digested serum obtained from cervical cancer patients, trypsin-digested serum 
from a single patient that was treated with varying pre-analytical parameters (factorial 
design study) and urine from pregnant and non-pregnant women. While COW-CODA 
did result in minor misalignments in rare cases, it was clearly superior to the COW-TIC 
algorithm, especially when applied to highly variable chromatograms (factorial design, 
urine). The presented algorithm thus enables automatic time alignment and accurate 
peak matching of multiple LC-MS datasets obtained from complex body fluids that are 
often used for biomarker discovery. 
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1 INTRODUCTION 
Comparative proteomics and biomarker discovery studies often use label-free 
liquid chromatography coupled to mass spectrometry (LC-MS) to detect differences 
between pre-classified sample sets. Easily accessible body fluids such as blood (plasma 
or serum) and urine are used primarily for this purpose. However, analyzing body 
fluids is challenging since they contain a large number of diverse compounds covering a 
wide dynamic concentration range leading to enormous amounts of raw data that need 
to be processed prior to statistical comparison. LC-MS data acquired in profile mode 
characterize compounds by their retention time and mass to charge ratio (m/z) and the 
quantity is reflected in the measured intensity (e.g. ion count). 
Data processing workflows must be designed in a way to extract accurate 
information related to the identity and quantity of the detected compounds to allow 
subsequent statistical analyses and to find concentration differences between pre-
classified sample sets1. One of the most important challenges in detecting concentration 
differences is to ensure that identical peaks are compared across multiple samples (peak 
matching procedure), since liquid chromatography separations are prone to non-linear 
elution time shifts as a result of slight variations in flow rate, gradient slope and 
temperature as well as to column aging and the need to renew eluents from time to time. 
This is especially important for complex mixtures, such as depleted and trypsin-digested 
serum (shotgun proteomics approach)2 or acid-precipitated urine, where many 
compounds elute with similar retention times. Improper correction of retention time 
shifts may thus lead to incorrect peak matching across multiple samples, resulting in 
statistical errors and the false discovery of biomarker candidates. Since clinical 
biomarker discovery and other proteomics or metabolomics applications require the 
comparative analysis of many samples to enhance statistical power, reliable, automatic, 
non-linear time alignment algorithms are required to avoid such pitfalls. 
Several techniques to correct non-linear retention time shifts have been 
developed. These methods differ in both the search space and the benefit function (a 
measure of similarity) used to find the optimum retention time shift correction. 
Furthermore, most of the reported algorithms arbitrarily choose one chromatogram as 
reference and align all other “sample” chromatograms to it as a way to co-align all 
chromatograms. 
The retention time vector in LC-MS data contains thousands of points. The 
search space, in which to find the optimal mapping between reference and sample 
retention time vectors, must be limited in order to keep computation time within 
reasonable limits and to avoid misalignment between distant, unrelated parts of the 
reference and sample chromatograms. Dynamic Time Warping (DTW)3-6 calculates the 
shift of data points in two chromatographic profiles and warps the trajectories in such a 
way that the distance between them is minimized using a set of constraints with respect 
to changes that are allowed for each point of the sample retention time vector. 
Correlation Optimized Warping (COW)3, 7-11 divides the chromatographic profile into 
segments and stretches or shrinks these in a linear manner within a limited search space 
to maximize the correlation to a reference chromatogram. Other approaches, such as 
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parametric12 and semi-parametric warping9 use the full length of the chromatographic 
profile and perform the time correction in one step. Parametric warping optimizes 
polynomial coefficients by minimizing the difference of the intensity for a given data 
point between reference and sample chromatographic profiles. 
The majority of the published time alignment methods use a 1-dimensional 
benefit function3, 7, 10, 12-18 to search for the optimal alignment even when the data was 
acquired with a detector providing 2-dimensional information in addition to the 
separation time (e.g. GC-MS, LC-DAD, LC-MS). For LC-MS data the benefit function is 
often based on the Total Ion Chromatogram (TIC, or sum of all intensities within one 
scan) or Base Peak Chromatogram (BPC, or the maximal intensity in each scan). Time 
alignment using a 1-dimensional benefit function may work well for samples where time 
and 1-dimensional information used for alignment are similar across the samples, but it 
can be inappropriate for proteomics and metabolomics samples containing a high 
number of partially overlapping, closely eluting peaks with varying intensities. A few 
time alignment methods have been reported using a 2-dimensional benefit function5, 19-
26. Some methods specifically note the advantages of using a 2-dimensional versus a 1-
dimensional benefit function5, 24-26. Certain methods use single-scan mass spectra, known 
to be noisy due to scan-to-scan fluctuations23, 27, 28, whereas other algorithms use 2-
dimensional peaks that are local maxima of the ion intensity in the retention time and 
m/z space16, 19, 20, 25, 29-33. 
Comparative studies have identified some of the advantages and 
disadvantages of warping algorithms using different search space and 1-dimensional 
benefit functions on samples containing a small number of well resolved compounds 3, 13, 
34, 35. However, until now no evaluation and comparison of time alignment algorithms 
on complex data have been reported. Bylund10 used covariance instead of the correlation 
coefficient as benefit function to calculate the similarity between two chromatograms. 
This work concluded that the covariance measure is more sensitive to the peak height 
and will favor the alignment of large peaks, avoiding interference from regions 
containing mostly noise and background. 
LC-MS chromatograms contain noise, background, and analyte peaks of 
varying quality with respect to the location in the chromatogram. Electrospray 
Ionization (ESI), which is the most often used ionization technique for LC-MS of bio-
molecules, generates chemical noise and contaminants from solvents or the atmospheric 
environment that may be present at different parts of a chromatogram. Therefore it is 
necessary to examine the local information content of LC-MS data and to locate regions 
containing high quality information (low noise and background and a relatively high, 
compound-related signal) and to use those for time alignment. The Component 
Detection Algorithm 36, 37 (CODA) measures the information content of mass 
chromatograms containing a minimal amount of high-frequency noise, spikes (peak 
width of only one scan) and background by comparing the magnitude of change 
between the original trace and the mean-subtracted trace that was smoothed using a 
moving average. Hence, regions of high information content can be located and 
subsequently used for time alignment by COW. 
In this chapter, we combine mass chromatogram selection using CODA with 
a modified COW algorithm in order to take the local information in LC-MS 
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chromatograms into account. The COW algorithm is applied segment-wise to pairs of 
selected mass chromatograms with the product correlation coefficient of the selected 
mass traces as 2-dimensional benefit function. The performance of the COW-CODA 
algorithm was evaluated using LC-MS data of urine and trypsin-digested human serum 
obtained from real-case proteomics and metabolomics studies38-40. These datasets exhibit 
different degrees of non-linear retention time shifts and contain a large number of 
compounds of highly variable properties and amounts. 
2 THEORY 
2.1 Conditions for proper time alignment using COW-CODA 
A number of conditions have to be met for successful application of the COW-
CODA algorithm. Alignment is based on the presence of common peaks (compounds) 
between the reference and the sample chromatograms. The first criterion is thus to find a 
minimal number of common peaks in each time segment that should be aligned using 
the COW algorithm. In case there are no high-quality mass traces in a given segment, 
this segment is left unchanged, as there is no information to base the alignment on. This 
should, however, be the exception, if an overall well-aligned dataset is to be obtained. 
The criterion of finding common, high-quality mass chromatograms is generally 
satisfied for all easily accessible body fluids in areas where compounds (peptides, 
metabolites) elute, since even highly variable body fluids such as urine contain a large 
number of conserved compounds. 
We selected COW as the search algorithm for time alignment, because it 
corrects non-linear time shifts by stretching or shrinking the data in a segment-wise 
fashion until optimal correlation has been reached. The limited search space of retention 
time range reduces the risk of large retention time corrections resulting in erroneous 
time alignments often occurring when the search space is too large. The aim of 
combining COW with CODA was fourfold: 1. assure that peaks with similar retention 
times but different m/z values are considered as separate features in the benefit 
function, 2. consider only data from common peaks between the reference and sample 
datasets in the benefit function, 3. avoid traces containing high noise and background, 
and 4. take into account that peaks, background and noise distribution vary strongly 
between different regions of the LC-MS dataset. 
 
2.2 Component Detection by CODA 
The CODA algorithm36, 37 was developed to select mass chromatograms with 
high quality peaks, low noise and low background. This algorithm contains two main 
steps: detection of spikes (single scan signals originating from electronic noise) and 
detection of high signal background (typically originating from the mobile phase). When 
a mass chromatogram contains noise and spikes, the smoothed version will be different 
from the original chromatogram. We use a moving average to smooth the data in a 
specific m/z trace segment using a window larger than the peak width of the spikes, 
which results in large differences between the smoothed and original data when spikes 
are present and a low CODA similarity index. A mass chromatogram that has a high 
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level of background noise will have a relatively high mean value. Hence it will differ 
strongly from its mean-subtracted version resulting also in a low similarity index. In 
contrast, a mass chromatogram with no spikes, a low level of background noise and 
significant peaks will have a high similarity to its mean-subtracted version. The quality 
of a mass chromatogram is defined by a single, combined index of the two similarity 
indices. A high-similarity index thus indicates high quality mass chromatograms with 
intense peaks. This similarity index is called Mass Chromatographic Quality (MCQ) with 
a minimum value of 0 and a maximum value of 1. The CODA algorithm has been 
described in detail by Windig et al . 
 
2.3 Combining COW and CODA (COW-CODA) 
2.3.1 Segmentation and search space 
The COW algorithm, as described by Nielsen et al.7, was employed in our 
procedure, with a modification of the benefit function, which was originally based on 
the sum of correlations of each segment using 1-dimensional information (e.g. TIC or 
single wavelength UV traces). Assume that we want to align a sample chromatogram S 
to a reference chromatogram R, with the number of scans in the reference and sample 
chromatograms being LS and LR, respectively. Each chromatogram may vary in length 
due to the different number of mass spectrometric scans (especially for ion trapping 
instruments). In our case, the number of mass traces d in each chromatogram is equal 
since we have used the same mass range for data acquisition (100-1500 Da) and both 
chromatograms have been identically smoothed from their original 0.1 amu resolution to 
1 amu (see Gaussian smoothing and data reduction in Material and Methods). In the 
COW algorithm, the reference chromatogram remains unchanged while the endpoints of 
the sample chromatogram segments are allowed to move according to three constraints 
(1) start and (2) endpoints of the sample chromatograms are unchanged, and  (3) sample 
segments lengths are allowed to change with the slack parameter (see point 3 of the 
Theory part in the support information). The flowchart of the warping process for two 
chromatograms is schematically described in Figure 1, while the detailed steps of the 
warping algorithm are described in the supporting information. COW specifies the 
degree to which the segment endpoints may move through the “slack” parameters. 
Details about the search space given by the slack parameters are discussed in Nielsen et 
al7. and in the Theory part of the supporting information. 
 
2.3.2 Segment-wise mass chromatogram selection 
The procedure for selecting high quality mass chromatogram is the same for 
each segment. The MCQ values from the CODA algorithm were calculated for each mass 
chromatogram from a given segment of chromatogram S and R, resulting in two vectors 
of length d containing the MCQ values of the corresponding traces. Since the segment 
endpoints of the reference chromatograms are fixed and the segments endpoints of the 
sample chromatograms can vary, a larger segment is chosen for the sample 
chromatogram compared to the corresponding segment in the reference chromatogram 
(a detailed description how segment endpoints of the mass chromatograms are obtained 
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is given under point 6 of the Theory part in the supporting information). The product of 
the MCQ values of the corresponding mass chromatograms for each segment of the 
sample and reference chromatograms were calculated and used as a measure of quality. 
Parameters were set to select mass chromatograms with MCQ products higher than 0.59 
with an upper limit of 30 mass chromatograms per segment. 
 
 
Figure 1. Flowchart of the COW-CODA algorithm, showing the main steps in warping a sample 
chromatogram S to the reference chromatogram R. This process is repeated until all sample 
chromatograms have been aligned to the chosen reference chromatogram in the dataset. 
 
For a given segment the product of correlation coefficients was calculated for 
each pair of selected mass chromatograms using the allowed segment endpoints for the 
reference and the sample chromatograms (see point 3 of the Theory section in the 
supporting information). The warping procedure uses dynamic programming. In case 
there is no mass trace selected for a segment, because there is no high quality mass 
chromatogram present, no warping is applied for this segment and the cumulated 
correlation from the previous segment is passed on to the next segment without 
modification. The algorithm may be improved by requesting a minimum number of 
selected mass traces for warping and relating the number of selected traces and the 
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product of their MCQ values to the allowed retention time correction thus tolerating 
larger retention time shifts for segments containing a high number of high-quality mass 
traces. 
The segment wise trace selection using MCQ products enables not only the 
selection of high-quality mass traces containing information about the peaks but also the 
selection of traces from peaks occurring in both chromatograms. This favors alignments 
that are based on conserved peaks (compounds) and reduces the risk of misalignments 
in crowded regions of chromatograms from highly complex samples. 
2.3.3 Form of the benefit function 
The benefit function in COW using 1-dimensional information for time 
alignment is the sum of the Pearson correlation between segments of reference and 
sample chromatograms. In COW-CODA, this output function is replaced with the 
correlation product of segments for the selected mass traces. The overall benefit function 
is therefore the sum of the correlation products. A detailed description of how the 
correlation product and the corresponding benefit function are obtained is given in 
Figure S-1 (supporting information). 
 
2.4 Choosing the reference chromatogram 
Aligning multiple chromatograms requires selection of a reference 
chromatogram to which the other chromatograms in the dataset shall be aligned. To 
select the best reference, we have calculated the correlation of LC-MS chromatograms 
based on the reconstructed TIC from all CODA-selected mass traces (CODA-TIC) with 
100 different MCQ thresholds between 0.80-0.99 (with an interval of 0.0019) across the 
entire retention time range, during which relevant peaks elute (~44-130 minutes for 
serum datasets and ~13-105 minutes for the urine dataset). For each chromatogram and 
each studied MCQ value, we calculated the sum of the correlation coefficients of the 
CODA-TIC profile before time alignment and the chromatogram giving the highest sum 
of correlation was chosen as the best reference. Consequently, the chromatogram giving 
the lowest sum was chosen as the worst reference. The selected best and worst reference 
chromatograms were plotted as a function of MCQ value and the chromatograms that 
were most often selected as best and worst references were chosen to perform the time 
alignment giving a “best” and “worst case” scenario. The complete flowchart of 
reference chromatogram selection is presented in Figure S-2 (supporting information). 
 
2.5  Global evaluation of the time alignment quality 
We can easily compare the quality of time alignment for single peaks by 
visual inspection of multiple datasets using internal standards (peptides or metabolites) 
that were added to the samples. However, it is difficult to judge the overall quality of the 
time warping algorithm for complex chromatograms by visualizing only a small number 
of selected compounds. To overcome this limitation, we have developed a procedure to 
assess the quality of time alignment based on the calculation of the overlapping peak 
area between pairs of chromatograms. Peak areas were calculated after applying a 
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modified local baseline subtraction method called M-N rules using M=3 and N=822. An 
increased quality of time alignment between two chromatograms is reflected in a larger 
overlapping peak area. The sum of overlapping peak areas from each chromatogram to 
all of the other chromatograms in the original dataset is then compared to the 
overlapping peak area after applying COW-TIC or COW-CODA. Using this approach, 
the performance of the time alignment methods can be compared relative to each other. 
This evaluation method considers a much larger number of chromatographic peaks than 
the internal standard method. It is, however, not able to judge if the time alignment 
method is entirely accurate. In order to check the number of possible misalignments 
after warping, we visually inspected three peaks per time segment (number of segments 
were 51, 84 and 41 for Dataset 1, 2 and 3 respectively) having the largest average peak 
intensity in each dataset. 
 
3 MATERIAL AND METHODS 
3.1 Chemicals 
Acetonitrile (ACN) HPLC-S gradient grade (Biosolve; Valkenswaard, The 
Netherlands), ultra pure water (18.2 MΩ/cm), trifluoroacetic acid (TFA) 99% 
spectrophotometric grade (Aldrich; Milwaukee, USA) and formic acid (FA) 98-100% pro 
analysis (Merck; Darmstadt, Germany) were used for reagent and solvent preparation. 
 
3.2 Serum samples 
3.2.1 Cervical cancer patients (Dataset 1) 
Serum samples from 10 cervical cancer patients at two different time points 
(time point A: before treatment with confirmed cancer; time point B: after treatment with 
no recurrence of the cancer for at least 6 months) were obtained from the Department of 
Gynecological Oncology (University Medical Centre Groningen, The Netherlands). The 
study protocol was in agreement with local ethical standards and the Helsinki 
declaration of 1964, as revised in 2004. All samples were stored at –80°C in aliquots. The 
samples from cervical cancer patients were depleted of the 6 most abundant serum 
proteins on a Multiple Affinity Removal column (4.6 × 50 mm, # 5185-5984, Agilent 
Technologies) followed by digestion of the remaining proteins with trypsin. Further 
details about the LC-MS analyses are described in Govorukhina et al40. 
3.2.2 Factorial design (Dataset 2) 
For the factorial design study serum samples from a healthy female volunteer 
were obtained from the Department of Gynecological Oncology (University Medical 
Centre Groningen, The Netherlands) and stored at –80°C in aliquots. The study protocol 
was in agreement with local ethical standards and the Helsinki declaration of 1964, as 
revised in 2004. 
The sample preparation of the serum in this dataset was similar to the sample 
preparation of the serum for dataset 1, except for the seven following pre-analytical 
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parameters, which were varied at two levels according to a 2IV
7!3  fractional factorial 
design (see Table 1). In brief, these factors were type of blood collection tube, hemolysis 
level, clotting time, number of freeze-thaw cycles, trypsin concentration, deactivation of 
trypsin after digestion and stability of the digested sample in the autosampler of the LC-
MS system. 16 from the 128 possible combinations were selected with four repetitions 
(chromatogram number 1,4,11,14) of one condition resulting in a total number of 19 










































N1 1 BD368430 Low 2 1 cycle 1:20 Yes 0 
N2 3 BD367784 Low 2 1 cycle 1:100 Yes 0 
N3 9 BD368430 High 2 1 cycle 1:100 No 0 
N4 17 BD367784 High 2 1 cycle 1:20 No 30 
N5 18 BD368430 Low 6 1 cycle 1:100 No 30 
N6 2 BD367784 Low 6 1 cycle 1:20 No 0 
N7 10 BD368430 High 6 1 cycle 1:20 Yes 30 
N8 16 BD367784 High 6 1 cycle 1:100 Yes 0 
N9 8 BD368430 Low 2 3 cycles 1:20 No 30 
N10 15 BD367784 Low 2 3 cycles 1:100 No 0 
N11 13 BD368430 High 2 3 cycles 1:100 Yes 30 
N12 7 BD367784 High 2 3 cycles 1:20 Yes 0 
N13 12 BD368430 Low 6 3 cycles 1:100 Yes 0 
N14 6 BD367784 Low 6 3 cycles 1:20 Yes 30 
N15 5 BD368430 High 6 3 cycles 1:20 No 0 
N16 9 BD367784 High 6 3 cycles 1:100 No 30 
N17 14 BD368430 Low 2 1 cycle 1:20 Yes 0 
N18 1 BD368430 Low 2 1 cycle 1:20 Yes 0 
N19 4 BD368430 Low 2 1 cycle 1:20 Yes 0 
Table 1. Overview over pre-analytical parameters and their levels in a fractional factorial design 
study of depleted and trypsin-digest serum (Dataset 2). 
 
3.3 Urine samples (Dataset 3) 
First-void midstream morning urine samples were obtained from 25 pregnant 
females from a local biobank (Department of Obstetrics and Gynecology of the 
University Medical Center in Groningen, The Netherlands) and stored frozen at -20 ºC. 
Twenty-five first-void midstream morning urine samples from non-pregnant females 
were collected in polypropylene containers and kept at 4 °C for a maximum of 1 day, 
after which they were aliquoted in 10 ml polypropylene tubes and stored at -20 °C. The 
study protocol was in agreement with local ethical standards and the Helsinki 
declaration of 1964, as revised in 2004. 
Urine samples were thawed, mixed and acidified with TFA to reach a final 
concentration of 1%. Samples were left overnight on melting ice, and centrifuged to 
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remove precipitate (10 min at 1500 g and 4 °C). The supernatant was diluted 1:1 with 
0.2% FA in 10% ACN and stored at 4 °C until analysis. Supernatants of the acid-
precipitated urine samples were analyzed by LC-MS as described by Kemperman et al.39. 
 
3.4 Data Analysis 
For processing and multivariate statistical analysis the original Bruker 
Daltoniks LC-MS data files were converted to ASCII-format with the Bruker Data 
Analysis software. The ASCII files were transformed into a matrix with the dimensions: 
retention time, m/z value and intensity. Data reduction was performed to combine m/z 
ratios into 1 amu bins (originally 0.1 amu) by multiplying the original data with a 
weight-normalized two-dimensional Gaussian weight matrix. This was followed by time 
alignment using the COW-CODA or the original COW-TIC algorithm. All alignments 
were done with respect to the best and the worst reference chromatogram. The following 
parameters were used for the datasets obtained from analyzing trypsin-digested serum 
(factorial design and cervical cancer respectively) segment length m: 139 data points 
(~2.3 min) and 84 data points (1.5 min), dividing each chromatogram into 51 and 84 
segments; slack parameter t: 28 and 17 data points. The following parameters were used 
for the dataset obtained from analyzing acid-precipitated urine: segment length m: 83 
data points (~2.2 min), number of segments: 41; slack parameter t 16 data points. 
For each aligned chromatogram, a peak list was generated using M-N rules 
with M set to 3 and N to 8. The peak lists, generated from all chromatograms (samples), 
were used to create one common matched peak matrix per study. In order to combine 
peak lists, one-dimensional peak matching was performed using the sliding window 
technique, in which the same m/z traces were evaluated for peaks that are proximate in 
time (step size 0.1 min; search window 1.0 min; maximal accepted standard deviation for 
all retention times within a group of matched peaks 0.75 min). Missing peak locations 
were filled with the calculated, background-subtracted local intensity in the respective 
chromatogram obtained at a location determined from the average m/z and retention 
time of the corresponding peaks in samples where they were detected. The generated 
peak matrix, created from the peak lists of the individual samples, consisted of a 
peak(row)-sample(column)-intensity(value) matrix. 
All data preprocessing work was done on a personal computer equipped with 
a +3800 MHz AMD processor and 4 GB of RAM. The Matlab code of this software is 
available at https://trac.nbic.nl/lcms_time_alignment_algorithms/. 
4 RESULTS AND DISCUSSION 
4.1 Design of the study 
The time alignment algorithm was applied and evaluated with three different 
datasets obtained from proteomics or metabolomics profiling studies. The first set of 
analyzed samples was serum depleted of the 6 most abundant proteins and trypsin-
digested. These samples resulted from a study to discover novel biomarker candidates 
for cervical cancer and they are typical for highly complex, shotgun proteomics samples. 
Previous work had shown that the concentration sensitivity of this method lies in the 
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0.5µM range40, an area where mainly high-abundant proteins with low biological (inter-
patient) variability are detected. It is, however, noteworthy that a number of 
investigators have recently shown that also this part of the proteome may change in a 
disease-dependent manner due to residual proteolytic activity41. This LC-MS dataset 
(referred to as Dataset 1) was acquired under strict standard operating conditions and 
thus contained low analytical variability40. The factorial design dataset (Dataset 2) was 
obtained from depleted and trypsin-digested serum from one healthy female volunteer 
and thus contained no biological variability. However, seven pre-analytical factors were 
deliberately varied and the effect on the overall proteomics profile studied at two 
different levels resulting in considerable analytical variability (see Table 1 for details). 
Dataset 3 was obtained by analyzing acid-precipitated urine, a body fluid containing 
largely low-molecular weight metabolic end products of the organism destined for 
excretion, from 50 different women. Due to a very high level of biological variability in 
this dataset, the generation of a common aligned peak matrix from different LC-MS 
analyses proved particularly challenging. As this dataset was also acquired under 
stringent standard conditions, it had low analytical variability39. The serum samples 
contain on average 10800 features extracted under the specified MN rules, 
corresponding to 2200-3600 peaks, while the urine samples contain 13550 extracted 
features, corresponding to 2700-4500 peaks. The distribution of peaks in the retention 
time-m/z space is quite uniform for urine samples, while the serum samples show an 
elliptical distribution from low retention time and low m/z values to high retention time 
and high m/z values (see Figure S-3 in the supporting information). 
 
4.2 Comparison between the COW-TIC and the COW-CODA 
algorithm 
The performance of the COW-TIC and the COW-CODA algorithms was 
evaluated based on annotated peaks originating from added, known compounds as well 
as by using a global evaluation strategy based on the calculated overlapping peak areas 
between the reference and the various sample chromatograms. 
4.2.1 Evaluation based on added, known compounds 
Figure 2 shows extracted ion chromatograms of selected internal standards 
using the original data (black traces), aligned data after applying the COW-TIC (blue 
traces) or the COW-CODA algorithm (red traces) using the best reference 
chromatograms. Visualization of these peaks (spiked peptides for urine samples and 
horse heart Cytochrome C-derived tryptic peptide fragments for serum samples) in the 
original datasets shows that the initial retention time shifts are on the average 0.52 min 
for Dataset 1 (cervical cancer), 0.23 min for Dataset 2 (factorial design) and 0.31 min for 
Dataset 3 (urine). The COW-TIC algorithm using a 1-dimensional benefit function was 
only able to align Dataset 1, which produced well-defined, highly similar TICs across all 
samples despite the sometimes rather large differences in retention time (up to 2.5 min) 
between runs (Figure 2a). Results obtained with the COW-CODA algorithm were 
comparable to COW-TIC in this case. 
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Although the complexity of the original Dataset 2 is similar to Dataset 1, the 
COW-TIC algorithm was unable to align the chromatograms correctly due to rather 
dissimilar TIC profiles (large analytical variability due to the deliberate variation of pre-
analytical parameters). Indeed, in some chromatograms COW-TIC increased the 
retention time shift differences compared to the original time differences. The COW-
CODA algorithm, on the other hand, resulted in clearly improved alignment resembling 
the result obtained with Dataset 1 (Figure 2b). The difference in performance of the 
algorithms was even more pronounced when trying to align the 50 chromatograms of 
Dataset 3 (urine), which contains large biological variability. The COW-TIC algorithm 
(Figure 2c) lead to a number of obvious misalignments, while COW-CODA resolved the 
initial misalignments correctly leading to a well-matched set of data, except for the 
standard peak eluting around 39 min (see Figure 2c). Even for this peak retention time 
shifts were considerably reduced. Thus only application of the COW-CODA algorithm 
resulted in clearly improved alignments of all studied datasets. Similar results were 
obtained when aligning to the worst reference chromatogram (Figure S-4 in the 
supporting information) indicating that selection of the reference chromatogram has no 
effect on the final quality of warping. This simplifies data processing, since one may start 
the alignment with any chromatogram as the reference. 
Performance of the COW-CODA algorithm might be improved by applying a 
higher extent of smoothing on a separate copy of the LC-MS data to be used for 
calculating the benefit function, while segment-based mass trace selection using CODA 
is still performed on the original LC-MS data using a small extent of smoothing or no 
smoothing at all. However, time alignment with COW-CODA was sufficiently accurate 
for correct peak matching.  
Representing the overlapping peak area of the reference and sample 
chromatograms per segment reveals the performance differences of the two time 
alignment algorithms for different segments. Figure S-6 shows the overlapping peak 
area of the segments between the best reference and a given sample chromatogram. The 
figure shows that for most of the segments the two algorithms give similar results. While 
COW-TIC is performing slightly but not substantially better than COW-CODA for some 
segments (segments 16-18, 20, 22-23 and 28 show slightly better performance and 
segment 19 shows moderately better performance), COW-CODA improves alignment of 
segments 21, 25-27, 29-31, 33, 38 with substantial improvements for segments 21, 29 and 
33. 
Retention time correction as a function of retention time obtained with the 
COW-CODA and COW-TIC algorithm are presented in Figure S-7 (Supporting 
Information; for chromatograms 1 and 14 for Dataset 2 (Factorial design)) showing 
substantial corrections between retention times of 110 and 125 min and the superior 





Figure 2. Extracted ion chromatograms of internal standard peptides (a) Dataset 1 (cervical cancer 
serum) comprised of 20 chromatograms, (b) Dataset 2 (factorial design serum) comprised of 19 
chromatograms, and (c) Dataset 3 (acid-precipitated urine) comprised of 50 chromatograms. Each 
peptide is presented before alignment (top/black), after alignment by COW-TIC (middle/blue), 
and after alignment by COW-CODA (bottom/red). These time alignment results were obtained 
using the best references, which were chromatograms number 2, 14 and 25 for Datasets 1, 2 and 3, 
respectively. Significant misalignments are observed for Datasets 2 and 3 when using the COW-TIC 
algorithm, while the COW-CODA algorithm resulted in well-aligned peak clusters. 
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4.2.2 Global evaluation of alignment quality 
The sums of overlapping peak areas between pairs of chromatograms from 
the same dataset were obtained with the original data, after applying the COW-TIC or 
the COW-CODA algorithm, using  the best or the worst reference chromatogram  
(Figure 3 and Figure S-5 in SI). The COW-CODA algorithm improved time alignment for 
all three datasets compared to the original, non-aligned data and for Datasets 2 and 3 
with respect to the COW-TIC algorithm confirming results obtained with the internal 
standards. The COW-TIC algorithm led to higher overlapping peak areas than COW-
CODA for Dataset 1, but the difference between the performances of the two algorithms 
is very small. The slightly better performance of COW-TIC in this case could be due to 
the fact that CODA-selected single mass traces contain higher levels of noise than the 
TIC, where the noise of the individual mass traces averages out. The slightly better time 
alignment using COW-TIC was also observed when inspecting individual peaks of 
tryptic peptides derived from the added Cytochrome C (see Figure 2a). 
 
4.3 Effect of reference chromatograms 
It may be argued that all COW-based algorithms depend strongly on the 
selected reference chromatogram (see Figure S-8 of the supporting information and the 
Material and Methods section on how reference chromatograms were selected). In order 
to study this factor in more detail, we compared the overlapping peak areas (Figure S-5) 
confirming earlier results that showed that the overall quality of alignment using the 
CODA-COW algorithm depends little on the reference chromatogram. However, small 
differences were observed in Dataset 1 for chromatograms 18 and 19 and for a few 
chromatograms in Dataset 3 (Figures S-5a and c). The stability of the algorithm for 
Datasets 1 and 2 with respect to the choice of the reference chromatogram increases our 
confidence that the extent of misalignment with any of the chosen reference 
chromatograms is small. We assume that a large number of misalignments would have 
resulted in variable overlapping peak areas depending on the selected reference 
chromatogram. The fact that the COW-CODA algorithm functions correctly and 
independently of the chosen reference chromatogram greatly simplifies automation of 
the time alignment step as part of the overall data processing pipeline for 
chromatograms obtained from depleted, trypsin-digested serum samples. The slight 
dependency of the final alignment on the chosen reference chromatogram for Dataset 3 
shows, however, the need for algorithms that select the best reference for datasets with 
high biological variability. Calculating the overlapping peak area appears to be a 





Figure 3. Calculated overlapping peak area after application of M-N rules to (a) Dataset 1 (cervical 
cancer serum), (b) Dataset 2 (factorial design serum), and (c) Dataset 3 (acid-precipitated urine). 
Original non-aligned data (black), aligned with the COW-TIC (blue) or with the COW-CODA 
algorithm (red). COW-CODA (red) improved the alignment for all three datasets compared to the 
non-aligned data and with respect to COW-TIC for Datasets 2 and 3. These time alignment results 
were obtained using the best references, which was the chromatogram number 2, 14 and 25 for 
Datasets 1, 2 and 3, respectively. 
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4.4 Assessing the inherent variability of the datasets and the required 
processing time 
With a properly aligned common peak matrix, it is possible to assess the 
variability of the different datasets. A first evaluation of the variability of Datasets 1-3 
was performed by plotting the number of detected peaks against the relative standard 
deviation (RSD)(Figure 4). Based on considerations discussed before, it is expected that 
the relative standard deviation (RSD) histogram obtained from the aligned peak matrix 
of the depleted and trypsin-digested serum samples from cervical cancer patients 
(Dataset 1) would be narrower relative to histograms obtained from the factorial design 
or urine datasets. Figure 4 shows further that the biological variability of urine not only 
increases the maximum RSD, but results also in a broader RSD distribution compared to 
serum datasets, indicating that peaks have rather high variability in intensity in urine. 
This stands in contrast to the serum-derived Dataset 2, where variation is only due to 
pre-analytical parameters, which increases only the mode of RSD without broadening 
the RSD distribution. Accurate time alignment thus allows to measure the variability 
that is inherent to the datasets resulting from analytical and biological variations. Such 
histograms may be used to perform statistical simulations, e.g. for power calculations, or 
to test the performance of different variable selection and classification algorithms. 
Alignment of one pair of chromatogram obtained with serum samples (~7100 
scans) took ~22 minutes using COW-CODA and 0.8 minutes using COW-TIC with an 
ordinary PC as described in the Material & Methods section. The processing time for 
chromatograms obtained from urine samples (~3450 scans) was 5.35 minutes for COW-
CODA and 0.2 minutes for COW-TIC. The ~27-times higher processing time of COW-
CODA is mainly due to the higher I/O, since the algorithm operates on the full LC-MS 
dataset contrary to the COW-TIC algorithm, which is only using a single trace, the TIC, 
for the time alignment procedure.  
 
5 CONCLUSIONS 
We describe an improved time alignment algorithm based on COW combined 
with a segment-wise selection of high-quality mass chromatograms using CODA. This 
algorithm is effective in aligning highly complex proteomics and metabolomics LC-MS 
datasets containing different levels of analytical and biological variability. The novel 
algorithm outperforms the original COW-TIC algorithm in the case of datasets 
containing either a high level of analytical (factorial design study) or biological (acid-
precipitated urine) variability. 
The presented algorithm uses a 2-dimensional benefit function in order to 
discriminate between peaks with different m/z values eluting at similar or identical 
retention times and to select mass traces sharing common, high-quality peaks. We have 
observed only very minor misalignments after visually inspecting a few hundred 
Extracted Ion Chromatograms for each of the analyzed samples. This strongly supports 
the conclusion that the COW-CODA algorithm results in a very high quality of time 
alignment and that the studied datasets contain a sufficient number of common peaks in 




Figure 4. Standard deviation of the intensity of peaks selected with M-N rules (M = 3; N = 8) in 
Datasets 1 (cervical cancer serum) (green), 2 (factorial design serum) (blue) and 3 (acid-precipitated 
urine) (red) divided by the mean before warping (top) and after warping with the COW-CODA 
algorithm (middle) and after warping with COW-TIC (bottom). These time alignment results were 
obtained using the best references, which were chromatograms 2, 14 and 25 for Datasets 1, 2 and 3, 
respectively. 
 
Another advantage of COW-CODA is that only a few parameters need to be 
selected and optimized depending on the dataset (e.g. adapting the chosen segment 
length to the observed chromatographic peak width) and that the final quality of 
alignment is rather independent on the initially chosen reference chromatogram. 
This chapter present results from low-resolution MS data. However, COW-
CODA is also applicable to high-resolution data using Gaussian smoothing and data 
reduction to 1 amu in the mass dimension, since the algorithm only calculates the 
corrected retention time of the mass scans (Figure S-9 in SI). This “binning” does not 
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affect the ultimate resolution of the MS data, since the warped retention time values of 
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Time alignment of complex LC-MS data remains a challenge in proteomics and 
metabolomics studies. This work describes modifications of the Dynamic Time Warping 
(DTW) and the Parametric Time Warping (PTW) algorithms that improve the alignment 
quality for complex, highly variable LC-MS data sets. Regular DTW or PTW use one-
dimensional profiles such as the Total Ion Chromatogram (TIC) or Base Peak 
Chromatogram (BPC) resulting in correct alignment if the signals have a relatively 
simple structure. However, when aligning the TICs of chromatograms from complex 
mixtures with large concentration variability such as serum or urine, both algorithms 
often lead to misalignment of peaks and thus incorrect comparisons in the subsequent 
statistical analysis. This is mainly due to the fact that compounds with different m/z 
values but similar retention times are not considered separately but confounded in the 
benefit function of the algorithms using only one-dimensional information. Thus, it is 
necessary to treat the information of different mass traces separately in the warping 
function to ensure that compounds having the same m/z value and retention time are 
aligned to each other. The Component Detection Algorithm (CODA) is widely used to 
calculate the quality of an LC-MS mass trace. By combining CODA with the warping 
algorithms of DTW or PTW (DTW-CODA or PTW-CODA), we include only high quality 
mass traces measured by CODA in the benefit function. Our results show that using 
several CODA selected high quality mass traces in DTW-CODA and PTW-CODA 
significantly improves the alignment quality of three different, highly complex LC-MS 
data sets. Moreover, DTW-CODA leads to better preservation of peak shape as 
compared to the original DTW-TIC algorithm, which often suffers from a substantial 
peak shape distortion. Our results show that combination of CODA selected mass traces 
with different time alignment algorithm is a general principle that provide accurate 
alignment for highly complex samples with large concentration variability. 
Time	  Alignment	  Algorithms	  using	  Selected	  Mass	  Traces	  
 65 
1 INTRODUCTION 
Time alignment is a critical step in the data pre-processing of comparative 
studies based on LC-MS analyses, which are widely used in ‘omics’ experiments. 
Without an accurate time alignment, nonlinear retention time shifts across different 
chromatograms lead to incorrect peak matching and invalid subsequent statistical 
comparisons. This is especially the case for highly complex data sets with large 
concentration variation, where incorrect alignment may result in misinterpretation of 
comparative ‘omics’ experiments.1-3 The importance of time alignment in comparative 
biomarker discovery studies is emphasized by the increasing number of published time 
alignment applications and review papers on the subject.1, 4-29 These time alignment 
methods differ in their benefit functions as the criterion to construct the warping 
function that transforms the original retention time to the corrected retention time of the 
sample chromatogram. Since the throughput of proteomics experiments is constantly 
increasing, continuous improvement of automated time alignment methods is needed to 
align accurately the large amount of generated complex LC-MS data. 
In this work, we focus on the modification of two widely used time alignment 
algorithms: Dynamic Time Warping (DTW)5 and Parametric Time Warping (PTW)6, and 
compare the results to our earlier work with the Correlation Optimized Warping-
Component Detection Algorithm (COW-CODA).4 Comparisons of time alignment 
quality of these algorithms using TICs or BPCs have been performed earlier for COW 
and DTW,18, 25 COW and PTW,26 or all of the three methods.24 These comparisons were 
performed on simple data sets having a low number of compounds and low 
concentration variability. The studies concluded that generally COW improved peak 
alignment and resulted in close location of the corresponding peaks in different 
chromatograms, however in some cases, DTW resulted tighter alignment compare to 
COW.  However, DTW is prone to distortion of peak shapes, while COW preserved well 
the peak shape after alignment. PTW was reported to be faster than DTW or COW but 
less precise in terms of time alignment.24 
Several modifications have been introduced to these algorithms in order to 
improve the quality of time alignment and to adapt to different data sets. DTW has been 
adapted to align data sets derived from capillary electrophoretic,24 gas 
chromatographic,18, 25, 30 and near infrared spectroscopic data sets.20 Peak shape 
distortions were observed and identified as major disadvantages of the DTW algorithm. 
This led to further work in order to preserve peak shape.10, 25 Tomassi et al.25 showed that 
changing the value of the slope constraint affected the extent of peak shape distortion 
after alignment. The optimum value was obtained empirically depending on the 
characteristics of the data (e.g. the initial retention time shift). Clifford et al introduced a 
variable penalty for each non-diagonal move in the warping path.10 Even though these 
modifications were able to retain the peak-shape after DTW, they were intended to work 
on one-dimensional profiles only. 
We show that both DTW and PTW fail in aligning the same compounds 
across multiple LC-MS data sets from complex proteomics or metabolomics samples, 
where many compounds with high concentration variability elute at similar retention 
times. The reason for this failure is that neither TICs nor BPCs provide information 




the mass spectrometric information into account have been published. Most of these 
approaches do not work on the full data but rather on peak lists that require prior peak 
picking using various algorithms.19, 21-23 The quality of time alignment using peak lists 
thus depends considerably on the quality of the peak detection algorithms. 
Only a few approaches use single stage mass spectra and thus separate the 
intensity information for peaks of different masses eluting at the same retention time.19, 
31, 32 The first two methods either use the entire mass spectrum and a complex gap 
penalty functions to avoid a large number of consecutive non-diagonal steps in DTW,19, 
31 or use score functions which involve all peaks in the mass spectra and try to calculate 
the score due to the pure signal by removing noise contribution obtained with random 
reordering of peaks within mass spectra and setting each score below 0.2 to 0.31 A third 
method use the 200 mass traces containing the highest peaks in the chromatograms.32 
The latter method provides insufficient description since it does not describe the form of 
the benefit function and the exact method used to combine the intensity information of 
different mass traces. 
In the present studies, we are using a Component Detection Algorithm 
(CODA)33 to select high-quality mass traces from a complete chromatogram prior to 
alignment. We subsequently separate the signals of the selected mass traces in the 
benefit function of DTW and PTW by summing up the differences between sample and 
reference chromatograms using each selected mass trace separately. 
Combining CODA with DTW or PTW required fundamentally different 
mathematical approaches as compared to COW,4 since the selection of high quality mass 
traces is performed prior to the alignment procedure while in COW-CODA mass trace 
selection is part of the warping procedure and different mass traces are selected for each 
COW segment. The alignment process of DTW and PTW, however, uses the same set of 
mass traces over the entire chromatographic time range and mass traces selection must 
be done prior to warping. 
Performance of DTW-CODA and PTW-CODA was compared to each other as 
well as to COW-CODA and to the one-dimensional time alignment approaches (DTW-
TIC, PTW-TIC and COW-TIC). The sum of overlapping peak areas was used as criterion 
to judge the time alignment quality on label-free single stage LC-MS data sets obtained 
during comparative profiling studies for biomarker discovery using trypsin-digested 
human serum and acid-precipitated urine samples. 
 
2 MATERIAL AND METHODS 
2.1 Computational Methods 
Time alignment is driven by time concordance of common peaks 
(compounds) that are shared between reference and sample chromatograms. The 
success of such a procedure depends on the capacity of an algorithm to find as many 
common peaks as possible with high accuracy and to use only the information from 
these common peaks in the retention time shift correction procedure (benefit function). 
In general, a time alignment algorithm for LC-MS data must have the following 
properties: 1) assuring that peaks with similar retention times but different m/z values 
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are considered as separate features in the benefit function to avoid merging of different 
peaks signal having similar retention time but different m/z values; 2) considering only 
data from peaks that are shared between the reference and sample chromatograms in the 
benefit function; 3) discarding data containing a high level of noise; 4) taking peaks, 
background and noise distribution in the LC-MS data set into account locally; and 5) 
assuming that there are no changes in elution order of analytes between different LC-MS 
chromatogram.8, 31 
Taking local peak distribution into consideration is more difficult using DTW 
or PTW than COW. This is because DTW performs retention time alignment data point-
by-data point instead of the segment-wise procedure of COW. Selection of local high-
quality mass traces, which are the same in the reference and sample chromatograms, but 
which could be different for each time point is not possible in DTW, because changing 
mass traces for different retention time data points will lead to discontinuity in the 
calculated minimal cumulative distance used in the benefit function of the algorithm. As 
is the case for DTW, it is not possible to use different mass traces at different retention 
times in PTW, since PTW computes the warping function using an iteration procedure. 
In each step it calculates the quadratic distance of the two traces using the entire time 
range, and locally different mass traces would result in similar discontinuity as with 
DTW. For that reason we have introduced a global mass trace selection procedure, to 
measure the quality of mass traces across the entire chromatogram based on the average 
local quality of the mass traces. We have further used these selected high quality mass 
traces for the entire retention time range in the warping procedure. 
 
2.1.1 Measuring the average quality of LC-MS mass traces 
This section describes how the local quality of a chromatogram is determined 
by measuring the quality of a mass trace and how high-quality mass traces are selected 
prior to the warping procedure. The quality of a chromatogram corresponds to the ratio 
between peak related information and noise. Three main types of noise in mass 
spectrometry data are spikes, chemical noise and electronic noise. Signals that 
correspond to a single data point, the so-called spikes, are generated at the ion source 
between the LC and MS and the MS ion optics interface.34 The other two noise 
components are due to ionized, contaminating chemical compounds (chemical noise)35 
and to the electronic noise from the detector. The local average of the combined noise is 
the local background level of the chromatogram. 
A mass trace with high background will have a high mean value, thus the 
mean subtracted mass trace will be rather different from the original signal. Similarly, a 
mass trace with spikes will differ strongly from the smoothed version that is obtained by 
using a moving average across several data points, as spikes are usually single-point 
events. Combining the measures of similarity between the mean-subtracted version and 
the smoothed version using a moving average of the original mass traces gives a single 
similarity value that takes both the contamination with spikes and the chemical and 
electronic background noise into account to result in a so-called quality index the Mass 
Chromatographic Quality (MCQ) after Windig et al.33 High quality mass traces contain 
low noise levels and low spikes relative to the intensity of detected peaks. The CODA 




calculating the MCQ of single mass chromatograms over the entire time range. 
However, in complex LC-MS data it is often the case that the quality of LC-MS signals 
varies with respect to retention time even within a single mass trace. For the DTW and 
PTW algorithm, it is preferable to select a mass chromatogram containing a large 
number of peaks more or less evenly distributed across the entire time range rather than 
mass traces with similar MCQ values but containing few peaks that are concentrated in a 
narrow retention time window. We have therefore modified CODA to take the local 
peak distribution into account giving preference to mass traces that contain an evenly 
distributed high number of intense peaks. 
The quality of the local signal for each mass trace is measured by applying 
CODA to overlapping moving windows with a length of a data points, where a is an odd 
number so that integer b satisfies a = 2b + 1. Chromatogram C has size 
€ 
m × t  where m 
corresponds to the index of mass traces and t to the index of retention times. For each 
position (i,j) in chromatogram C, an MCQ value of C(i,j−b...j+b) is calculated. This MCQ 
value is regarded as the quality of the signal at position (i,j). This step produces a matrix 
Q, with the same size as the respective chromatogram, containing MCQ values for each 
data point of the chromatogram based on the equation below: 
Q (i , j ) =
CODA (C (i , j !b... j +b))
CODA (C (i ,1...2b +1)) for j " b








The quality of a mass trace is the average of the local MCQ values obtained 
for the same mass trace. Each chromatogram has thus a corresponding vector with size 
equal to the number of mass traces m. This vector contains the average MCQ values for 
the respective mass traces, and is used as quality scores to select mass traces prior to 
DTW and PTW (DTW-CODA, PTW-CODA). 
 
2.1.2 Mass Trace Selection for Time Alignment 
The alignment of two chromatograms requires the selection of several mass 
traces based on their respective quality in sample and reference chromatograms. 
Suppose chromatograms CR and CS have respectively a mean MCQ vector AR and AS, 
where index R and S refer to reference and sample chromatograms, respectively. The 
product AS · AR indicates the combined quality of mass traces in both chromatograms. 
Mass traces that result the highest product are then selected to be included in the 
warping function. In this paper, the product of average MCQ values obtained with 
moving windows will be referred to as the “Local Component Detection Algorithm”, 
abbreviated as LCODA. 
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2.1.3 Dynamic Time Warping combined with LCODA-Selected Mass Traces 
(DTW-CODA) 
The DTW algorithm using one-dimensional signals has been described 
previously in a number of publications.1, 5, 10, 18-20, 24, 25 This section describes an extension 
of DTW algorithm using selected high quality mass traces based on the LCODA 
procedure. The concept of this method is illustrated schematically in Figure 1. 
 
Figure 1. Schematic representation of the DTW-CODA algorithm. The grid representation shows 
the dynamic programming approach to calculate the cumulative minimal distance between sample 
S and reference R chromatograms using a set of LCODA-selected mass traces K. The area rounded 
by bold diagonal lines represents the search space of the DTW algorithm as defined by constraint c. 
In this area the cumulative minimum distance is calculated as the minimal sum of the intensities of 
LCODA-selected mass traces using the predecessor rules (see Equation 3) starting from grid point 
(1,1) until reaching the final grid point (LS, LR). Score and path matrices corresponding to the grid 
coordinates contain the cumulative minimum distance and the grid location indices of the points 
according to the cumulated minimal distance obtained using predecessor rules and the constraint c. 
The final optimal warping path is determined by backtracking the preceding grid indices 








Suppose two chromatograms R (reference chromatogram with number of 
time scans LR) and S (sample chromatogram with number of time scans LS) are to be 
aligned using a set of LCODA-selected mass traces K, for each combination i and j, 
where |i - j| ≤ c (constraint). The local distance d(i,j) is calculated by: 
d (i , j ) = (S k (i )
k !K
" # Rk ( j ))2    Eq. 2. 
Sk(i) is the intensity value of mass trace k at time point i in chromatogram S 
and Rk(j) is the intensity value of mass trace k at time point j in chromatogram R. Two 
matrices of size LS × LR, which correspond to the grid presented in Figure 1, are 
constructed. The first matrix (score matrix) contains the minimal cumulative distances 
between S and R. The second matrix (path matrix) contains the index of the optimum 
warping position that gives the respective cumulative minimum distance in the score 
matrix. The search space defining the allowed retention time transitions between the 
sample and reference chromatograms is defined by constraint c, which limits the 
maximal deviation from the diagonal by c number of points. For each position (i, j) in the 
defined search space, the minimum cumulative distances D(i,j) are obtained from one of 
the three allowed predecessors {(i−1, j), (i−1, j −1), (i, j − 1)} based on Eq. 3. If the lowest 
score is obtained from different predecessors and one of them is the diagonal, then the 
diagonal path will be chosen to be included in the warping path. 
D (i , j ) =min
D (i !1, j )+ d (i , j )
D (i !1, j !1)+ d (i , j )













         Eq. 3. 
The global minimal distance between chromatograms S and R is obtained by 
means of dynamic programming from the score matrix by calculating D(i,j) from position 
(1,1) until (LS,LR) within the search space defined by constraint c. The global optimal 
warping path is obtained from the path matrix by backtracking the points resulting in the 
minimal cumulative distance as the last step of the time alignment procedure. 
 
2.1.4 Parametric Time Warping combined with LCODA Selected Mass Traces 
(PTW-CODA) 
The PTW algorithm for aligning one-dimensional signals between a sample 
s(ti) and a reference chromatogram r(ti) was introduced by Eilers.6 The algorithm 
optimizes the coefficient ad of the polynomial warping function w(ti) with d degrees so 
that the aligned sample signal s(w(ti)) has the lowest cumulative distance G to the 
reference. In the present study we use a second-degree polynomial warping function 
with the form of w (ti ) = a0 +a1ti +a1ti
2 . The equation of the benefit function G is defined 
as follows: 




    Eq. 4. 
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H indicates the set of indices i for which 
! 
ˆ s(w(ti))  can be computed after 
interpolation of the sample chromatogram data points to the retention time vector 
(sampling points) of the reference chromatogram. In order to include the information of 
LCODA-selected traces, the benefit function G has been adapted to align two-
dimensional signals based on a set of LCODA-selected traces K (Eq. 5). Based on a set of 
LCODA-selected traces one obtains one warping function w(t) using iterative process, 




" [rk (ti )# sˆk (w (ti ))]
i!H
"
2     Eq. 5. 
2.2 Property of the Data Sets and Data Pre-Processing 
The algorithms were evaluated with three different LC-MS data sets with 
different analytical and biological characteristics as described in Christin et al.4 Two data 
sets were derived from the analysis of trypsin-digested human serum (cervical cancer 
data set and factorial design data set) depleted of the six most abundant proteins and 
one data set from acid-precipitated urine of pregnant or non-pregnant women. The 
study protocol of the three data sets was in agreement with local ethical standards and 
the Helsinki declaration of 1964, as revised in 2004. At the University Medical Center 
Groningen (UMCG, Groningen, The Netherlands) all newly referred patients are 
routinely asked to give written informed consent for collection and storage of 
pretreatment and follow-up serum, urine and tumor samples in a serum/urine/tissue 
bank for future research. Relevant patient data and follow-up are also retrieved and 
transferred into an anonymous, password-protected, database. According to Dutch 
regulations, these precautions mean no further institutional review board approval is 
needed (http://www.federa.org). 
All chromatograms were acquired on an ion trap mass spectrometer (Agilent 
Technologies, LC-MSD SL series, Santa Clara, California, USA) in randomized order 
with automated gain control of accumulation time of ions to reach fixed number of 
30.000 ions in the trap, using a rolling average of two spectra in single-stage MS mode. 
The acquired data were converted and subsequently stored in centroid mode. 
 
2.2.1 Serum Samples 
Serum samples were obtained from the Department of Gynecological 
Oncology (UMCG) and stored at -80ºC in aliquots until analysis. Blood was collected in 
glass tubes (Becton Dickinson, Franklin Lakes, New Jersey, USA) with a siliconized inner 
wall, allowed to clot for at least 2 hours at room temperature before centrifugation at 
1000 g for 10 minutes to obtain serum. Serum samples were stored at –80°C in the local 
serum bank until use. Before LC-MS analysis the serum samples were depleted of the six 
most abundant proteins using a Multiple Affinity Removal column (4.6 × 50 mm, 
Agilent Technologies). After trypsin digestion of the remaining proteins, all serum 
samples were stored at -80° C in aliquots until the final LC-MS analysis. The depletion 




2.2.1.1 Cervical Cancer Data Set 
This data set is derived from a biomarker discovery study for cervical cancer. 
Serum samples from 10 patients were taken at two time points: before treatment (time 
point A) and after treatment with no recurrence of the disease for at least 6 months (time 
point B). These samples were analyzed by LC-MS resulting in 20 chromatograms. All 
patients in time point A showed high squamous cell carcinoma antigen-1 (SCCA-1) level 
(above 1.9 µg/ml) and no recurrence of disease after therapy except for two patients, one 
with partial remission and the other with stable disease where tumor remains without 
progression. The diagnosis was done by histological analysis and gynecological 
examination: inspection and palpation of the genitalia and SCCA-1 test. Patients with 
remission have no complains and normal SCCA-1 concentrations in time point B. All 
patients used in this study had advanced disease (stage III or IV) according to the 
International Federation of Gynecology and Obstetrics (FIGO) classification37 and 
belonged to a group of long-term survivors. The level of the SCCA-1 was determined by 
ELISA.38 Further details about the analysis of these samples using LC-MS are described 
in Govorukhina et al. 36 
2.2.1.2 Factorial Design Data Set 
The serum sample for the factorial design study was obtained from one 
healthy female volunteer. The sample preparation procedure for this dataset was similar 
to the cervical cancer data set except for the following seven factors that were varied 
deliberately to investigate the influence of pre-analytical factors on the LC-MS profiles: 
blood collection tube, hemolysis level, clotting time, number of freeze-thaw cycles, 
trypsin to protein ratio, deactivation of trypsin after digestion, and stability of the 
digested sample in the autosampler of the LC-MS system at 4° C. Each factor was varied 
at two levels (high and low) and from 128 possible combinations, 16 combinations were 
selected according to a two-level 2IV
7!3  fractional design with resolution VI and with 3 
repetitions of one condition. Detailed description of the factors and condition are 
described in Christin et al.4 Nineteen LC-MS analyses were performed using the same 
protocol described by Govorukhina et al.36 
 
2.2.2 Acid-precipitated Urine Data Set 
Twenty-five first-void midstream morning urine samples from pregnant 
women were obtained from a local biobank (Department of Obstetrics and Gynecology 
of the University Medical Center in Groningen, The Netherlands) and directly stored 
frozen at -20° C. Twenty-five first-void midstream morning urine samples of non-
pregnant women were collected in polypropylene containers and kept at 4° C for a 
maximum of 1 day before the samples were stored at -20° C in aliquots. The acid-
precipitated urine samples were analyzed by LC-MS as described in Kemperman et al.39 
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2.3 Data Pre-processing 
The original LC-MS chromatograms were converted to ascii files using the 
Bruker DataAnalysis (version 3.4, Build 181) software. Each ascii file was transformed 
into a two-dimensional matrix containing intensity values using an in-house developed 
data pre-processing pipeline. In this matrix each row has a corresponding m/z and each 
column a respective retention time value. During transformation, data reduction from 
0.1 to 1 amu per bin was performed in the m/z dimension using two-dimensional 
Gaussian smoothing, while no data reduction was performed in the retention time 
dimension. All time alignment algorithms were applied to the transformed matrices. For 
each data set, one chromatogram was selected as the reference according to the 
procedure described in Christin et al.4 Briefly, the best reference is the most frequently 
selected chromatogram having the highest sum of correlation to all other 
chromatograms in the data set based on the reconstructed TIC from a variable number of 
CODA selected mass traces. Similarly the worst reference is the most frequently selected 
chromatogram having the lowest sum of correlation to all other chromatograms in the 
data set of the reconstructed TIC from a variable number of CODA-selected mass traces. 
The list of the best and the worst reference for each data set can be found in the Table S-1 
(Supporting Information). 
A peak picking algorithm was applied to the transformed matrices based on a 
filter developed by Radulovic et al. called M-N rules40 with M = 8 and N = 3. Signals are 
only retained if their intensity exceeds n times the local baseline for m consecutive data 
points in a single mass trace. The matrices obtained after peak picking are used later to 
evaluate and compare the quality of the time alignment algorithms by calculating the 
sum of overlapping peak area of two matrices. The data processing pipeline was 
executed on a personal computer equipped with an Intel® Core™ Quad CPU Q9300 @ 
2.5 GHz processor and 8 GB of RAM. The time alignment software is written in Matlab 
and available at https://trac.nbic.nl/lcms_time_alignment_algorithms/. 
 
3 RESULTS 
3.1 Importance of data preprocessing 
Ion trap mass spectrometers provide low resolution data, which contain small 
m/z shifts of peaks caused by local space charge effects.41 Binning procedures summing 
up intensity in mass spectra between predefined borders are often used to reduce the 
amount of data and thus the processing time.19 However, binning procedures processing 
centroided ion trap data result in very noisy data because of the local space charge effect. 
Application of two-dimensional smoothing using a Gaussian kernel, on the other hand, 
results in smooth data in both dimensions, which contain less noise, especially in the 
retention time dimension, which leads to a lower accumulated error in the benefit 
function of the time alignment algorithms (Figure S-1a,b). Figure S-1c shows an 
extracted ion chromatogram (EIC) of two adjacent masses of binned data and one mass 
trace of the data obtained after two-dimensional Gaussian smoothing of one peak. The 
binned data are fluctuating between the two adjacent mass traces, since the highest 




data are used to calculate the correlation, such fluctuations between two adjacent mass 
traces will result in noise, as the fluctuation is a random event with respect to different 
chromatograms. On the other hand, data obtained by two-dimensional Gaussian 
smoothing will result in smooth Gaussian type profiles for each of the m/z mass traces 
providing thus an efficient contribution to the correlation between two chromatograms. 
In our application we have used two-dimensional Gaussian smoothing to improve time 
alignment. 
 
3.2 DTW-CODA and PTW-CODA 
To compare the quality of the alignment with DTW and PTW in combination 
with CODA to the performance of the original algorithms (DTW-TIC and PTW-TIC 
respectively), we applied them to label-free LC-MS data from complex biological 
samples. To present the operating principle of the DTW/PTW CODA algorithms, two 
chromatograms from the urine data set were chosen randomly. We selected 
chromatograms from this dataset, because it is most challenging when it comes to time 
alignment problems due to the large concentration variation of compounds as a result of 
inter-individual (biological) differences. 
 
3.2.1 Performance of DTW-CODA 
An internal standard peptide (YPFPG, m/z 580, retention time 49.3 min), 
which was not included in the 200 selected mass traces, was used to assess the local time 
alignment quality. A visual comparison of the alignment of this peptide by DTW-CODA 
using different numbers of LCODA-selected traces shows that a minimum of 20 selected 
mass traces is needed to reduce the extensive misalignments that were observed with 
DTW-TIC. However, peak shape distortions were only avoided when the number of 
selected mass traces was extended to more than 50. Selecting 200 mass traces proved to 
give the best alignment with negligible peak shape distortion. 
The difference in the optimal warping path obtained with DTW-TIC and 
DTW-CODA indicates that the algorithms do not arrive at the same final warping 
function (Figure 2). This is due to the fact that the TIC of the sample chromatogram is 
rather different from that of the reference chromatogram in the depicted region (45 – 55 
min) making it difficult, if not impossible, for the DTW warping function to find the 
optimal warping path, since mass spectrometric information is not considered 
separately. The result is a ‘random’ warping path that leads to poor alignment and a 
distorted peak shape (Figure 3-middle panel). Simplifying the initial alignment problem 
by selecting 200 high-quality mass traces allows the DTW algorithm to find a warping 
path that deviates little from the diagonal of the score and path matrices reflecting the true 
small shifts between retention times in the original sample and reference chromatograms 
(see Figure 3-top panel). Such a "smoother" warping path leads to time alignment 
without peak distortion and tight alignment of peaks (see Figure 3-bottom panel). On 
the other hand, DTW-TIC will only succeed in aligning LC-MS data sets when the TIC 
profiles are “well-defined” and similar as a result of little concentration variability in the 
analyzed samples. For that reason, time alignment using the TIC of complex ‘omics’ LC-
Time	  Alignment	  Algorithms	  using	  Selected	  Mass	  Traces	  
 75 
MS analyses of body fluids containing many compounds with high concentration 
variability is challenging and in most cases impossible. 
 
Figure 2. Comparison of the warping paths obtained with DTW-TIC and DTW-CODA using 200 
high-quality LCODA-selected mass traces over a retention time window of 45-55 min in two 
chromatograms (5082628 and 5082630) from the acid-precipitated urine data set. DTW-TIC results 
in a rather ‘chaotic’ warping path ending in incorrect time alignment (Figure 3, middle panel). 
Using 200 pre-selected, high-quality mass traces, DTW-CODA follows a much smoother warping 
path correcting for the minor shifts in retention time that were present in the original data (Figure 3, 
top panel). Indeed DTW-CODA was able to find the optimal warping path by minimizing the sum 
of the cumulative distance of the LCODA-selected mass traces between the sample and reference 
chromatograms (see Figure 3, bottom panel). 
 
Figure 3 shows the difference of the performance between DTW-TIC and 
DTW-CODA exemplified for a section of the EIC for m/z 580 related to the added 
standard peptide YPFPG. A major problem with the DTW-TIC algorithm is that it may 
lead to distortion of the chromatographic peak shape (see Figure 3-middle panel). When 
using several mass traces in the warping function of DTW-CODA, the algorithm tries to 




traces. This results in a smoother warping path and a decreasing number of consecutive 
non-diagonal moves resulting in less peak distortion. 
Figure S-2 (Supporting Information) shows the overlaid two-dimensional 
image of the reference and sample chromatogram obtained from urine samples with the 
original retention time, and after correcting retention time shifts using DTW-CODA 
(present the entire elution range of compounds (42-92 min) over an m/z range between 
80-620 amu). This figure shows that non-linear retention time shifts in the sample 
chromatogram are accurately corrected with respect to the reference chromatogram by 
the DTW-CODA algorithm. A few peaks can be observed in the reference chromatogram 
(red) or sample chromatograms (green), which are absent in the corresponding other 
chromatogram (orphan peaks), while the shared common peaks present in both 
chromatograms (yellow) are well aligned. The retention times of these orphan peaks are 
also shifted by DTW-CODA to follow the same trend as the shared common peaks (e.g. 
peak at 335 m/z and 49 min of original retention time). This indicates that these peaks 
are also positioned correctly in the aligned chromatograms. In addition, the larger extent 
of retention time shifts observed in the beginning of the original chromatograms (20–40 
min) (Figure S-2-b), most probably due to the use of a trapping column, were effectively 
corrected. One major advantage of combining DTW with LCODA-selected mass traces is 
that even without the use of special rules for the allowed predecessor steps in time 
alignment, the algorithm is highly conservative with respect to preserving the peak 
shape. 
 
3.2.2 Performance of PTW-CODA 
The same internal standard peptide (YPFPG, m/z 580, retention time 49.3 
min) was used to assess the local alignment quality of PTW-CODA. To define the 
optimal number of selected mass traces, we calculated the sum of squared intensity 
differences using all points in single-stage LC-MS images between 8 randomly selected 
pairs of reference and the sample chromatograms after time alignment using a variable 
number of LCODA-selected mass traces ranging from 20 to 600. Two hundred selected 
mass traces resulted in the stabilized sum of squared intensity differences for these pairs 
of chromatograms (see Figure S-3 in Supporting Information). We have used the same 
200 LCODA-selected mass traces for PTW-CODA as with DTW-CODA in order to 
facilitate comparison and to be sure that we are using a value, which is optimal for all 
chromatogram pairs. 
The value of the 200 highest quality LCODA-selected mass traces gave 
accurate alignment in all three data sets. However, other data sets or different 
chromatogram pairs with different peak distribution or concentration variance may 
require a different number of high quality mass traces for optimal alignment. In that case 
the above described optimization procedure using the sum of squares of the intensity 
differences for all mass traces after applying the PTW-CODA algorithm should be used 
prior to the final application of PTW-CODA. 
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Figure 3. Application of DTW-TIC or DTW-CODA to two chromatograms obtained from acid 
precipitated urine sample (chromatograms 5082628 and 5082630; see also Figure 2. for the 
corresponding warping paths). a) original TICs (sample: blue; reference: red) prior to time 
alignment showing rather dissimilar profiles due to biological variability between samples; b) 
original EICs (580 +/- 0.5 amu) of the internal standard peptide YPFPG (m/z 580) prior to time 
alignment; c) TICs after time alignment with the DTW-TIC algorithm showing peak distortions at 
various locations; d) EICs (580 +/- 0.5 amu) of the internal standard peptide YPFPG after time 
alignment with the DTW-TIC algorithm showing major distortion of the peptide peak and a larger 
retention time shift compared to the original data; e) TICs after time alignment with the DTW-
CODA algorithm showing tight alignment of the common peaks between sample and reference 
chromatograms even though the two most abundant peaks are absent in the sample chromatogram; 
f) EICs (580 +/- 0.5 amu) of the internal standard peptide YPFPG after time alignment with the 
DTW-CODA algorithm showing tightly aligned peaks without observable peak distortion. 
 
The main parameter to choose for the PTW algorithm is the degree of the 
polynomial of the warping function. It has been investigated that the alignment quality 
using a cubic warping function did not result in a significant difference to the alignment 
quality using a quadratic warping function, since the coefficient for the highest degree 
term was always close to zero (results not shown). This means that the quadratic 
function was able to accurately adjust to the true form of the non-linear retention time 
shifts in the studied data sets. This may not be true for other data sets, where the true 
retention time shifts may have a more complex form. For that reason, if poor time 
alignment performance is observed with a quadratic function, using a higher order 
polynomial warping function may help to obtain a more accurate alignment. The only 
other user-defined parameter in PTW-CODA is the starting value of the coefficients of 
the warping function. As a starting point, we used the “no warping situation” in which 


































































Figure 4. Comparison of the warping function of PTW-TIC and PTW-CODA using 200 high-quality 
LCODA-selected mass traces over a time window of 20-90 min applied to chromatograms 5082628 
and 5082630 of the acid-precipitated urine data set. (a) shows the warping function obtained by 
PTW-TIC (red line) and the warping function obtained by PTW-CODA (blue line). The ellipse 
indicates the region presenting almost the largest retention time shifts of spiked standard peaks 
between the reference and sample chromatograms after applying PTW-TIC. (b) The EICs of a 
standard spiked peptide YPFPG (m/z 580 and retention time 49,34 min) before alignment (top 
panel), after alignment with PTW-TIC (middle panel) and after alignment with PTW-CODA using 
200 LCODA-selected traces (bottom panel). 
 
Figure 4 shows the comparison between PTW-TIC and PTW-CODA using 200 
LCODA-selected mass traces. The warping function of PTW-TIC deviates strongly from 
the diagonal in comparison with the warping function of PTW-CODA, which resulted in 
major misalignment of the corresponding peaks (see Figure 4b, middle panel). The 
largest retention time shifts between identical peaks were observed in the middle of the 
chromatograms, where the retention time shifts after warping were actually larger than 
in the raw data. The ellipse in Figure 4a indicates the region with the largest retention 
time shift after alignment with PTW-TIC. This resulted major misalignment of the 
standard peptide YPFPG (EIC m/z 580 +/- 0.5 amu) (Figure 4b-middle panel). In 
contrast, PTW-CODA was able to correct the slight retention time shift between the 
original chromatograms of the standard peptide (Figure 4b, bottom panel). 
 
3.3 Comparison of DTW, PTW and COW coupled with LCODA-
selected Mass Traces 
We have shown that the combination of DTW, PTW, and COW with CODA 
or LCODA significantly improves the alignment quality compared to the original 
algorithms that use the TIC in the benefit function. The question remains which time 
alignment algorithm combined with CODA or LCODA will provide the best time 
alignment for a given experimental LC-MS data set. In this section we compare the 
performance of DTW-CODA, PTW-CODA and COW-CODA by applying them to 
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experimental data sets with different compound distributions in m/z and retention time 
space (see Figure S-3 in Christin et al.4) and different concentration variability caused by 
contributions of various analytical and biological sources. The increasing order of the 
overall variance of the three data sets based on their respective relative standard 
deviation is: cervical cancer < factorial design < urine (see Figure 4c in Christin et al.).4 
Concerning the COW-CODA algorithm, we have used the same values for the 
segment length and slack parameter as described previously.4 Briefly, the segment 
length for the cervical cancer data set was 84 points (~1.5 min), for the factorial design 
data set 139 points (~2.3 min) and for the urine data set 83 points (~2.2 min). The slack 
parameter was set to 20% of the given segment length. In the COW-CODA algorithm, 
the selection of high quality mass traces by CODA was performed segment-wise with a 
maximum number of 30 traces per segment. In cervical cancer, factorial design and urine 
data sets, the number of selected mass traces during the time alignment procedure 
(union of all traces of all segments) was 507, 396, and 307, respectively. The value of the 
global constraint c in DTW was equal to the optimal segment length used in COW-
CODA. Comparison of the performance of DTW-CODA and PTW-CODA was 
performed with 200 high-quality selected mass traces as discussed earlier. The constraint 
c has to be chosen to satisfy c > LR ! LS , which is generally not a problem even for ion 
trap mass spectrometry data, where the data dependent accumulation time results in 
small difference in the number of data points. However, if large differences in sampling 
rate occur, such as warping a chromatogram acquired in single-stage MS to a 
chromatogram acquired in MS/MS mode, the 3-5 times differences in sampling rate of 
single-stage MS information should be corrected by interpolation in order to apply the 
DTW-based algorithm with success. 
The large dynamic concentration range of analytes and the accurate 
quantification to detect discriminating compounds between healthy and diseased states 
requires that LC-MS data is acquired in single stage MS mode for biomarker discovery. 
In that case all time available for acquisition is used to collect quantitative information, 
while automated MS/MS would provide only quantitative information for every third 
or fifth scan time resulting in a decreased measured dynamic concentration range and 
less accurate quantification. After choosing the peaks of interest, the compound identity 
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Figure 5. Local evaluation of the performance of the DTW-TIC and DTW-CODA (green) and the 
PTW-TIC and PTW-CODA (blue) algorithms in comparison with the previously described COW-
TIC and COW-CODA (red) algorithms1. Extracted ion chromatograms show the retention time 
differences of spiked standard peptides in the cervical cancer (a), factorial design (b) and urine data 
sets (c) compared to the original data (top panel, black traces) using the best reference 
chromatograms. The x-axes correspond to the intensity and the y-axes correspond to the retention 
times (in minutes). 
 
In order to assess the performance of the algorithms, we chose data sets 
acquired in single stage MS mode. However, it is difficult to assess the true performance 
of time alignment algorithms using single stage MS data, since peaks cannot be related 
to identified compounds as compared to data obtained with automated MS/MS data 
acquisition, where peak identity is generally used to assess the accuracy of time 
alignment19 or the overall performance of time alignment/peak matching algorithms.42 
In consequence, the alignment quality was evaluated locally by comparing EICs of 
added internal standard peptides that were present in each chromatogram of a given 
data set before and after time alignment with DTW-TIC, DTW-CODA, PTW-TIC, PTW-
CODA, COW-TIC and COW-CODA using the best reference chromatograms. 
Visualization of the EICs of one standard peptide each in the cervical cancer (a), factorial 
design (b) and urine (c) data sets served to judge the time alignment accuracy of the 
different algorithms visually (Figure 5). For all data sets the original DTW-TIC algorithm 
Time	  Alignment	  Algorithms	  using	  Selected	  Mass	  Traces	  
 81 
showed the worst performance with considerable peak distortions and poor alignment 
while combining DTW with LCODA-selected mass traces (DTW-CODA) resolved these 
problems (see Figures S-4, S-5, S-6 in Supporting Information for other standard 
peptides). In general, all algorithms showed clearly improved alignment quality when 
combined with LCODA- or CODA-selected high-quality mass traces. 
The initial concentration variability in the experimental LC-MS data sets plays 
an important role in the performance of the different time alignment algorithms. All 
algorithms (even DTW-TIC except for some remaining peak distortion) performed well 
on the cervical cancer data set (trypsin-digested serum; Figure 5a, left column) despite 
larger initial shifts in retention time, since the overall pattern was fairly conserved across 
the entire data set even at the TIC level. On the other hand, performance of time 
alignment methods was different for the factorial design data set (trypsin-digested 
serum; Figure 5b, middle column) containing larger analytical variability. For the 
factorial design data set all of the TIC-based algorithms did not resolved retention time 
shifts for the standard peptides and even increased retention time shifts with respect to 
the original data. Combination of all alignment algorithms with CODA- or LCODA-
selected mass traces improved the overall alignment quality and resulted in tight peak 
clusters. A similar tendency was observed for the more variable urine data set, where 
the algorithms that work with CODA- or LCODA-selected mass traces improve 
alignment quality or at least maintain the original quality of the data, in cases where 
retention time shifts were already low (see also Figures S-4, S-5, and S-6 in Supporting 
Information). 
Our earlier observation showed that time alignment with COW-CODA is not 
sensitive to the choice of reference chromatogram. We confirm this important behavior 
for DTW and PTW algorithms combined with LCODA-selected mass traces (Figures S-4, 
S-5, S-6, for alignment with the best and Figures S-7, S-8, S-9 for the worst reference in 
the Supporting Information). It is thus not necessary to select the optimal reference 
chromatogram. It is, however, noteworthy that large non-linear retention time shifts for 
peptides weakly binding to the chromatographic stationary phase, as sometimes 
observed at the beginning of the chromatographic elution gradient, are better corrected 
using the best reference chromatogram (see Figures S-6 and S-9 right column). The 
stability of the time alignment performance of algorithms using CODA- or LCODA-
selected mass traces with respect to the reference chromatogram selection confirm 
further that all these methods results in tight alignment for the three experimental data 
sets. 
To assess the global time alignment quality of different approaches, we 
compared the sum of the overlapping peak area between all possible pairs of 
chromatograms in the same data set as previously described.4 An increased sum of the 
overlapping peak area is a measure of a globally improved time alignment. Figure 6 
gives an overview of the sum of overlapping peak areas for each chromatogram with the 
remaining chromatograms in the three data sets using the best reference. The main 
observation is that all time alignment algorithms that make use of CODA- or LCODA-
selected mass traces result in clearly increased overlapping peak areas when compared 
to the original data set independently of the variability in the original experimental data 
(Figure 6). The COW-TIC and the PTW-TIC algorithms show similar performance 




the lowest compound concentration variability (Figure 6a). This result is in agreement 
with the local evaluation using EICs of spiked standard peptides and can be explained 
with the well-defined character and high similarity of TIC traces of the chromatograms 
in this data set. It is noteworthy, that TIC-based algorithms may result in considerably 
higher retention time shifts than observed in the original data sets, especially for dataset 
with high compound concentration variability. For example, in the factorial design data 
set, which has the lowest initial retention time shifts, all algorithms using TICs resulted 
in lower overlapping peak area than the original chromatograms for the majority of 
samples (see Figure 6b). This effect was less pronounced in case of the urine data set, 
where alignment quality was largely unaffected by the TIC-based algorithms (see Figure 
6c). The global assessment of DTW-TIC is more difficult because of the large extent of 
peak distortion. The observed lower overlapping peak area for all three data sets shows 
that this method is not appropriate to align complex LC-MS data sets. In contrast to 
DTW-TIC, the DTW approach combined with LCODA-selected mass traces resulted in 
vast improvements and makes the DTW-CODA algorithm the most accurate in many 
instances. 
The sum of overlapping peak areas obtained using the worst reference 
resulted in similar results as with the best references (Figure S-10). This confirms that the 
algorithms using high-quality CODA- or LCODA-selected mass traces perform well 
independently of the reference chromatograms. This omits the application of a reference 
selection method in the time alignment procedure. 
 
4 CONCLUSIONS 
Complex LC-MS data sets with many overlapping peaks in the retention time 
dimension are difficult to compare unless one can assure that compounds are correctly 
matched prior to statistical analysis. We show that time alignment algorithms, that were 
originally developed for rather simple data sets, cannot be applied to this complex 
situation, as they either do not improve alignment or even make time alignment worse 
when using the TIC in a one-dimensional benefit function. We show furthermore that it 
is possible to simplify the initial complex data set by selecting m/z traces based on their 
respective Mass Quality Indices (MCQ values) using a modification of the CODA 
algorithm originally described by Windig.33 The combination of DTW, PTW or COW 
algorithms with CODA-based trace selection, considering the different selected mass 
traces separately in the benefit function, resulted in clear time alignment improvements 
in three different complex LC-MS data sets containing increasing levels of concentration 
variability. Local and global assessment of the performance of the new algorithms 
showed that they were successful in aligning complex data sets as obtained during 
biomarker discovery and other quantitative comparative proteomics or metabolomics 
studies. Furthermore the time alignment algorithms using CODA- or LCODA-selected 
mass traces do not increase the number of parameters that need to be optimized. The 
optimal number of selected mass traces can be obtained from the data itself through 
optimization procedures. 
 






































































































































Figure 6. Sum of overlapping peak area of all chromatogram pairs using the best reference after 
applying M-N rules as peak filter to the cervical cancer (a), factorial design (b), and urine (c) data 
sets. The original chromatograms before time alignment (black) are compared to the 
chromatograms obtained after alignment with COW (red), PTW (blue) and DTW (green) using TICs 
(dashed lines, empty circles) or CODA-/LCODA-selected mass traces (full lines, filled circles). The 
chromatogram names corresponding to the chromatogram indices in the figures are reported in 
Supporting information (Table S2, S3, S4). 
 
A distinct advantage of DTW-CODA algorithm is that it does not use any gap 
penalty function next to the constraint c to limit the search space. This facilitates the use 
of this algorithm; as compared to other versions of the DTW algorithm using separate 
mass information in their benefit functions.19, 31 The form of the benefit function, may 




benefit function, such as using the cumulative covariance or the cumulative 
correlation.19 We did not explore these possibilities, since we obtained highly accurate 
time alignments for all pairs of chromatograms in the studied data sets withthe 
cumulative sum of quadratic distances as benefit function for DTW or PTW. We have 
shown that combination of CODA-selected mass traces with different time alignment 
methods is a general principle to align complex LC-MS data sets with high compound 
concentration variability. The main characteristics of the three time alignment 
algorithms based on our implementation in this work are presented in Table 1. 
Although all three time alignment algorithms using mass trace selection 
perform similarly well on highly complex LC-MS data sets, there are certain features, 
which discriminate them from a user perspective. The need to set parameters may 
complicate the proper use of an algorithm. User-defined values for parameters are an 
important point for some time alignment algorithms, since they affect the results 
significantly and should be adapted to the characteristics of the data sets (e.g. initial 
retention time shifts, average peak width, concentration variability). PTW-CODA has a 
distinct advantage in this respect for it does not require the user to set any parameters 
prior to starting the alignment procedure. The degree of the polynomial order of the 
warping function and the initial setup of the polynomial coefficients does not affect the 
alignment result, which is robust with respect to the changes of key analytical properties 
of the datasets such as peak distribution or concentration variation. Second, the 
requirements for computing capacity may be a limiting factor for users, especially if they 
do not have access to distributed computing facilities. DTW-CODA is advantageous in 
this respect, as it completes one round of time alignment for two complex LC-MS data 
sets in about 15 sec on a powerful personal computer (Intel® Core™ Quad CPU 
Q9300@2.5 GHz processor and 8 GB of RAM) while COW-CODA takes about 12 min. 
The significantly different execution time of COW-CODA is due to the fact that this 
algorithm includes segment-wise CODA trace selection as part of the warping function, 
while both DTW- and PTW-CODA require prior selection of high-quality mass traces, 
which takes 12 min per chromatogram. However, once the quality measurement by the 
LCODA procedure has been performed, this LCODA matrix can be reused for both 
DTW-CODA and PTW-CODA making this a one-time investment in computing time 
per data set. A note of caution has to be added with respect to using the DTW-CODA 
algorithm, as it may still introduce peak distortions, albeit much less than the original 
DTW-TIC algorithm. This must be carefully evaluated and can be considered as the 
main disadvantage of this approach. However, if peak quantification is performed 
before the time alignment and the alignment results are only used for peak matching, 
small peak distortions do not affect the statistical outcome of the comparative profiling 
study. In this case time alignment will only affect peak clustering performance, which 
will be highly accurate as the chromatographic signal is tightly aligned in the dataset, 
even though the peaks are slightly distorted. 
To compare the performance of time alignment algorithms, the global 
evaluation based on overlapping peak areas is a reliable guide. However, since minor 
peak distortions and local misalignments may still occur, it is recommended to inspect 
the aligned chromatograms also visually using EICs of defined peaks (e.g. added 
internal standards or CODA-selected traces) before and after alignment. 
 
Time	  Alignment	  Algorithms	  using	  Selected	  Mass	  Traces	  
 85 




constraint c (in time) 
to limit the borders 




Two parameters: segment 
length (in time) and slack 














Local, segment-wise trace 
selection during algorithm 
execution. 
Execution time for 
one pair of 
chromatograms1 
~15 sec excluding 
mass trace selection 
(12 minutes per 
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excluding mass 
trace selection 
(12 minutes per 
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12 minutes including mass 
trace selection. 









                                                                  
 
1 7000 time scans, 200 selected mass traces, using Intel® Core™ Quad CPU Q9300 @ 2.5 GHz 
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In this chapter, we compare the performance of six different feature selection methods 
for LC-MS based proteomics and metabolomics biomarker discovery: t-test, Mann-
Whitney-Wilcoxon-test (mww-test), Nearest Shrunken Centroid (NSC), linear Support 
Vector Machine – Recursive Features Elimination (SVM-RFE), Principal Component 
Discriminant Analysis (PCDA) and Partial Least Squares Discriminant Analysis 
(PLSDA) using urine samples that were spiked with a range of peptides at different 
concentration levels. The ideal feature selection method should select the complete list of 
discriminating features that are related to the spiked peptides. While many studies have 
to rely on classification error to judge the reliability of the selected biomarker candidates, 
we assessed the accuracy of selection directly from the list of spiked peptides. The 
statistical methods were applied on data sets with different sample size and extent of 
sample class separation determined by the concentration level of spiked compounds. For 
each statistical method and data set, the performance for selecting a set of features 
related to spiked compounds was assessed using the harmonic mean of the recall and 
the precision (f-score) and the geometric mean of the recall and the true negative rate (g-
score). We conclude that the univariate t-test and the mww-test with multiple testing 
correction are not applicable to data sets with small sample size (n=6), but that their 
performance improves markedly with increasing sample size. PCDA and PLSDA select 
small feature sets with high precision, NSC strikes a reasonable compromise between 
recall and precision for all data sets while linear SVM-RFE performs poorly for selecting 
features related to the spiked compounds. 
 




Biomarker discovery plays an important role to advance medical research by 
allowing early diagnosis of disease and prognosis of treatment interventions 1, 2. 
Biomarkers may be proteins, peptides or metabolites as well as mRNAs or other kinds of 
nucleic acids (e.g. microRNAs) whose level changes in relation to the stage of a given 
disease and that may further be used to accurately assign the disease stage of a patient 
based on a biochemical test. The accurate selection of biomarker candidates is crucial, 
since it determines the outcome of further validation studies and the ultimate success of 
developing diagnostic and prognostic assays with high specificity and sensitivity. The 
success of biomarker discovery depends on several factors: consistent and reproducible 
phenotyping of the individuals from whom biological samples are obtained, the quality 
of the analytical methodology which in turn determines the quality of the collected data, 
the accuracy of the computational methods to extract quantitative information to define 
the molecular identity of biomarker candidates from raw analytical data and finally the 
applied statistical method to select a limited list of compounds with the potential to 
discriminate between predefined classes of samples. De novo biomarker research consists 
of a biomarker discovery and a biomarker validation part 3. Biomarker discovery uses 
analytical techniques, which try to measure as many compounds as possible in a 
relatively low number of samples. The goal of subsequent data preprocessing and 
statistical methods is to select a limited number of compounds, which are subsequently 
subjected to targeted analysis in large number of samples. Advanced technology, such as 
high-throughput and high-resolution liquid chromatography – mass spectrometry (LC-
MS), is increasingly applied in biomarker discovery research. Such analyses detect tens 
of thousands of compound and background-related signals in a single biological sample 
generating enormous amounts of multivariate data. Data preprocessing workflows 
reduce data complexity considerably by extracting only the information related to 
compounds resulting a quantitative feature matrix, where rows and columns correspond 
to samples and extracted features or vice versa. Features are data preprocessing 
components, which are mainly related to sample-constituting compound peaks, such as 
isotopologues for data obtained with high resolution mass spectrometers or peaks 
corresponding to the average mass in data acquired with low resolution mass 
spectrometers. Features may also be related to data preprocessing artifacts, and the ratio 
of such erroneous features to peptide-related features depends on the performance of 
the data preprocessing workflow. Preprocessed LC-MS data sets contain a large number 
of features compared to sample size. These features are characterized by their m/z value 
and retention time, and in the ideal case they are combined and linked to compound 
identity such as metabolites, peptides and proteins. In LC-MS based proteomics and 
metabolomics studies, sample analysis is time consuming so that it is impossible to 
increase the number of samples to a level to balance the number of features in a data set. 
Therefore the success of biomarker discovery depends on powerful biomarker candidate 
selection methods that can deal with a low sample size and a high number of features. 
Due to the unfavorable statistical situation, it is, however, pivotal to validate the 
discovered biomarker candidates in a set of independent samples, preferably in a 




Biomarker selection is often based on classification methods, which are 
preceded by feature selection methods (filters), or have built-in techniques (wrappers 
and embedded) to select a list of compounds/peaks/features, which provide the best 
classification performance on predefined sample groups (e.g. healthy and disease) 4. 
Classification methods with feature selection can also be used as classifiers (e.g. to 
classify an unknown sample into a predefined sample class), however they should be 
distinguished from classifiers having no feature selection option, but perform the 
classification using all variables. A few feature selection methods such as filters can be 
used independently of the classifiers. Classification methods without feature selection 
ability cannot be used for biomarker discovery because these methods aim to classify 
samples into predefined classes correctly but cannot identify the variables 
(features/compounds) causing the separation of sample groups 5, 6. 
Different statistical methods with feature selection have been developed 
according to the complexity of the analyzed data, and have been extensively reviewed 4, 
5, 7, 8. Ways of optimizing such methods, to improve sensitivity and specificity, have 
become a major topic in biomarker discovery research and in the many ‘omics-related’ 
research areas 5, 9, 10. Some comparisons of classification methods related to their 
classification and learning performance have been initiated. Dougherty et al. 11 studied 
the properties of feature selection methods, such as the relation of the selected feature 
sets to the theoretically best feature sets based on the classification error and optimal 
number of selected features, observation of the ‘peaking phenomenon’ and the accuracy 
of feature selection methods in high-dimensional data. Another study focused on 
finding the most accurate classifiers for simulated data sets with sample sizes ranging 
from 20 to 100 12. Rubingh et al. 13 compared the influence of sample size in an LC-MS 
metabolomics data set on the performance of three different statistical validation tools: 
cross validation, jack-knifing model parameters, and a permutation test. This study 
concluded that for small sample sets the outcome of these validation methods is 
influenced strongly by individual samples and therefore cannot be trusted and the 
validation tool cannot be used as warning mechanism for problems due to sample size 
or representability of sampling. This implies that reducing the dimensionality of the 
feature space is critical when approaching a classification problem where the number of 
features exceeds the number of samples by a large margin. Dimensionality reduction, 
whether it is built into (such as wrappers and embedded methods) or independent of a 
classification method (filters), retains a smaller set of features to bring the feature space 
in line with sample size to allow application of statistical methods, which perform only 
with acceptable accuracy when sample and feature size are similar. 
In this study we compared different classification methods focusing on 
feature selection in a spiked LC-MS data set that mimics the situation of a biomarker 
study. Our results provide guidelines to researchers that will engage in biomarker 
discovery or other differential profiling ‘omics’ studies with respect to sample size and 
to selecting the most appropriate classification method with feature selection for a given 
data set. We evaluated the following approaches: univariate t-test, Wilcoxon-Mann-
Whitney test (mww-test) with multiple testing correction 14, Nearest Shrunken Centroid 
(NSC) 15, 16, Support Vector Machine – Recursive Features Elimination (SVM-RFE) 17, 
Partial Least Squares – Discriminant Analysis (PLSDA) 18, and Principal Component – 
Discriminant Analysis (PCDA) 19. PCDA and PLSDA were combined with the rank-
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product as feature selection criterion 20. These methods were evaluated with data sets 
having two characteristics: varying sample size and varying class separation due to 
different concentration levels of the added compounds. Data were acquired by LC-MS 
from urine samples that were spiked with a set of known peptides (true positives) at 
different concentration levels. These samples were then combined in two classes 
containing peptides spiked at low and high concentration levels. The performance of the 
classification methods with feature selection was measured by their ability to select 
features that are related to the spiked peptides. Since true positives are known in our 
data set, we quantify performance by the f-score (the harmonic mean of precision and 
recall) and the g-score (the geometric mean of accuracy). 
 
2 EXPERIMENTAL PROCEDURES 
2.1 Dataset Design 
Fifty urine samples were obtained from 15 healthy females and 35 healthy males 
over the age range of 26.9 to 72.9 years. Two hundred µL were taken from each sample 
creating one pooled urine sample. The pooled urine sample was spiked with a tryptic 
digest (Promega, Madison, WI, V5111) of carbonic anhydrase (Sigma, Steinheim, 
Germany, C3934) as well as with seven synthetic peptides at 8 different dilutions: 6.25, 
12.5, 25, 50, 100, 200, 400, and 2000 times dilution (called groups A-H, respectively), of 
the stock solution containing 240 µM trypsin-digested carbonic anhydrase and the 
following concentrations (in µM) for the seven synthetic peptides: VYV, 83; YGGFL, 57; 
DRVYIHPF, 29; YPFPGPI, 46; YPFPG, 60; GYYPT, 54; and YGGWL, 57. At each 
concentration level, the sample was analyzed 5 times resulting in 40 LC-MS 
chromatograms. These chromatograms were pre-processed with constant resolution of 
0.1 amu 21, 22 resulting in a final common peak list of 29529 peaks with 151 peaks 
originating from the added peptides. Details on sample preparation and LC-MS data 
acquisition is provided in Supporting Information. 
From these 40 chromatograms, six data sets consisting of two classes with 2 
different levels of class separation and 3 different sample sizes were designed following 
the scheme in Table 1. These six datasets were combined into Data set 1 (large class 
separation) and Dataset 2 (small class separation) and 3 different sample sizes (indicated 
with a, b and c; see Table 1 for details). Data set 1 contains samples from groups A-C as 
high concentration spiked class (class 1) and from groups F-H as low concentration 
spiked class (class 0). Data set 2 contains groups B-D as high concentration spiked class 
(class 1) and groups E-G as low concentration spiked class (class 0). From each data set, 
three different subsets were formed with 6, 12 and 15 samples per class, respectively. For 
data sets with a total of 6 samples per class, 2 samples were taken randomly from each 
group (A-H). For data sets with a total of 12 samples per class, 4 samples were chosen 
randomly from each group. For data sets with a total of 15 samples per class, all samples 
were included. Feature selection for each combination of methods and datasets was 
repeated 100 times using each time a different combination of samples that were selected 






Data Set Class Separation Sample size per class 
Data Set 1a-c Large class separation 
High spiked class = 
combination of groups A-C 
Low spike class = combination 
of groups F-H 
1a 6: two samples were randomly 
taken from each of the groups A-
C (class 1) and F-H (class 0) 
1b 12: four samples were randomly 
taken from each of the groups A-
C (class 1) and F-H (class 0) 
1c 15: all samples from groups A-C 
(class 1) and F-H (class 0) 
Data Set 2a-c Small class separation 
High spiked class = 
combination of groups B-D 
Low spike class = combination 
of groups E-F 
2a 6: two samples were randomly 
taken from each of the groups B-D 
(class 1) and E-F (class 0) 
2b 12: four samples were randomly 
taken from each of the groups B-D 
(class 1) and E-F (class 0) 
2c 15: all samples from groups B-D 
(class 1) and E-F (class 0) 
Table 1. Description of the sample groups that were combined to give data sets 1a-c and 2a-c. This 
scheme was used to select files for the 100 repetitions of each combination of feature selection 
methods and data sets (see Table S-1 for results). 
 
2.2 Biomarker discovery methods 
2.2.1 Univariate Tests 
The parametric univariate t-test ranks features according to their p-value and is 
not a classification method. Since the data sets contained six to fifteen samples per class, 
it is difficult to test the normality of the data, which in this case is the distribution of the 
peak intensities. We therefore also used a non-parametric univariate filter, the Wilcoxon-
Mann-Whitney test (mww-test). Since the data sets contain a large number of features, 
we corrected the calculated p-values using the Benjamini-Hochberg approach 14. A 
feature was considered significant when the p-value was below 0.05 after multiple 
testing correction. 
 
2.2.2 Semi-Multivariate - Nearest Shrunken Centroid 
The Nearest Shrunken Centroid (NSC) approach aims to find a set of features that 
gives the minimum classification error or the highest sum of correct class probability in a 
set of training samples using double cross-validation by progressively eliminating 
features that do not contribute to construction of the shrunken class centroid. This 
method was proposed by Tibshirani et al. for classification of cancer samples based on a 
microarray data set 15, 16. The double cross-validation scheme for this method is outlined 
in the Figure 1. Other classification methods with feature selection used in this article 
were implemented according to similar double cross-validation schemes (see Figures S-1 
and S-2, Supporting Information). 
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The distance dik  between a feature i in class k and its respective overall centroid is 
calculated as the difference between the within class mean xik  and the overall mean xi , 
standardized by the standard error. The standard error (Eq. 1) is calculated using the 
pooled within class standard deviation of the respective feature si, a constant s0 (median 
of the standard deviation si across all features) to avoid large distances due to small 
standard deviations and the constant mk = 1 nk !1 n . The shrinkage threshold Δ is 
iteratively subtracted from this distance, and features whose shrunken distance in all 
classes is zero or negative are eliminated. A test sample x* is attributed to the class to 
which it has the highest class probability !k . The discriminant score for class k and for 
test sample x* is!k x*( ) , which is the sum of the standardized squared distances between 
each relevant feature in the test sample x* and the kth shrunken centroid x 'ik  corrected 
by the prior probability πk of class k (Eq. 2). This distance is basically similar to a simple 
diagonal covariance matrix between the test sample and the shrunken centroid of the 
respective class. Since feature elimination is done univariately, but classification of the 
test sample to the class-specific shrunken centroid at a given shrinkage is calculated 
multivariately, we call this a semi-multivariate method. 
d ik =
xik ! xi
mk " si + s0( )
 Eq. 1 
 
!k (x*) =
(xi* ! x 'ik )2
si2i=1
p
" ! 2 log" k  Eq. 2 
 
Based on the discriminating score, we can calculate the class probability 















 Eq. 3 
 
Once the class probability has been calculated for each test sample, and for each 
shrinkage value, the probability of the true class for each sample is summed up. We now 
have two measurements based on which we select the optimum subset of features: a) the 
subset that minimizes the classification error (Eq. 2), and b) the subset that maximizes 
the sum of true class probabilities (Eq. 3). In our study the optimum shrinkage is chosen 
based on the maximum true class probability of the test data set, since it gives a 
continuous plot and a well-defined optimal shrinkage value. Once the optimum 
shrinkage has been obtained in the inner cross-validation loop (see Figure 1), it is 
applied to the training data set in the inner loop to obtain the optimal corresponding 
feature set. Based on this feature set, the discriminant and the true probability scores are 
calculated for the independent test data set in the outer loop to assess the classification 
model performance. Since each passage through the outer loop yields a different value 




scores at each shrinkage value from all the outer loops at the end of the double cross 
validation scheme. Fluctuation of the true class probability curves as a function of the 
optimal shrinkage values obtained for various outer loop evaluations reflects the 
stability of the model and small class differences in the studied data set. The shrinkage at 
the maximum of the median true class probability curve is used to select the optimal 
feature set using all samples in the data set. 
 
 
Figure 1. Double cross validation scheme for the Nearest Shrunken Centroids (NSC) algorithm. In 
the inner loops of the double cross validation scheme, the sum of the true class probability score at 
the respective shrinkage is calculated (maximum provides the optimal shrinkage). The final optimal 
feature set is selected using the shrinkage at the maximum of the median of the sum of the true 
class probability and the shrinkage plot after the double cross validation procedure. Performance of 
the classification is measured using optimal parameters in the outer loop by calculating the 
classification error rate on the outer loop training data set (double cross validation error). 
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2.2.3 Multivariate Support Vector Machine – Reduced Features Elimination (SVM-
RFE) 
A Support Vector Machine (SVM), originally proposed by Vapnik 23, is a 
multivariate supervised learning method that constructs a hyperplane which separates 
two groups in a given data set. Optimal separation between two classes is reflected by 
obtaining a hyperplane that has the largest distance to the nearest training data point of 
any class. A sample is viewed as m-dimensional vector, where m is the number of 
features. The goal of the SVM is to find a hyperplane with dimension m-1 that separates 
the vectors based on their respective classes. The hyperplane acts as a discriminant that 
assigns new data to a given class. SVM has been widely used and gained popularity for 
classification and prediction problems in medical research where the feature size far 
exceeds the available number of samples such as in microarray or mass spectrometry 
analyses 24-33. Lately, approaches have been developed to adapt SVM for feature 
selection purposes 17, 34, 35. In this study we use a linear SVM classifier combined with 
recursive feature elimination approach (RFE) for feature selection method as introduced 
by Guyon et al. 17. This approach utilizes the weight vector w, which corresponds to the 
weight magnitude of features as the selection criterion during recursive feature 
elimination. The SVM-recursive feature elimination (SVM-RFE) procedure works as 
follows: 
1. Initially, using all the features in the training set, train the SVM classifier 
2. Compute weight vector w 
3. Remove the feature with the lowest weight from the classification procedure 
4. Train the SVM classifier using the remaining features 
5. Repeat steps 2-4 until there is no remaining feature 
To obtain the optimal feature subset, we used a double cross validated 
support vector machine combined with recursive feature elimination (SVM-RFE). The 
optimal number of features is determined in the inner loop. Each time the feature with 
the lowest weight is eliminated, the classification error based on the new set of features 
is calculated. Each inner loop delivers a classification error for a given set of features and 
the rank of each feature is given by its weight. The optimal number of features is the 
smallest feature set that gives the minimum mean classification error. To select the 
optimum feature subset, a rank product procedure is applied to the feature rank lists 
produced in the inner loops. In the outer loop, the classification error of the optimal 
feature subset is computed using an independent test data set. The exact cross-validation 
scheme is shown in Figure S1 (Supporting Information). 
 
2.2.4 Multivariate PCDA and PLSDA 
PCDA and PLSDA take the relation between features into account in 
constructing new feature sets. Principal Component Analysis (PCA) constructs new 
features by finding linear transformations that best explain the variance in the data. PCA 
has been combined with Linear Discriminant Analysis (LDA) as the classifier applied on 
the PCA scores. This approach, originally proposed by Hoogerbrugge et al 19, has been 
used for feature selection and classification in biomedical research using mass 




PLSDA (Partial Least Squares - Discriminant Analysis) is a popular method in 
metabolomic studies 39-45 and was shown to be suitable for classification and 
discrimination in other applications 18, 46, 47. It consists of a classical PLS regression 
analysis, where the response regressor is the class label. PLS components are built by 
trying to find a proper compromise between describing the data set and predicting the 
response. Further explanation and extensive assessment of this method can be found in 
Westerhuis et al. 48-50. 
In our study we used a combination of double and single cross validation 
procedures for both PCDA and PLSDA. In double cross validation, the number of 
principal components (for PCDA) and the number of PLS components (for PLSDA) is 
optimized in the inner loop. At the end of each inner loop, a rank product procedure 20 is 
used to rank the features based on their discriminant coefficients obtained in the inner 
loop. The outer loop calculates the classification error from a model that uses the optimal 
number of PC/PLS components obtained in the inner loop and different numbers of 
features based on the ranked feature list. The feature size that gives the minimum 
classification error in the outer loops is selected as the optimal number of features. Based 
on this double cross validation procedure, the optimal number of principal 
components/PLS components and the optimal number of features are selected. To select 
the optimum feature sets, we utilize single cross validation separately from the double 
cross-validation procedure. In the cross validation loop, the model using the optimal 
number of components is built and the rank product of the discriminant coefficients of 
the features is calculated at the end using ranks obtained in each loops. The optimal 
feature set is selected from this ranked feature list whose size was given by the 
preceding double cross validation procedure. The complete scheme of PCDA and 
PLSDA in selecting the optimal feature set is shown in Figure S-2 (Supporting 
Information). 
 
2.3 Evaluation criteria 
We have performed the evaluation of the described approaches based on their 
performance as biomarker selection methods rather than as learning algorithms by 
measuring each algorithm’s ability to construct an optimal feature set. In our case, where 
the discriminating features in the data sets are known, the optimal feature sets are 
supposed to contain only features related to the spiked peptides (true positives). True 
positives, false positives, true negatives and false negatives are subsequently identified 
in each feature set as proposed by a given method constructing a confusion matrix51 
(Table 2).  
Truth \ by Methods 
Selected as optimal features 
(Positive) 
Not selected (Negative) 
Spiked peptide-related 
features (Positive) 
True Positive (tp) False Negative (fn) 
Non-spiked peptide-related 
features (Negative) 
False Positive (fp) True Negative (tn) 
Table 2. The confusion matrix51. The columns correspond to features as predicted by a given 
method, while the rows correspond to the actual class of the features. 
Statistical	  Methods	  for	  Biomarker	  Selection	  Candidate	  
 
99 
Several measures were calculated to compare and reveal the characteristics of the 
algorithms’ performance (Table 3). Recall expresses the proportion of selected spiked-
compound related features relative to all features that are related to the spiked peptides. 
Precision refers to the proportion of features that are related to the spiked peptides 
relative to all features selected by a given statistical method. The geometric mean 
accuracy (g-score) measures the ability of a method to classify both negative (not related 
to the spiked-peptides) features and positive (spiked-peptide related) features correctly. 
It assesses the overall performance of the feature selection methods, since it attributes 
the same importance to both true positive and true negative features. The f-score is a 
composite measure that concentrates on the correct classification of true positive features 
based on recall and precision. Recall calculates the proportion of the spiked-peptide 
related features that were selected as part of the optimal feature set relative to all spiked-
peptide related features and assesses the effectiveness of an algorithm in identifying the 
true positive features. Precision is the proportion of the spiked-peptide related features 
amongst the selected feature sets and assesses the predictive power of a method. Recall 
and precision are balanced in the f-score when the ß constant parameter is set to 1 and is 
in favor of precision when ß > 1. In our work, we set ß equal to 1. We use the balanced f-
score since we are interested in the correct identification of all spiked-peptide related 




Recall = True Positive Rate (TPR) 
tp
tp+ fn  
Precision 
tp
tp+ fp  
Specificity = 
True Negative Rate (TNR) 
tn
tn+ fp  
Geometric Mean Accuracy 
(g-score) 
TPR !TNR  
f-score 
(! 2 +1) ! precision ! recall
! 2 ! precision+ recall  
Table 3. Definition of the scores that were used to compare the performance of different feature 
selection methods. 
 
Besides evaluating the optimal feature sets based on the aforementioned scores, 
performance of the methods can be measured based on several additional criteria: the 
classification error of the learning model that is built on its selected features, the 
complexity/number of the selected features and the stability of the selected feature 
subsets. Since the complexity of the learning model depends on the complexity of the 
feature set, the selected feature size has an impact on both performance and 




In biomarker discovery research, the size of the feature set determines the scale of 
subsequent experiments, such as the identification of selected peptides or proteins and 
their validation as biomarkers. Thus minimizing the number of false positives 
(maximizing precision) is more favorable than maximizing recall. In this paper we used 
designed data sets where the true positives are known. Therefore recall and precision 
can be calculated and compared across different algorithms. The confidence in selecting 
a set of biomarker candidates can be judged by the stability of the selected feature set 
upon repetition of the selection procedure. More confidence is achieved when the 
feature selection method gives similar feature sets across multiple repetitions of cross 
validation runs using different sample sets. Though the stability of the obtained feature 
sets cannot override the classification error with respect to new test samples, it is still a 
useful additional criterion for selecting an optimal feature subset from different models 
when the list of spiked-peptide related features is unknown. 
 
3 RESULTS AND DISCUSSION 
Six different statistical approaches were evaluated on LC-MS data sets from 
urine samples spiked with a range of peptides at different concentration levels as 
simulation of a biomarker discovery experiment. Figures 2 to 4 show the bar charts of 
the medians of the scores with the respective inter-quartile-ranges (IQRs) from 100 
repetitions for each combination of statistical biomarker candidate selection method and 
data set. The median is used, since it gives robust measurements even when the 
distribution of the scores is not normal. Figure 2 shows the natural logs of the feature 
size (top) and the number of true positives (bottom) that are contained in the 
corresponding feature set. Figure 3 shows the recall (top) and precision (bottom) based 
on the number of true positive features found in the respective feature set. Figure 4 
shows the f-scores and g-scores, which are a composite measure of recall, precision, and 
true negative rate. These scores were used to compare and assess the performance of 
each method with respect to sample size and class separation. 
 
3.1 Comparison of individual methods 
3.1.1 t-test and mww-test 
Figures 2 and 3 show that neither the t-test nor the mww-test are capable of finding 
discriminating features between the two classes when sample size is low, independent of 
the magnitude of the concentration difference of the spiked peptides between the classes 
(data sets 1a and 2a, 6 samples per class). This improves markedly when increasing the 
number of samples per class to 15 (data sets 1c and 2c), where both tests are amongst the 
best performing methods. As expected from univariate methods, sample size has a 
strong influence on performance with a clear threshold between no or very poor 
performance for 6 samples per class and rather good performance for 15 samples per 
group. Figure 3 shows, however, that the high number of true positives in the results 
from data sets with 15 samples and a large class separation (see Figure 2, data set 1c) is 
accompanied by a relatively high number of false positives lowering precision in spite of 
a high recall. Despite a mediocre precision, univariate feature selection methods give the 
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highest g-score and f-score for this dataset (Figure 4, data set 1c), showing, that the trade-
off between recall and precision results overall in the best performance. It is interesting 
to note that univariate tests give a lower recall but a higher precision when class 
separation decreases (data set 2c), which is primarily due to a 2-fold lower number of 
detected true positives (Figure 2, data set 2c) leading to a clearly decreased recall (Figure 
3, data set 2c). The same tendency is observed for data sets 1b and 2b with 12 samples 
per class. The composite f-score and g-score show that the overall performance of 
univariate feature selection is mainly affected by sample size and slightly by class 
separation, and that standard univariate statistical methods perform as well as the more 
sophisticated multivariate or semi-multivariate methods with a class size of 15 samples 
in the case of spiked urine samples. 
 
 
Figure 2. Bar charts of the median (± interquartile range) of the number of selected features (top) 
and the number of true positives (bottom) for each combination of feature selection statistical 
methods and data sets (see Table 1 for details concerning data sets). Results for the univariate tests 
(t-test and mww-test) on data sets 1a and 2a are denoted by **, since these methods selected no 
features at a sample size of 6. Univariate tests (t-test and mww-test) were performed once for data 







Figure 3. Bar charts of the median (± interquartile range) of recall (top) and precision (bottom) for 
each combination of feature selection statistical methods and data sets. Recall and precision are not 
available for the t-test and the mww-test on data sets containing 6 samples (denoted with **). 
Univariate tests (t-test and mww-test) were performed once for data sets 1c and 2c comprising all 
available samples per class without repetition. 
 
3.1.2 NSC 
NSC selected the highest number of true positives for the smallest sample size of 6 
samples per class, however, at the expense of selecting also a fairly high number of 
features that are not related to the spiked peptides (Figure 2, data sets 1a and 2a). This 
leads to a high recall but intermediate precision when compared to the other algorithms 
(Figure 3, data sets 1a and 2a). Notably PLSDA outperforms NSC with respect to 
precision for data sets with a low number of samples due to a very low number of 
selected features that are not related to the spiked peptides (false positives). NSC 
remains amongst the better performing algorithms for data sets with a higher number of 
samples (data sets 1b or c and 2b or c) thus showing a fairly stable performance across 
all evaluated data sets, which is also reflected in rather similar g-scores and f-scores 
(Figure 4). NSC benefits from an increasing sample size when it comes to precision 
(Figure 3) since it selects less features that are not related to the spiked peptides, while 
the number of true positives decreases only slightly resulting in improved precision 
without sacrificing recall significantly. It is also noteworthy that the robustness of the 
statistical model improves with increasing sample size based on the reduced 
Statistical	  Methods	  for	  Biomarker	  Selection	  Candidate	  
 
103 
interquartile range (see error bars in Figures 2 to 4). The difference of recall and 
precision between data sets with 12 and 15 samples was not significant (Figure 3, data 
set 1b vs 1c, and 2b vs 2c). Higher recall and slightly lower precision are observed for 
data sets with large class separation (1b and 1c) compared to those with small class 
separation (Figure 3, data sets 1b and 1c versus data sets 2b and 2c), which holds also for 
both the f-score and g-score (Figure 4). 
 
 
Figure 4. Bar charts of the median (± interquartile arnge) of f-score (top) and g-score (bottom) for 
each combination of feature selection statistical methods and data sets. The f-score and g-score are 
not available for the t-test and the mww-test on data sets containing 6 samples (denoted with **). 
Univariate tests (t-test and mww-test) were performed once for data sets 1c and 2c comprising all 
available samples per class without repetition. 
 
3.1.3 SVM-RFE 
SVM-RFE selected the highest number of features in almost all data sets, while the 
number of selected true positives was lower than for most of the other methods resulting 
in many false positives (Figure 2). Even though there is a trend to better performance as 
sample size increases and class separation is large (data set 1), scores remain low with a 
maximum recall of 0.2 and a maximum precision of 0.05 (Figure 3). The large number of 
selected features lowers precision and consequently the f-score (Figure 3 and 4). The g-
score is also lower than for most other algorithms. It is the property of SVM that many 




feature is not a very useful measure for feature selection. This could be the reason why 
the size of the selected feature set by SVM-RFE is rather large. Our results with peptide-




For most of the studied data sets PCDA tends to select a low number of true 
positive features as well as a low number of features overall, however, often with 
considerable fluctuation resulting in low recall and high precision notably for large 
sample sizes (Figures 2 and 3, data sets 1b and c and 2b and c). PCDA may thus be 
considered a fairly ‘conservative’ approach to biomarker discovery, since the selected 
feature list has a relatively high content of true positive features. Contrary to NSC and 
the univariate tests (t-test and mww-test), PCDA tends to select fewer features from data 
sets with large class separation (data set 1), which is most pronounced for data set 1c. 
While the number of selected features is low (mean of 5.3 +/- 0.8), the selection contains 
essentially only true positive features (mean of 5.13 +/-0.8) resulting in a very high 
precision (mean of 0.97 +/- 0.06). This may be considered a positive characteristic of this 
approach when it comes to having to validate the selected biomarker candidates in large 
numbers of samples. It comes, however, at the expense that most of the true positives are 
missed using this statistical approach. Accurate selection of a low number of true 
positive features with low recall is reflected by the poor values of the composite 
measures f-score and g-score (Figure 4). Precision of the PCDA method is lower in data 
sets with low sample size irrespectively of class separation (Figure 3, data sets 1a and 
2a), which makes the method adequate for biomarker candidate selection in data sets 
having a sample size equal or higher than 12 samples per group. 
 
3.1.5 PLSDA 
The most striking characteristic of PLSDA is the extremely high precision no 
matter the sample size or the class separation (Figure 3). This is advantageous in cases 
where subsequent biomarker validation is tedious and requires significant efforts. The 
stability of the model underlying feature selection increases with increasing sample size 
as shown by the reduced interquartile range. High precision comes at a price, however, 
since the number of selected true positives is small when compared to the number of 
expected true positive features related to the spiked peptides (Figure 2). The low number 
of selected true positives is likely due to the fact that PLSDA and PCDA exclude 
redundant discriminating features based on correlations between them. Since signals 
related to the spiked peptides are highly correlated, PCDA and PLSDA only select a few 
of them, which represent class separation well. Globally, PLSDA is not really affected by 
the strength of class separation in the data set, since the patterns of recall and precision 
in data sets 1 and 2 are comparable (Figure 3). When sample size increases, there is a 
pattern of slightly improving recall although recall remains overall low. Contrary to 
PCDA, PLSDA shows high precision also on data sets with a low sample size (Figure 3, 
data sets 1a and 2a) making this method more adequate for accurately selecting true 
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positive features in low sample size data sets such as 6 samples per sample group than 
PCDA. 
3.2 Comparison between methods 
While all methods benefit from a larger sample size, only some of them are 
affected by class separation. The univariate t-test, mww-test results are affected both by 
class separation and sample size (based on the comparison of f-score, g-score, recall and 
precision). They require furthermore a minimum sample size to function. Multivariate 
methods that use feature transformation prior to selecting a given feature set, such as 
PCDA and PLSDA, are not strongly affected by class separation or sample size. The 
performance of NSC is overall rather independent of class separation and sample size. 
When the characteristics of the data set are profitable (large sample size and 
large class separation), univariate t-test and mww-test performed the best, since they 
assign most of the true positives within a reasonably sized total feature set. They are 
furthermore the fastest and simplest methods to use. Univariate methods fail, however, 
when sample size is small (e.g. 6 samples per class). Based on the f-score, g-score, recall 
and precision, the semi-multivariate NSC outperforms all other methods including 
multivariate methods in terms of feature selection, since it strikes the best balance 
between recall and precision, keeping both f-scores and g-scores high. The multivariate 
methods PLSDA and PCDA provide high-quality feature sets, which are reflected in 
high precision approaching 100% at the expense of a low recall. Globally speaking, NSC 
is applicable to all tested data sets and might be considered a good compromise when 
performing small-scale biomarker discovery studies. 
Additional assessment criteria are the classification error rate or sum of true 
class probability in the case of NSC and the stability of the models. When repeating the 
calculation for a number of times, the result is trustworthier if all repetitions yield 
similar conclusions. To test this, we assessed the variability of feature selection 
performance across 100 repetitions based on g-score and f-score, variation of the 
classification error rate and the sum of true class probability in the case of NSC. 
Variability of g-score and f-score was measured using the IQR for a given data set. In 
general, there is a tendency of decreasing IQR for all approaches as the number of 
samples increases (see error bars in Figures 2 to 4), except for SVM-RFE, which may due 
to the poor performance of the approach resulting in quasi randomly selected feature 
set. 
Variability of the classification error rate or the sum of true class probability 
in each cross validation loop reflects the stability of the model that is used as a classifier. 
Two different kinds of classification error can be derived from such a double cross 
validation scheme: the error in the inner loops, which determines the optimal values for 
the parameters and the classification error in the outer loops when using optimal 
parameter values. The inner loop classification error rate or sum of true class probability 
shows considerable dependency on the sample size of the data sets as shown in Figures 
S-3 to S-6 (Supporting Information). However class separation does not have an effect on 
inner loop classification error rates or on the sum of true class probabilities. The error in 
the outer loop averaged at 20% for data sets with large class separation (1a-c) and at 30% 
for data sets with small class separation (2a-c) independently of the applied method. The 




is due to different values for the optimal parameters determined in the inner loops 
obtained from varying training samples sets and can be assessed in a classification error 
or sum of true class probability against parameter plot. These plots indicate whether the 
minimum error, which determines the optimum parameter value, is located in a 
smooth/stable region. All plots that were used to determine the optimal parameters in 
this study are shown in s S-3 to S-6 (Supporting Information). The spread of the error 
decreases with increasing sample size showing that stability of the models increases 
with increasing sample number. The results show also that it is not justified to rely on a 
classification result from a model obtained from a training data set with only 6 samples 
per group, except in the case of the NSC algorithm. 
To assess the variability of the selected feature sets delivered by each method, 
we compared the count of features that were selected at least once across 100 repetitions 
(unique features) relative to the count of features that were selected in each repetition 
(common features) (shown in Table S-1, Supporting Information). The stability of the 
feature set for the mww-test and the t-test for data sets 1c and 2c is not available because 
only one repetition was possible in these data sets due to the lack of a double cross-
validation scheme for these methods. From this result, NSC produced the most stable 
feature set of all methods as shown by the high ratio of the number of common features 
to the number of unique features. 
 
4 CONCLUSIONS 
We have assessed different feature selection methods with respect to their 
capacity to deliver biomarker candidates from a number of well-controlled data sets that 
were obtained by LC-MS analysis of peptide-spiked human urine samples. Six widely 
used statistical methods were compared and their performance measured based on how 
well they find true positives (features that are related to the spiked peptides) and how 
well they avoid false positives (all other features) for data sets with different sample size 
and class separation. We derive five main conclusions from this study. (1) As expected, 
all methods benefit from a higher sample size. (2) Univariate methods and semi-
multivariate methods are more sensitive to class separation, while multivariate methods 
(especially PLSDA) are hardly affected by class separation. (3) SVM-RFE performed 
poorly on all data sets with respect to selecting relevant features, showing that the 
weight vector is not a suitable criterion for feature selection/elimination. (4) True 
multivariate methods like PCDA and PLSDA aim at high precision by sacrificing recall, 
i.e. they are conservative with respect to selecting true positive features. PLSDA 
performs best for data sets with low sample size. (5) The semi-multivariate NSC strikes 
the best compromise between recall and precision regardless of sample size and class 
separation. Figure 5 provides an overview over the best performing biomarker 
candidate selection statistical methods based on the f-score for data sets with different 
class separation and sample size. This figure provides a summary concerning the choice 
of a given statistical method and should help practitioners to select the most suitable 
method for biomarker discovery studies. 




Figure 5. Overview over the two best performing feature selection statistical methods for data sets 
of different sample size and class separation based on the f-score. NSC shows its superior 
performance for data sets with 6 samples independent of class separation, while univariate tests 
rank on top when sample size increases to 15 samples per class. 
 
Since biomarker discovery is usually intended to support clinical diagnosis, it 
is advantageous to obtain a discriminating feature set with a minimum number of false 
positives, and with the potential to classify new sets of samples correctly. Based on this 
criterion, PLSDA is a good choice due to its excellent precision. When additional 
discriminating features are required, for example to support pathway analysis, PLSDA 
may miss relevant features that could be informative. In this case, NSC provides a better 
compromise between recall and precision, with a higher number of true positives at a 
reasonable false positive rate. In cases where data from more samples are available 
(more than 15 samples per group/class in our case), univariate tests (t-test or mww-test 
with multiple testing correction) are able to identify biomarker candidates with high 
confidence. For classes with low sample numbers (six samples per class in our case) NSC 
has the highest potential to select biomarker candidates successfully. However our 
results show that there is a considerable danger when relying on results from data sets 
with such a small sample size, since classification models and the values for optimized 
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The development of new data analysis algorithms and the optimization of 
existing algorithms to support biomarker discovery research is a continuing challenge. It 
has to be continuously adapted  to the variety of data  produced by newly developed 
LC-MS techniques as one of the most important analytical tools for biomarker and 
biological knowledge discovery in the past decade. Improvements in data processing 
methods are crucial to strengthen a vast breakthrough in biomarker discovery research. 
This thesis presents recent supplements contributing to the continuous progress in 
achieving accurate methods and analysis for complex LC-MS data sets. A fundamental 
strategy in tackling time alignment problems raised from progressing complexity of 
research objectives and some guidelines in applying feature selection methods on low 
sample size data sets are discussed in this thesis. 
As an introduction, chapter 1 provides an overview of the main modules in 
label-free data processing pipelines including statistical analysis and validation. Here, 
the importance of the modules both as individual and as interconnected workflows is 
discussed while focusing on fundamental means of data processing and current 
challenges in biomarker discovery research using LC-MS of label free, shotgun 
proteomics data. In this chapter we showed that none of the modules in a data 
processing pipeline can be neglected. The choice and the combination of how these 
modules are connected must be adapted to the experimental and analysis design.  
Different types of LC-MS instruments generating varied data sets and different 
strategies in handling the corresponding data set are provided as additional information 
in this chapter.  
Chapters 2 and 3 provide a strategy to overcome challenges in correcting 
retention time shifts across complex LC-MS chromatograms. Many time alignment 
algorithms, that were developed in their time were able to correct time shifts across 
different LC-MS runs only by using one-dimensional data such as total ion 
chromatogram (TIC) or base peak chromatogram (BPC), but failed to fix recent 
alignment problems when data sets and chromatograms became much more complex. 
Complex data sets contain more information as they contain more noise. Time alignment 
algorithms for data sets where thousands of biological compounds elute within a close 
time range require a step forward in handling and correcting the time shifts, such as: 
filtering mass traces with low noise but high signal, and taking this mass information 
into account in the time alignment function. In chapter 2, we proved that by considering 
the two mentioned important factors, the modified algorithm (COW-CODA) was able to 
align complex data sets, whereas the original algorithm Correlation Optimized Warping 
(COW) that used TIC failed to do so.  We combined the original COW algorithm with 
the Component Detection Algorithm (CODA) to select high quality mass traces. These 
principals did not only work on COW, as shown in chapter 3, but also on other well-
known and widely used time alignment algorithms: Parametric Time Warping (PTW) 
and Dynamic Time Warping (DTW). The result of the modified algorithms (DTW-
CODA and PTW-CODA) performed strongly superior to their original. These 
modifications have improved the alignment quality of three different data sets: cancer 
serum, factorial design and urine.  We showed that it is possible to add mass 
information in the benefit function of the three afore-mentioned algorithms, which work 
on different search spaces. For some other existing time alignment algorithms, which 
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originally developed to align one-dimensional data such as TIC/BPC, considering 
separated mass traces in the warping procedure, this may not be straightforward. 
However, in developing new time alignment algorithms, this principal must be 
incorporated.  
Another aspect to consider when aligning a set of complex chromatograms is 
the choice of the reference chromatogram. In chapter 2, we proposed an approach to 
choose the best chromatograms based on the correlations between chromatograms in the 
data set. Even though the three algorithms investigated in this work are not significantly 
affected by the choice of reference chromatogram, it is certainly useful to always 
consider the reference selection prior to time alignment in various data sets using other 
time alignment algorithms. Reference selection is compulsory especially when the 
chromatograms in the data sets originate from high-variability biological samples, 
different analytical factors, different laboratories and/or instrumentation. Before the 
next data processing pipeline process can be carried out, the quality of the time 
alignment results must be checked. If present in the data set, internal standards should 
be considered as one of the validation criteria to examine the quality of individual 
algorithms. Since the internal standards are usually only a small representative of a 
complex chromatogram, or some data sets may not contain any internal standard at all, 
visualization of time alignment can be done simply by superimposing the reference 
chromatogram and sample chromatogram before and after alignment as this approach 
provides a better readout through the whole area of chromatogram. The validation of 
time alignment quality by visualization is based on a subjective judgment and requires 
more manual work. In complement, the overlapping peak area across all chromatograms 
gives a quantitative global approach to compare time alignment algorithms. 
Local/global visualization and the overlapping peak area provide a complete approach 
for validating and comparing the quality of time alignment algorithms. 
While pre-processing methods deal with signal detection to recognize 
whether a signal belongs to a compound or noise, post-processing deals with giving this 
signal a further meaning: whether or not it is related to the disease stage. Discrimination 
processes have been developed in the statistical field and/or as part of classification 
problems. While other fields, which deal with classification or discriminant analysis, 
may have sufficient sample size, data sets in clinical research often suffer from an 
extreme high-dimensionality-small-sample (HDSS) problem. In chapter 4 we present a 
comparative study of six different feature selection methods for LC-MS based 
proteomics and metabolomics biomarker discovery: t-test, Mann-Whitney-Wilcoxon-test 
(mww-test), Nearest Shrunken Centroid (NSC), linear Support Vector Machine – 
Recursive Features Elimination (SVM-RFE), Principal Component Discriminant Analysis 
(PCDA) and Partial Least Squares Discriminant Analysis (PLSDA) tested on data sets of 
urine samples that were spiked with a range of peptides at different concentration levels. 
In this chapter we investigated the behavior and performance of these methods using a 
data set with known discriminating compounds to facilitate the validation of the 
methods in selecting discriminating feature set. The statistical methods were applied to 
six data sets with different sample sizes and different class separations determined by 
the concentration level of spiked compounds. This study showed that all the methods 




though these methods are widely used for feature selection problem in proteomics and 
clinical research, not all of them gave an acceptable result when tested on the spiked 
urine data sets. Univariate t-test and mww-test gave poor and unreliable results when 
applied on data sets with six samples per group, even though these univariate tests 
outperformed other methods when fifteen samples per group were used. Surprisingly, 
linear SVM-RFE gave inadequate performance in all six different data sets by selecting 
high numbers of features not related to the spiked compounds (leading to very low 
precision).  PCDA performed rather unstable in data sets with six samples per group, 
but improved on data sets with larger sample size. Only PLSDA and NSC performed 
reasonably in the six data sets. PLSDA strikes excellent precision, while NSC provides a 
better compromise between recall and precision, with a higher number of true positives 
at a reasonable expense of false positives. In conclusion, it is worth noting that the 
results from feature selection methods require further validation when applied on data 
set with six samples per group. Therefore, one of the future works in this field should be 
dedicated to designing a strategy to validate the discriminating features in complement 
of cross-validation schemes for low sample size data sets with unknown discriminating 
compounds.  
Even though the methods developed in this thesis are intended for 
proteomics research, they can be easily adapted to metabolomics research and data sets 
analyzed by different kinds of mass-spectrometry technique (GC-MS, LC-FT-MS, etc.). 
Furthermore, newly developed or enhanced algorithms are emerging within 
bioinformatics research groups. Therefore, future work should draw attention to the 
integration and the usability of these tools for a larger community. Rapid collaboration 
between groups and laboratory leads to high analytical variability within the data set. 
The data processing has to be able to distinguish this analytical variability within 
samples analyzed under different conditions from biological variability across different 
groups. Some advanced methods may require more computing and hardware power 
that may not be supported by the computers of users. In this case, the centralization and 
accessibility of computing power should be one of the important foci in developing 
bioinformatics platform for analyzing various biological experiments from diverse 
locations.  










De ontwikkeling van nieuwe dataanalysealgoritmen en de optimalisatie van 
bestaande algoritmen om onderzoek naar het vinden van biomarkers te ondersteunen is 
een voortdurende uitdaging. Het moet continu worden aangepast aan de variëteit van 
data die worden geproduceerd door nieuw ontwikkelde LC-MS-technieken als een van 
de belangrijkste analytische middelen voor biomarker- en biologische kennis in het 
afgelopen decennium. Verbeteringen in methoden voor dataverwerking zijn van 
cruciaal belang in een grote doorbraak in onderzoek naar nieuwe biomarkers. Dit 
proefschrift presenteert recente aanvullingen die bijdragen aan de continue vooruitgang 
in het realiseren van nauwkeurige methoden en analyse voor complexe LC-MS-datasets. 
In dit proefschrift worden een fundamentele strategie voor het oplossen van 
uitlijnenproblemen die ontstaan door de toenemende complexiteit van 
onderzoeksdoelstellingen en enkele richtlijnen voor het toepassen van 
variabelenselectiemethoden voor databestanden met weinig monsters beschreven. 
Als inleiding geeft hoofdstuk 1 een overzicht van de belangrijkste modules in 
label-free dataverwerkingslijnen waaronder statistische analyse en validatie. Hier wordt 
het belang van de modules als individuele en onderling verbonden werkstromen 
besproken waarbij de aandacht uitgaat naar fundamentele manieren van 
dataverwerking en huidige problemen binnen onderzoek naar biomarkerbepaling met 
behulp van LC-MS van label-free, willekeurige proteomicsdata. In dit hoofdstuk is 
aangetoond dat geen van de modules in een dataverwerkingslijn kan worden 
genegeerd. De keus en de combinatie van hoe deze modules zijn verbonden, moeten 
worden aangepast aan het experimentele en analyseontwerp. Verschillende soorten LC-
MS-instrumenten die verschillende datasets en verschillende strategieën genereren bij 
het werken met het corresponderende data worden in dit hoofdstuk als aanvullende 
informatie gegeven. 
Hoofdstukken 2 en 3 bieden een strategie voor het oplossen van problemen 
bij het corrigeren van verblijftijdverschuivingen over complexe LC-MS-
chromatogrammen. Veel uitlijnalgoritmen die in hun eigen tijd zijn ontwikkeld, konden 
tijdverschuivingen corrigeren over verschillende LC-MS-uitvoeringen door het gebruik 
van eendimensionale data zoals Total Ion Chromatogram (TIC) of Base Peak 
Chromatogram (BPC), maar konden geen recente problemen oplossen als datasets en 
chromatogrammen veel complexer worden. Complexe datasets bevatten meer 
informatie naarmate ze meer ruis bevatten. Uitlijnalgoritmen voor datasets waar 
duizenden biologische samenstellingen binnen een korte tijd uitwassen, vereisen een 
stap voorwaarts in de aanpak en het corrigeren van tijdverschuivingen, zoals het filteren 
van massasporen met weinig ruis maar hoog signaal, en rekening houden met deze 
massa-informatie in de uitlijnen functie. In hoofdstuk 2 hebben we aangetoond dat door 
rekening te houden met de twee genoemde, belangrijke factoren, het gewijzigde 
algoritme (COW-CODA) complexe datasets aankon, terwijl het oorspronkelijke 
algoritme Correlation Optimized Warping (COW) dat gebruikmaakte van TIC dit niet 
kon. We combineerden het oorspronkelijke COW-algoritme met het Component 
Detection Algorithm (CODA) om goede massasporen te selecteren. Dit werkte niet 
alleen bij COW, zoals aangetoond in hoofdstuk 3, maar ook bij andere bekenden en 
veelgebruikte uitlijnalgoritmen: Parametric Time Warping (PTW) en Dynamic Time 
Warping (DTW). Het resultaat van de gewijzigde algoritmen (DTW-CODA en PTW-
CODA) presteerde veel beter dan hun origineel. Deze wijzigingen hebben de kwaliteit 
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van drie verschillende datasets verbeterd: serummonsters uit onderzoek naar 
baarmoederhalskanker, serummonsters uit factoriële onderzoeksopzetten en 
urinemonsters uit metabolomica-onderzoek. We hebben aangetoond dat het mogelijke is 
massa-informatie toe te voegen voor de verbeterde functie van de drie eerder genoemde 
algoritmen die op verschillende “search-space” werken. Voor bepaalde andere, 
bestaande uitlijnalgoritmen die oorspronkelijk zijn ontwikkeld voor eendimensionale 
data zoals TIC/BPC, rekening houdend met afzonderlijke massasporen binnen het 
warpingproces, kan dit gecompliceerd zijn. Maar bij de ontwikkeling van nieuwe 
uitlijnalgoritmen moet dit worden meegenomen. 
Een ander belangrijk aspect bij het uitlijnen van een reeks complexe 
chromatogrammen is de keuze van het referentiechromatogram. In hoofdstuk 2 hebben 
we een aanpak voorgesteld voor het kiezen van de beste chromatogrammen gebaseerd 
op de correlaties tussen chromatogrammen in het dataset. Hoewel de drie algoritmen 
die in zit werk zijn onderzocht niet significant worden beïnvloed door de keus van het 
referentiechromatogram, is het zeker handig de referentieselectie te overwegen voor 
uitlijnen in verschillende dataset met behulp van andere uitlijnalgoritmen. 
Referentieselectie is noodzakelijk, vooral als de chromatogrammen in de datasets van 
biologische monsters met hoge variabiliteit, verschillende analytische factoren, 
verschillende laboratoria en/of instrumentatie komen. Voordat het volgende proces 
voor dataverwerking kan worden uitgevoerd, moet de kwaliteit van de 
uitlijnentresultaten worden gecontroleerd. Indien aanwezig in het data moeten interne 
normen worden gezien als een van de validatiecriteria om de kwaliteit van individuele 
algoritme te onderzoeken. Omdat de interne normen vaak slechts een kleine 
representatie zijn van een complex chromatogram, of omdat bepaalde dataset mogelijk 
helemaal geen interne norm bevatten, is visualisering van uitlijnen mogelijk door het 
referentiechromatogram en monsterchromatogram voor en na alignment toe te voegen 
omdat dit een betere uitlezing biedt door het hele gebied van het chromatogram. De 
validatie van de kwaliteit van de uitlijnen via visualisatie is gebaseerd op een subjectieve 
beoordeling en vereist meer handmatig werk. Het overlappende piekoppervlak voor alle 
chromatogrammen geeft een kwantitatieve, algemene benadering om uitlijnalgoritmen 
te vergelijken. Lokale/algemene visualisatie en het overlappende piekoppervlak bieden 
een complete benadering voor het valideren en vergelijken van de kwaliteit van 
uitlijnalgoritmen. 
Voorverwerkingsmethoden hebben te maken met signaaldetectie om te zien 
of een signaal tot een samenstelling of ruis behoort, en bij naverwerking krijgen deze 
signalen meer betekenis: of de signalen gerelateerd zijn aan het ziekteverloop. In het 
statistische veld en/of als onderdeel van een classificatieprobleem zijn er 
discriminatieprocessen ontwikkeld. Terwijl andere velden waarin men zich bezighoudt 
met classificatie of discriminantanalyse mogelijk voldoende monsters bevatten, kampen 
datasets in klinisch onderzoek vaak met extreme problemen in “high-dimensionality-
small-sample” (HDSS; hoge dimensionaliteit en beperkte aantallen monsters). In 
hoofdstuk 4 geven we een vergelijkende studie van zes verschillende 
variabelenselectiemethoden voor op LC-MS gebaseerde proteomica en metobolomica 
biomarkeronderzoek: t-test, Mann-Whitney-Wilcoxon-test (mww-test), Nearest Shrunken 
Centroid (NSC), lineair Support Vector Machine - Recursive Features Elimination (SVM-
RFE), Principal Component Discriminant Analysis (PCDA) en Partial Least Squares 
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Discriminant Analysis (PLSDA) getest op datasets van urinemonsters met verschillende 
peptiden in verschillende concentraties. In dit hoofdstuk hebben we het gedrag en de 
prestatie van deze methoden onderzocht met behulp van een dataset met bekende 
discriminerende samenstellingen om de validatie van de methoden bij het selecteren van 
een discriminerende variabelen te vergemakkelijken. De statistische methoden werden 
toegepast op zes datasets met diverse aantallen monsters en verschillende 
klassescheidingen bepaald door het concentratieniveaus van spiked samenstellingen. Dit 
onderzoek toonde aan dat alle methoden profiteren van datasets met veel monsters, 
vijftien monsters per groep in dit onderzoek. Hoewel deze methoden algemeen worden 
gebruikt voor variabelenselectieproblemen in proteomica en klinisch onderzoek, gaven 
ze niet allemaal een acceptabel resultaat toen ze werden onderzocht op de datasets van 
spiked urine. Univariate t-test en mww-test gaven slechte en onbetrouwbare resultaten 
als ze werden toegepast op datasets met zes monsters per groep, hoewel deze univariate 
testen het beter deden dan andere methoden als er vijftien monsters per groep werden 
gebruikt. Verrassend genoeg gaf lineaire SVM-RFE ontoereikend prestatie op alle zes 
verschillende datasets door hoge aantallen kenmerken te selecteren die niet waren 
gerelateerd aan de spiked samenstellingen (wat leidde tot minimale precisie). PCDA was 
nogal instabiel in datasets met zes monsters per groep maar verbeterde zich bij meer 
monsters. Alleen PLSDA en NSC presteren redelijk binnen de zes datasets. PLSDA heeft 
uitstekende precisie, en NSC geeft een beter compromis tussen recall en precisie met een 
hoger aantal terecht positieven bij een redelijk aantal vals positieven. Concluderend kan 
worden opgemerkt dat het resultaat van variabelenselectiemethoden verdere validatie 
vergt als het wordt toegepast op datasets met zes monsters per groep. Daarom moet er 
in de toekomst in dit veld worden gewerkt aan het ontwerpen van een strategie om de 
discriminerende variabelen in aanvullende of kruisvalidatieschema voor datasets met 
weinig monsters en met onbekende discriminerende samenstellingen te valideren. 
Hoewel de methoden die in dit proefschrift zijn ontwikkeld, zijn bedoeld voor 
proteomicaonderzoek, kunnen ze eenvoudig worden aangepast aan 
metabolomicaonderzoek en datasets die worden geanalyseerd door verschillende 
soorten massaspectometrietechnieken (GC-MS, LC-FT-MS, etc.). Bovendien komen er 
nieuwe ontwikkelde of verbeterde algoritmen uit onderzoeksgroepen van de 
bioinformatica. Het werk moet dus aandacht vestigen op de integratie en de 
bruikbaarheid van deze middelen voor grotere gemeenschappen. Snelle samenwerking 
tussen groepen en laboratoria leidt tot een grote analytische variabiliteit binnen het data. 
De dataverwerking moet deze analytische variabiliteit kunnen onderscheiden binnen 
monsters die onder verschillende omstandigheden van biologische variabiliteit worden 
geanalyseerd over verschillende groepen. Bepaalde geavanceerde methoden vereisen 
misschien meer rekenkracht en hardware die mogelijk niet wordt ondersteund door de 
computers van gebruikers. In dat geval moet de centralisatie en toegankelijkheid van 
rekenkracht een van de belangrijke focuspunten zijn in de ontwikkeling van een 
bioinformaticaplatform voor het analyseren van verschillende biologische experimenten 









1 THEORY OF COW-CODA 
1.1 GLOSSARY 
Mathematical notations: 
Uppercase bold letter: matrix 
Lowercase bold letter: vector 
Italic upper and lowercase letter: constant element of matrices and vectors 
Upper case superscripts: reference to the type (sample and reference) of 
chromatogram, except for retention time vector and LC-MS data. 
 
Data transformation notation: 
* denotes interpolated data 
!s  denotes warped data 
Variables: 
N number of segment 
m length of segment 
t slack parameter 
F cumulated correlation matrix with size of (N+1)×(LR +1)  
U best position matrix with size of (N+1)×(LR +1) 
S raw data of sample chromatogram in matrix of (d × LS) 
R raw data of reference chromatogram in matrix of (d × LR) 
s original retention time vector of the sample chromatogram with size of (1 × LS) 
r original retention time vector of the reference chromatogram with size of
 (1 × LR) 
!s  warped retention time vector of the sample chromatogram with size of (1 × LS) 
LS length in number of elements of the sample retention time vector 
LR length in number of elements of the reference retention time vector 
d number of mass chromatograms 
a remainder after segmentation with length m of the sample chromatogram 
b remainder after segmentation with length m of the reference chromatogram 
si  retention times of  size (1 × m) from the vector s for a segment i 
ri  retention times of size (1 × m) from the vector r for a segment i 
Si ith segment of S based on si  with size of (d × m) 
Sij jth mass trace and ith segment of S based on si  with size of (1 × m) 
Ri ith segment of R based on ri  with size of (d × m) 
Rij jth mass trace and ith segment of R based on rn
idx  with size of (1 × m) 
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xi
R  index of segment node i in the reference chromatogram,  
xiS  initial index of segment node i in the sample chromatogram 
xiSV  allowed index of segment node i in the sample chromatogram 
IiS  set of allowed positions for segment node i of the sample chromatogram 
ki number of selected traces in segment i 
ciS  index vector where CODA is applied to sample chromatogram S for segment i 
J i  set of indices that correspond to the indices of selected mass chromatograms for 
segment i 
pij MCQ product of segment i and mass trace j 
pi MCQ product vector of segment i 
MCQ implicit form to calculate MCQ (mass chromatographic quality) value using 
CODA as explained in Windig et al.1 
































1. Windig, W.; Phalp, J. M.; Payne, A. W., A Noise and Background Reduction Method for 
Component Detection in Liquid Chromatography/Mass Spectrometry. Analytical Chemistry 
1996, 68, (20), 3602-3606. 
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1.2 Warping procedure 
1. Data characteristics. We want to align a sample chromatogram S (size of d × LS) 
with retention time vector s (size of 1 × LS) to a reference chromatogram R (size 
of d × LR) with retention time vector r (size of 1 × LR). d is the number (size) of 
m/z values. The warping procedure warps s to match reference r based on the 
best matching S to R, resulting in !s  having the same number of data points 
than s (size of 1 × LS). 
 
2. Segmentation of the reference and sample chromatograms. First, s and r are 
partitioned into segments of length m in the time dimension. We choose m in 
such a way that it divides LS and LR into the same number of segments N: 
 SL N m a= ⋅ +      (1) 
 RL N m b= ⋅ +      (2) 
where a and b are < m. 
We create a series of index vectors from si  and ri  of size (1 × m) and, using the 
index vectors, a series of segmented matrices Si and Ri with size of (d × m) 
for 0 ! i ! N " 2 . 
The last segment index vectors sN !1  and rN !1  have different lengths, since they 
take the remaining points after division of LS and LR by m, into account. The 
length of the last segment is obtained by addition of m to the differences of the 
segment length in order to assure a minimal length of m for the last segment: 
length(sN -1) = m + L
S ! N "m = m +a    (3) 
length(rN -1) = m + L
R ! N "m = m +b    (4) 
The last segment matrix SN-1 and RN-1 is obtained similarly with dimensions of 
(d ! (m+ a))  and (d ! (m+ b)) , respectively. Each segment border refers to a 
node. Since the last index of a segment equals the first index of the next 
segment, there are N+1 segment borders, or rather N+1 nodes. 
 
3. Segment node indices and allowed changes in search space for optimal time 
alignment. The index of segment nodes xiR  for chromatogram R, where 
i = 0,!,N of segment ri in chromatogram R, are calculated as: 
 xi
R = i !m +1; for i = 0,…,N "1  and xNR = LR    (5) 
Initially the segment nodes xiS of the chromatogram S are segmented similarly: 
 xi
S = i !m +1; for i = 0,…,N "1   and xNS = LS    (6) 
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Indices of segment nodes xiS  of chromatogram S are allowed to vary ( xiSV ) 
during the warping procedure in a way that the changed segment length of !si  
must be within m±t as defined by the new node indices xiSV  and xi+1SV , where t is 
the slack parameter which is given in number of points. This variation defines 
also the set of node indices, where segment shrinking and stretching are 
allowed. Besides this there are three additional constraints, which limit the 




V <! < xN !1
SV < xN
SV = LSV     (7) 
The set IiS  of possible nodes is for segment i defined in the following way. First 
define the set of lower boundaries by  
 I ilower
S = i ! (m " t );i ! (m + t )#$ %&; i =1,!,N "1 ,  (8) 
and then the set of upper boundaries by 
 I iupper
S = LS ! N ! i( ) " m + t( ); LS ! N ! i( ) " m ! t( )#$ %&; i =1,!,N !1 . (9) 
Note that the intervals will only contain integer values since the nodes can 
attain only integer values. The allowed nodes xiSV  are now provided by the 
intersection of the intervals in (9) and (10):  
xi
Sv ! I i
S = I ilower
S " I iupper
S ; i =1,!,N #1; where I 0
S ={0} and I N
S ={LS}  (10) 
Warping segment si  onto !si  such that it matches with segment ri  is finding 
the optimal nodes x0
Sv , x1
Sv ,..., xN
Sv   in formula (10) that maximize the 
cumulative benefit function f (Si
*,R i ) , in such away that the length of the 
interval [xi
SV ;xi +1
SV ] is within (m± t ). Here Si*  is obtained from and Si  with linear 
interpolation to R i , to make as many intensity points as R i . 
f (Si*,Ri )  is the value of the benefit function calculated from Si* and Ri ,  which 
is used as criterion to find the optimum pathway between the reference and 
sample chromatograms, as explain later in the coming section (formula 14). 
Appendix	  B	  
 124 
Segment-wise trace selection using CODA.  
In the COW-CODA algorithm, for each segment i, ki mass chromatograms are 
selected using CODA, with 0 ! ki ! 30  and i = 0,!N !1 . First MCQ values for 
all segments with nodes defined by equation (5) are calculated for the reference 
chromatogram. Since the segment length can vary in the sample chromatogram 
and the calculation of MCQ values for each pair of allowed segment index 
positions between each I i
S  and I i +1
S  will result in increased calculation time, 
the MCQ values for sample chromatograms are calculated in larger intervals 
than the original segment nodes as defined by equation (6) as follows: 
 ci
S = min( I iS),xi +1S + t!" #$ for i =1,!,N % 2    (11) 
and for the last segment: 
 cN !1
S = min( I N !1S ),(LS)"# $%      (12) 
The presented boundary ciS  does not cover the entire interval of segment 
indices, but was chosen after trying several combinations of intervals. 
After selection of segment nodes, MCQ values are calculated for both 
chromatograms and the product of MCQ values for each mass trace in every 
segment is determined. For a given segment: 
 pij =MCQ (Sij [ci
S]) !MCQ (R ij ) for j =1,!,d  and i = 0,!,N (13) 
For segment i mass traces corresponding to the first n highest values in pi  with 
a lower limit of 0.772 are selected Ji and further used to determine the value of 
the benefit function. Figure S-2 shows an example of a mass trace (m/z = 466) 
with an MCQ product of 0.59 demonstrating that mass traces at the lower MCQ 
limit are still of high quality.  
4.  Now define the cumulative benefit function f  in the nodes x0
Sv , x1

















& ,    (14) 





$  for segment i =0,1,2,…., N !1  given by 
















Sv , ..., xN
Sv  in (10) that maximizes the cumulative benefit 
function in (14) under the restriction that m ! t " xi +1
Sv ! xi
Sv " m + t  holds for all 
i =0,1,2,…., N !1  are the selected nodes for the time alignment. Thus the 
selected nodes are defined by 
 











Sv % I i
S &m ' t ( xi +1
Sv ' xi
Sv ( m + t ,

















Retention times of these selected nodes are adapted to match the retention time 
of the corresponding nodes xi
R . The warped retention time vector !s  is 
determined by segment wise linear interpolation to xi
R  in order to keep the 
original sampling rate of s. 
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1. Select ki traces using
coda filter.
2. Calculate correlation
for each selected mass traces
at each possible warping        
positions (2t+1).
3. Calculate the correlation
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the start position of segment i.
2. For every possible start and 
end segment position, which is 
allowed, calculate correlation 
for each selected mass traces 





3. Calculate the maximal correlation 














The possible end position    
for the end position of segment i.
vS S
+1 +1i ix ∈ I
Index vector      used to calculate to 





ρ1S Sv ,i i ix
f
⎡ ⎤∈⎣ ⎦








Figure S-1. (a) Alignment of the last segment using CODA selected mass chromatograms. R is the 
reference chromatogram and S is the sample chromatogram to be aligned. S and R (containing d 
mass chromatograms) are divided into N segments of length m. t is the slack parameter, except for 
the last segment (SN and RN), because this segment includes the remaining data points. The CODA 
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algorithm is applied to segments SN and RN, resulting in kN (where kN ≤ 30) selected mass 
chromatograms having MCQ ≥ 0.77. There are (2·t + 1) possible warping positions of segment SN, 
which can be chosen to match the starting position of RN. The correlation !
xN
Sv
 is obtained from 
!
xN
Sv , jj =1
kN
!  between allowed segment positions of sample and the corresponding segment of the 
reference chromatogram of the kN CODA selected mass traces which will be stored in matrix F. 
(b) Alignment procedure for the remaining segments. The CODA algorithm was applied to Si and 
Ri for 0 ≤ i ≤ N-1, which are the ith segments, and aligned following the (i+1)th segments. I i
S  set 
contains the possible starting node positions of segment i. I i +1
S  is the possible position of node (i+1), 
whose cumulated correlation product from the last segment to segment i were calculated. (Figure S-
2; b-2). There will be g allowed positions with length m±t between nodes (i+1) and i. (Figure S-2; b-
3). The correlation product !
xi
Sv , jj =1
ki
!  between every allowed node positions xi
SV  and xi +1
SV  is 
added to the cumulated correlation product of xi +1
SV (node i+1). For each position of node i the 
position of node i+1, which gives the maximum cumulated value, is chosen as the best warping 
position for this node i and is saved in matrix U at the location of xi
SV ,i!"
#
$ , while its cumulated 
value is saved in matrix F at the same location. The procedure starts with the last segment (see 
Figure 2a) and continues in backward direction, as described in Figure b, until reaching the first 
segment. The best warping position is then obtained from U starting from u1, 1. 
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Figure S-2. Flow-chart to chose the best and worst reference chromatogram in a given LC-MS 
dataset. The algorithm is based on correlation between the TIC reconstructed from CODA-selected 
mass chromatograms having the nth square root of the MCQ product of all (n) selected mass 
chromatograms with values above a given threshold (between 0.80 and 0.99). 
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Figure S-3. Image plot with intensity coloration of depleted and trypsin-digested serum sample (a) 
and acid-precipitated urine (b). 
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Figure S-4. Extracted ion chromatogram of internal standard peptides. (a) Dataset 1 (cervical cancer 
serum) comprised of 20 chromatograms, (b) Dataset 2 (factorial design serum) comprised of 19 
chromatograms, and (c) Dataset 3 (acid-precipitated urine) comprised of 50 chromatograms. Each 
peptide is presented before alignment (top/black), after alignment by COW-TIC (middle/blue), 
and after alignment by COW-CODA (bottom/red). These results were obtained using the worst 
references, which were chromatograms with the numbers 19, 19 and 45 for Dataset 1, 2 and 3, 
respectively. Significant misalignments are observed for Dataset 2 and 3 when using the COW-TIC 
algorithm, while COW-CODA algorithm resulted in well aligned peak clusters. 
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Figure S-5. Calculated peak area overlap for Dataset 1 (a), Dataset 2 (b), and Dataset 3 (c) with 
respect to the chosen reference chromatogram (best [red-filled circle] or worst [red-empty circle]). 
Calculated peak areas are compared within each dataset before warping (black), after warping 
using COW-TIC (bleu) and COW-CODA (red). The overlapping peak area does not change 
considerably with respect to the chosen reference chromatogram, showing that the COW-CODA 



























Figure S-6. Calculated peak area overlap for chromatograms 1 and 14 (best reference) for Dataset 2 
(factorial design) for each segment. Calculated peak areas are compared for each segment before 
warping (black), after warping using COW-TIC (blue) and COW-CODA (red). While most 
segments show that the two time alignment methods perform equally well, it is obvious that COW-
CODA is substantially superior to COW-TIC for 21, 25-27, 29-31, 33, 38. 
 



























Figure S-7. Warping function obtained with COW-TIC (blue) and COW-CODA (red) on 
chromatograms 1 and 14 from Dataset 2 (factorial design). The region between 110 and 125 min 
shows large differences between the retention time shifts made by COW-TIC and COW-CODA. The 
better performance of the COW-CODA algorithm in this region is also observed in Figure S-6. 
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Figure S-8. Plots of MCQ values against chromatograms with the highest correlation (blue) and the 
lowest correlation (red) for Dataset 1 (a), Dataset 2 (b) and Dataset 3 (c). The x-axis represents the 
MCQ value and the number of selected traces to construct the CODA-TIC. A chromatogram is 
selected as the best or the worst reference if it has the highest or lowest correlation in the majority of 
the cases. Chromatogram 2 was selected as the best and chromatogram 19 as the worst reference for 
Dataset 1 (a). Chromatogram 14 was selected as the best and chromatogram 19 as the worst 
reference for Dataset 2 (b). Chromatogram 25 was selected as the best and chromatogram 45 as the 
worst reference for Dataset 3 (c). 
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Figure S-9. Selected ion chromatograms of peaks of 3 chromatograms obtained from the TRANCHE 
database, “Pepper, a platform for experimental Proteomic Patter Recognition: Peak lists in mzxml 
format” project and acquired using a ThermoFinnigan LTQ FT instrument. The upper black traces 
show the original retention time, the lower traces (red) were obtained after applying COW-CODA. 
 













Figure S-10. Example of selected mass traces at the lowest threshold (MCQ product of 0.59) for the 
reference (chromatogram 25, black) and a sample chromatogram (chromatogram 1; blue: before 
alignment; red: after alignment with COW-CODA) from the urine dataset for segment 32. 
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Figure S-11. Example of the warping procedure showing the diamond structure of the F and U 
matrices (green box with broken line) for m = 10, t = 3, and N = 5. Interval I i
S  = [8;14] shows the 
possible positions of node x1, and interval I 3












































































binned data at m/z 677
binned data at m/z 678























































































































































































Figure S-1. Raw centroided ion trap single stage LC-MS image of depleted, trypsin-digested human 
serum obtained after binning (summing up intensity across 1 amu intervals having borders of 
0.5 m/z for each integer m/z value) (a) and after applying a two-dimensional Gaussian filter using 
the same data reduction in the m/z dimension as for binning (b). Binning results in noisy data, 
which lead to a higher accumulated error in the score of the benefit function of the time alignment 
algorithms, in contrast to smoother data obtained with Gaussian smoothing. The contribution of 
this noise to the benefit function is shown in panel (c) representing part of an LC-MS image 
highlighting a peak using the extracted ion chromatogram, where the highest intensity of the peak 
in centroid data fluctuates between the border of the bins. Binned data will result in random 
fluctuations, which will be different for each chromatogram, and will lead to a lower correlation 
and a higher error in the benefit function of the time alignment algorithms. 
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(a) (b)
 
Figure S-2. Two-dimensional image view of the overlaid raw data in a section of the label-free 
single stage LC-MS analysis of two urine samples (5082628 and 5082602) before alignment (a) and 
after applying DTW-CODA (b) for m/z between 80-620 amu and the retention time between 42-
92 min. The intensity of the reference chromatogram image is colored between red and black from 
high to low values, the sample chromatogram image is colored between green and black from high 
to low values. The overlay of the two chromatogram is transparent, which results in a yellow color 
if a pixel has the same intensity in the two chromatograms providing an image similar to two-
dimensional fluorescence difference gel electrophoresis. Common peaks are superimposed after 
warping (indicated in yellow), while orphan peaks remain red and green. 
 
 


























Figure S-3. Sum of squared intensity differences using all points in single-stage LC-MS images 
between the reference chromatogram and a sample chromatogram aligned using different numbers 
of high quality LCODA-selected mass traces using the PTW-CODA algorithm. The minimum sum 
of squared intensity differences is reached at around 200 selected mass traces in 9 pairs of 
chromatograms randomly selected from the urine dataset. 
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Figure S-4. Extracted ion chromatograms of spiked internal standard peptides, which are present in 
all trypsin-digested serum samples (cervical cancer data set, 20 chromatograms). Each column 
corresponds to one standard peptide and each row corresponds to a different time alignment 
algorithm with the following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, 
PTW-TIC, PTW-CODA, COW-TIC and COW-CODA. The original dataset is in black, the DTW 
based algorithms are in green, PTW based algorithm in blue and COW based algorithms are in red. 
All time alignments were obtained with respect to the best reference chromatogram. All time 
alignment algorithms, except for DTW-TIC, are able to correct retention time shifts observed in the 
original dataset. Major misalignments and peak distortions are observed for all spiked standard 
peptides using DTW-TIC. 
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Figure S-5. Extracted ion chromatograms of spiked internal standard peptides, which are present in 
all serum samples of factorial design data set (19 chromatograms). Each column corresponds to one 
standard peptide and each row corresponds to a different time alignment algorithm with the 
following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, PTW-TIC, PTW-
CODA, COW-TIC and COW-CODA. The EIC’s of corresponding mass traces in the original dataset 
are in black, the DTW based algorithms are in green, PTW based algorithm in blue and COW based 
algorithms are in red. All time alignments were obtained with respect to the best reference 
chromatogram. Major peak distortions and misalignments are observed for all peptides using the 
alignment with DTW-TIC. Two peptides are misaligned using COW-TIC and PTW-TIC. 
Improvements in the time alignment are clearly visible using algorithms combined with CODA- or 
LCODA-selected mass traces. The most striking differences in the time alignment performance can 
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Figure S-6. Extracted ion chromatograms of spiked internal standard peptides, which are present in 
all acid-precipitated urine samples (urine data set, 50 chromatograms). Each column corresponds to 
one standard peptide and each row corresponds to the different time alignment algorithm with the 
following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, PTW-TIC, PTW-
CODA, COW-TIC and COW-CODA. The EIC’s of corresponding mass traces in the original dataset 
are in black, the DTW based algorithms are in green, PTW based algorithm are in blue and COW 
based algorithms are in red. All time alignments were obtained with respect to the best reference 
chromatogram. Major misalignments are observed for all peptides using the alignment with COW-
TIC, PTW-TIC, and DTW-TIC. Significant improvements in time alignment of standard added 
peptides were observed for all algorithms combined with CODA- or LCODA-selected mass traces. 
However some misalignments of the peptide GYPPT (the forth column) can still be observed even 
after alignment with PTW-CODA and DTW-CODA. Slight peak distortion can be observed for this 
peptide after alignment with DTW-CODA. 
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Figure S-7. Extracted ion chromatograms of spiked internal standard peptides, which are present in 
all trypsin-digested serum samples (cervical cancer data set, 20 chromatograms). Each column 
corresponds to one standard peptide and each row corresponds to a different time alignment 
algorithm with the following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, 
PTW-TIC, PTW-CODA, COW-TIC and COW-CODA. The EIC’s of corresponding mass traces in the 
original dataset are in black, the DTW based algorithms are in green, PTW based algorithm are in 
blue and COW based algorithms are in red. All time alignments were obtained with respect to the 
worst reference chromatogram. Major misalignments are observed for all peptides using DTW-TIC 
and misalignment for two peptides is visible in EIC obtained using PTW-TIC. COW-TIC, COW-
CODA, PTW-CODA and DTW-CODA show improved time alignment for all peptides compared to 
the original data. 
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Figure S-8. Extracted ion chromatograms of spiked internal standard peptides, which are present in 
all serum samples of factorial design data set (19 chromatograms). Each column corresponds to one 
standard peptide and each row corresponds to a different time alignment algorithm with the 
following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, PTW-TIC, PTW-
CODA, COW-TIC and COW-CODA. The EIC’s of corresponding mass traces in the original dataset 
are in black, the DTW based algorithms are in green, PTW based algorithm are in blue and COW 
based algorithms are in red. All time alignments were obtained with respect to the worst reference 
chromatogram. Major misalignments are observed for all peptides using DTW-TIC, which also 
results in considerable peak distortions. Misalignment for three peptides is visible in EIC obtained 
using PTW-TIC and COW-TIC. COW-CODA, PTW-CODA and DTW-CODA show improved time 
alignment for all peptides compared to the original data, although DTW-CODA still shows minor 
peak distortion (right column, peptide R/IPIEDGSGEVVLSR/K). 
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Figure S-9. Extracted ion chromatograms of spiked standard peptides, which are present in all acid-
precipitated urine samples (urine data set, 50 chromatograms). Each column corresponds to one 
standard peptide and each row corresponds to a different time alignment algorithm with the 
following order from top to bottom: original dataset, DTW-TIC, DTW-CODA, PTW-TIC, PTW-
CODA, COW-TIC and COW-CODA. The EIC’s of corresponding mass traces in the original dataset 
are in black, the DTW based algorithms are in green, PTW based algorithm are in blue and COW 
based algorithms are in red. All time alignments were obtained with respect to the worst reference 
chromatogram. Major misalignments are observed for all peptides using DTW-TIC with 
considerable peak distortions. Misalignment for all peptides is visible in EIC obtained using PTW-
TIC and COW-TIC. COW-CODA, PTW-CODA and DTW-CODA show improved time alignment 
for all peptides compared to the original data except for the GYYPT (right column). This peptide is 
one of the first eluting peaks, and has a low number of neighbor peaks in other mass traces with 








































































































































Figure S-10. Sum of overlapping peak areas of all chromatogram pairs using the worst reference 
chromatogram after applying M-N rules as peak filter to the cervical cancer (a), factorial design (b), 
and urine (c) data sets. The original chromatograms before alignment (black) are compared to the 
chromatograms obtained after alignment with COW (red), PTW (blue) and DTW (green) using TICs 
(dashed lines, empty circles) or CODA-/LCODA-selected mass traces (full lines, full circles). The 
chromatogram names corresponding to the chromatogram indices in the figures are reported in 
Supporting information (Table S2, S3, S4). 
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Cervical Cancer 17060511 2006052 
Factorial Design 16090537 16090542 
Acid-Precipitated 
Urine 05082628 05090150 
Table S-1. File name of the chromatograms selected as the best and the 










1 17060510 11 1706052 
2 17060511 12 1706053 
3 17060512 13 1706054 
4 17060513 14 1706055 
5 17060514 15 1706056 
6 17060515 16 1706057 
7 17060516 17 1706059 
8 17060517 18 2006051 
9 17060518 19 2006052 
10 17060521 20 2006053 










1 16090524 11 16090534 
2 16090525 12 16090535 
3 16090526 13 16090536 
4 16090527 14 16090537 
5 16090528 15 16090538 
6 16090529 16 16090539 
7 16090530 17 16090540 
8 16090531 18 16090541 
9 16090532 19 16090542 
10 16090533   





















1 5082602 26 5082629 
2 5082603 27 5082630 
3 5082604 28 5090131 
4 5082605 29 5090132 
5 5082606 30 5090133 
6 5082607 31 5090135 
7 5082608 32 5090136 
8 5082609 33 5090137 
9 5082610 34 5090138 
10 5082611 35 5090139 
11 5082613 36 5090140 
12 5082614 37 5090141 
13 5082615 38 5090142 
14 5082616 39 5090143 
15 5082617 40 5090144 
16 5082618 41 5090146 
17 5082619 42 5090147 
18 5082620 43 5090148 
19 5082621 44 5090149 
20 5082622 45 5090150 
21 5082624 46 5090151 
22 5082625 47 5090152 
23 5082626 48 5090153 
24 5082627 49 5090154 
25 5082628 50 5090155 












1 SAMPLE  PREPARATION 
 
LC-MS data acquisition 
Sample preparation was performed as previously described 1. The amount of 
urine injected into the LC-MS system was normalized to 50 nmol of creatinine. The 
study protocol was in agreement with local ethical standards and the Helsinki 
declaration of 1964, as revised in 2004. 
 
Preparation of spiked urine samples 
600 µL carbonic anhydrase (CA) solution of 22 mg/mL dissolved in 50 
mmol/L NH4HCO3 buffer at pH 7.8 were divided into 6 equal aliquots. Ten µL of 100 
mM DTT were added to each aliquot and the solution was incubated at 50°C for 30 min 
followed by addition of 40 µL of 137.5 mM iodoacetamide and incubation at room 
temperature for another 60 min. Reduced and alkylated CA was digested by adding 40 
µL of 0.5 µg/µL trypsin and subsequent incubation at 37°C over night. The reaction was 
stopped by addition of 10 µL pure formic acid (FA). The excess of DTT and 
iodoacetamide was removed by solid-phase extraction using a 100 mg Strata C-18 SPE 
column with the following protocol: the column was conditioned with 2 mL methanol, 
followed by one washing step with 2 mL water. Each aliquot of digested CA was loaded 
on the SPE column and the column was subsequently washed with 2 mL of 5% aq. 
methanol. Peptides were eluted with 1 mL of 80% aq. methanol. The eluate was dried in 
a vacuum centrifuge and re-dissolved in 200 µL 30% acetonitrile (ACN) and 1% FA. 
Finally 500 µL of digested CA were mixed with 200 µL of a stock solution of the 
synthetic peptides resulting in a standard mixture stock solution with a calculated 
digested CA concentration of 240 µM and the following concentrations (in µM) for the 7 
synthetic peptides: VYV, 83; YGGFL, 57; DRVYIHPF, 29; YPFPGPI, 46; YPFPG, 60; 
GYYPT, 54; and YGGWL, 57. 
 
Reversed-Phase LC-MS 
All LC MS analyses were performed on an 1100 series capillary HPLC 
system equipped with a cooled autosampler (4°C) and an SL ion trap mass spectrometer 
(Agilent Technologies, Santa Clara, CA, United States). Samples were desalted on an 
Atlantis dC18 precolumn (Waters Corporation, Milford, MA, USA, 2.1 × 20 mm, 3 µm 
particles, 10 nm pores) using 0.1% FA in 5% ACN at a flow rate of 50 µL/min for 16 min. 
Compounds were back-flushed from the precolumn onto a temperature-controlled 
(25°C) Atlantis dC18 analytical column (1.0 × 150 mm, 3 µm particles, 30 nm pores) and 
separated over 90 min at a flow rate of 50 µL/min during which the percentage of 
solvent B (0.1% FA in ACN) in solvent A (0.1% FA in ultrapure H2O) was increased from 
5.0 to 43.6% (eluent gradient of 0.43%/min). Settings of the electrospray ionization 
interface and the mass spectrometer were as follows: nebulization gas, 40.0 psi N2; 
drying gas, 6.0 L/min N2; capillary temperature, 325°C; capillary voltage, 3250 V; 
skimmer voltage, 25 V; capillary exit voltage, 90 V; octapole 1 voltage, 8.5 V; octapole 2 
voltage, 4.0 V; octapole RF voltage, 175 V; lens 1 voltage, −5 V; lens 2 voltage, −64.6 V; 
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trap drive, 67; scan speed, 5500 m/z s-1; accumulation time 50 ms (or 30 000 ions); scan 
range, 100−1500 m/z; a Gaussian smoothing filter (width 0.15 m/z) was applied for each 
mass spectrum; rolling average was disabled, resulting in a rate of approximately 70 
mass spectra per minute. Spectra were saved in profile mode. 
Following the gradient, both columns were washed with 85% B for 5 min and 
equilibrated with 5% B for 10 min prior to the next injection. Different volumes of the 
standard mixture (CA digest plus peptides) were injected on the pre-column prior to 
injection of the pooled urine sample to obtain the desired final concentrations. The 
injection system was cleaned with 70% ACN after each injection and filled with 0.1% FA 
in 5% ACN. Mass spectrometry settings were optimized for detection of singly- and 
doubly-charged ions of DRVYIHPF without provoking upfront fragmentation. Raw data 
converted to mzXML format are available at http://tinyurl.com/statisticsComparison. 
After the LC-MS analysis, the raw LC-MS profile data was exported in mzXML format 
using CompassExport v1.3.6. 
 
1. Kemperman, R. F., Horvatovich, P. L., Hoekman, B., Reijmers, T. H., Muskiet, F. A., and 
Bischoff, R. (2007) Comparative urine analysis by liquid chromatography-mass 
spectrometry and multivariate statistics: method development, evaluation, and application 




2 FIGURES AND TABLES 
 
Figure S-1. Double cross validation scheme for a Support Vector Machine combined with Recursive 
Feature Elimination (SVM-FRE). The optimal number of features is obtained in the inner loops. The 
optimum model is then tested against the test data in the outer loop to obtain the overall 
classification error. 




Figure S-2. Double cross validation scheme for PCDA and PLSDA. The optimal number of PC/PLS 
components is obtained in the inner loops. In the outer loop, the optimal number of features is 
determined by calculating the classification error for each ranked feature set. Once the optimal 
number of PC/PLS components and the optimal number of features has been obtained, a single 
cross validation scheme is performed to determine the optimal feature set. The optimum model is 





Figure S-3. Error plots of the PCDA model based on 100 repetitions of the double cross validation 
scheme on data set 1a (a), data set 1b (c), data set 1c (e), data set 2a (b), data set 2b (d), and data set 
2c (f) (see Table 1 for details about the data sets). The error plots show a decreasing variability with 
increasing sample size per class. 




Figure S-4. Error Plot of the SVM-RFE model based on 100 repetitions of the double cross validation 
scheme on data set 1a (a), data set 1b (c), data set 1c (e), data set 2a (b), data set 2b (d), and data set 





Figure S-5. Probability plot of the NSC model based on 100 repetitions of the double cross 
validation scheme on data set 1a (a), data set 1b (c), data set 1c (e), data set 2a (b), data set 2b (d), 
and data set 2c (f) (see Table 1 for details about the data sets). The probability plots show a 
decreasing variability with increasing sample size per class. 





Figure S-6. Error plot of the PLSDA model based on 100 repetitions of the double cross validation 
scheme on data set 1a (a), data set 1b (c), data set 1c (e), data set 2a (b), data set 2b (d), and data set 





Methods: mw-test  Methods: PCDA 
















1a 0 0 0 0  1a 51 0 28748 0 
1b 96 13 366 24  1b 134 0 857 0 
1c 108 108 274 274  1c 12 1 14 1 
2a 0 0 0 0  2a 151 0 29043 0 
2b 22 2 34 3  2b 89 0 394 0 
2c 41 41 52 52  2c 72 0 142 0 
Methods: t-test  Methods: PLSDA 
















1a 1 0 22 0  1a 22 2 49 2 
1b 101 18 348 23  1b 77 2 425 2 
1c 90 90 168 168  1c 60 2 221 2 
2a 1 0 17 0  2a 46 2 1298 2 
2b 7 0 17 0  2b 51 2 2044 2 
2c 39 39 46 46  2c 7 2 12 2 


















1a 141 1 3352 1  1a 89 0 8428 2 
1b 87 47 143 53  1b 75 0 6356 70 
1c 59 55 69 65  1c 32 1 3236 84 
2a 137 6 10262 6  2a 116 0 10756 4 
2b 49 25 82 25  2b 53 0 4331 7 
2c 42 36 47 38  2c 37 0 2976 33 
 
Table S-1. Overview of the performance of different methods based on the ratio between unique 
true positives (Unique TP; selected at least once) and common true positives (Common TP; selected 
each time). The stability of the delivered feature set can be seen by comparing the number of unique 
features to the number of common features selected across each of the 100 repetitions (except for the 
mww-test and the t-test on data sets 1c and 2c, where repetitions were not possible, since all samples 
were used). Unique True Positive (Unique-TP) is a spiked-peptide-related feature that is selected at 
least once in 100 repetitions. Common True Positive (Common TP) a spiked-peptide-related feature 
that is always selected in each repetition. Unique Positive (Unique-P) is any feature that is included 
in a selected feature set at least once in 100 repetitions. Common Positive (Common P) is any 
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